Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
| þ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2006
OR
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE TRANSITION PERIOD FROM TO
Commission File Number 000-27701
HEALTHSTREAM, INC.
(Exact name of registrant as specified in its charter)
| Tennessee | 62-1443555 | |
| (State or other jurisdiction of | (I.R.S. Employer Identification No.) | |
| incorporation or organization) | ||
| 209 10th Avenue South, Suite 450 | 37203 | |
| Nashville, Tennessee | (Zip Code) | |
| (Address of principal executive offices) |
(615) 301-3100
(Registrant’s telephone number, including area code)
(Registrant’s telephone number, including area code)
Securities Registered Pursuant To Section 12(b) Of The Act:
| Title of each class | Name of each Exchange on which registered | |
| Common Stock, No Par Value | NASDAQ Global Stock Market |
Securities Registered Pursuant To Section 12(g) Of The Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule
405 of the Securities Act. Yes o No þ
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 of
15(d) of the Act. Yes o No þ
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is
not contained herein, and will not be contained, to the best of registrant’s knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K. o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in
Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o Accelerated filer o Non-accelerated filer þ
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Act). Yes o No þ
The aggregate market value of the Common Stock issued and outstanding and held by non-affiliates of
the Registrant, based upon the closing sales price for the Common Stock on the NASDAQ National
Market on June 30, 2006 was $60,129,214. All executive officers and directors of the registrant
have been deemed, solely for the purpose of the foregoing calculation, to be “affiliates” of the
registrant.
As of March 26, 2007, there were 22,182,056 shares of the Registrant’s common stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the Registrant’s definitive Proxy Statement for its 2007 Annual Meeting of Shareholders
are incorporated by reference into Part III hereof.
HEALTHSTREAM, INC.
TABLE OF CONTENTS
ANNUAL REPORT ON FORM 10-K
ANNUAL REPORT ON FORM 10-K
Table of Contents
PART I
This Annual Report contains forward-looking statements within the meaning of Section 21E of the
Securities Exchange Act of 1934. Such forward-looking statements include, among others, those
statements including the words “expects,” “anticipates,” “intends,” “believes,” “may,” “will,”
“should,” “continue” and similar language or the negative of such terms or other comparable
terminology. Although we believe that the expectations reflected in the forward-looking statements
are reasonable, HealthStream’s actual results may differ significantly from those projected in the
forward-looking statements. Factors that might cause or contribute to such differences include, but
are not limited to, those discussed in the section “Risk Factors” and elsewhere in this document.
In addition, factors that we are not currently aware of could harm our future operating results.
You should carefully review the risks described in other documents HealthStream files from time to
time with the Securities and Exchange Commission. You are cautioned not to place undue reliance on
forward-looking statements, which speak only as of the date of this Annual Report on Form 10-K.
HealthStream undertakes no obligation to publicly release any revisions to the forward-looking
statements or reflect events or circumstances after the date of this document.
Item 1. Business
OVERVIEW AND HISTORY
HealthStream, Inc. (“HealthStream” or the “Company”) provides Internet-based learning and research
solutions to meet the training, information, and education needs of the healthcare industry. Our
learning products are used by healthcare organizations to meet a broad range of their training and
assessment needs, while our research products provide our customers information about patients’
experiences, workforce challenges, physician relations, and community perceptions of their
services. HealthStream’s customers are healthcare organizations (HCO) and pharmaceutical and
medical device companies (PMD) and include over 1,400 healthcare organizations (predominately
acute-care facilities) throughout the United States and some of the top medical device and
pharmaceutical companies.
The
Company’s flagship learning product is the “HealthStream
Learning
Center®” (HLC),
our proprietary, Internet-based learning platform, which at December 31, 2006 had approximately
1,452,000 contracted hospital-based subscribers. We deliver educational and training courseware to
our customers through the HLC platform. Our research products were added as a result of our
acquisition of Data Management & Research, Inc. (DMR) in March 2005, which expanded our service
offering to include quality and satisfaction surveys, data analyses of survey results, and other
research-based measurement tools focused on physicians, patients, employees, and members of the
community.
Services provided to and on behalf of pharmaceutical and medical device companies are focused on
the development and delivery of education initiatives to reach hospital-based healthcare
professionals, including physicians, and industry sales representatives. Our products and services
include live and online education and training activities as well as Internet-based medical device
training within hospitals through our HospitalDirect® platform. Pharmaceutical and
medical device companies provide commercial support for some of our continuing education
activities.
Headquartered in Nashville, Tennessee, the Company was incorporated in 1990 and began marketing its
Internet-based solutions in March 1999. Including satellite offices in Denver, Colorado and
Franklin, Tennessee, HealthStream had approximately 160 employees as of December 31, 2006. From an
initial focus on technology-based training, HealthStream has evolved to provide full-service
delivery of training, information and education to healthcare organizations. The Company completed
its initial public offering (IPO) in April of 2000.
RECENT DEVELOPMENTS
On March 12, 2007, the Company acquired all of the issued and outstanding common stock of The
Jackson Organization, Research Consultants, Inc. (“TJO”) for approximately $12.6 million,
consisting of approximately $11.6 million payable in cash and 252,616 shares of HealthStream common
stock. Approximately $5.0 million of the cash consideration is being held in escrow and will be
released upon the occurrence of future events. All of the common stock shares are held in an escrow
account until eighteen months after March 12, 2007, and are subject to any claims for
indemnification pursuant to the stock purchase agreement. The Company expects direct, incremental
expenses associated with the acquisition of TJO will approximate $0.7 million. TJO provides
healthcare organizations with quality and satisfaction surveys, data analyses of survey results,
and other research-based measurement tools. TJO is based in Laurel, Maryland and employs
approximately 200 full time and part time employees.
1
Table of Contents
INDUSTRY BACKGROUND
According to the deputy director of the National Health Statistics Group at the Centers for
Medicare and Medicaid Services (CMS), spending in the healthcare industry reached approximately
$2.0 trillion in 2005, or 16.0 percent of the gross domestic product. Hospital care expenditures
accounted for nearly 31 percent of the $2.0 trillion industry. Approximately 10.4 million
professionals are employed in the healthcare segment of the domestic economy, with more than 5.0
million employed in hospitals, our target market for the HealthStream Learning Center,
HealthStreamDirect™, and HealthStream’s survey and research products.
The five million hospital-based healthcare professionals that work in the nation’s approximately
5,000 acute-care hospitals are each required by federal mandates and accrediting bodies to complete
training in a number of areas. This training includes safety training mandated by both the
Occupational Safety and Health Administration (OSHA) and the Joint Commission on Accreditation of
Healthcare Organizations (JCAHO), as well as training on patient information confidentiality
required under the Health Insurance Portability and Accountability Act (HIPAA).
In hospitals, staffing issues and personnel shortages have also contributed to the need for
enhanced workforce development as well as additional competency based training. The American
College of Healthcare Executives reported in October 2004 that 72% of hospital CEO’s were
experiencing nursing shortages at their facilities. According to U.S. Bureau of Labor Statistics
(February 2004) Monthly Labor Review, more than one million new and replacement nurses will be
needed by 2012. For the first time, the U.S. Department of Labor has identified Registered Nursing
as the top occupation in terms of job growth through the year 2012. We believe that offering
training and education for hospital personnel is increasingly being utilized as a retention and
recruitment incentive.
Many healthcare professionals use continuing education to keep abreast of the latest developments
and meet licensing, certification, and credentialing requirements. Continuing education
requirements include continuing education for nurses, emergency medical services personnel, first
responder personnel, radiologic personnel and physicians. Pharmaceutical and medical device
companies must also provide their medical industry sales representatives with training mandated for
the healthcare industry and training for new products. They also provide support for education and
training for those audiences that use their products in healthcare organizations.
A large portion of the nation’s hospitals utilize research and survey tools to gain valuable
insight about patients’ experiences, to assess workforce competency and engagement, determine the
status of physician relations and measure the perceptions about the hospitals’ in the communities
they serve. Industry-wide, interest is increasing in research, due, in part, to the
CAHPS® (Consumer Assessment of Health Plan Survey) Hospital Survey launched by CMS in
partnership with the Agency for Healthcare Research and Quality (AHRQ). According to the Deficit
Reduction Act of 2005, hospitals must now submit data for all required quality measures — which
includes the CAHPS® Hospital Survey — in order to receive the full market basket
increase to their reimbursement payment rates from CMS. Hospitals that fail to submit this survey
data, beginning in July 2007, will incur a reduction of two percentage points in payment rates in
2008. Through both DMR and TJO, we have been designated as a certified vendor, and will continue to
offer CAHPS® Hospital Survey services.
Finally, the hospital industry continues to operate under intense pressure to reduce costs as a
result of reductions in government reimbursement rates and increased focus on cost containment
consistent with participation of patients in managed care programs. In addition, hospitals, as well
as pharmaceutical and medical device companies, continue to experience rising operating costs,
coupled with increased pressure to measure and report on the outcomes of the dollars spent on
training. Our products and services are designed to meet these needs by reducing healthcare
organizations’ costs of training while improving learning outcomes, enhancing reporting
capabilities, and supporting customers’ business objectives.
HEALTHSTREAM’S SOLUTIONS
Services to healthcare organizations
HealthStream’s solutions help healthcare organizations meet their ongoing training, education,
information, and compliance needs. We bring training and education content together with
administrative and management tools through our Internet-based platforms, the HealthStream Learning
Center® and a more streamlined version, HealthStream Express™. This combination
supports healthcare administrators in configuring training to meet the precise needs of different
groups of employees, modifying training materials, and documenting that training has been
completed. At December 31, 2006, 1,452,000 healthcare professionals had contracted subscriptions
for our services. Pricing for the HLC is subscription based, with fees based on the number of
subscribers, courseware provided and other factors. We offer training, implementation, and account
management services to facilitate adoption of our platform. Fees for training are based on the
time and efforts of the personnel involved.
Our platform and our courseware are hosted in a central data center that allows subscribers
Internet access to our services, thereby eliminating the need for onsite local implementations of
installed learning management products. A significant number of our customers that historically
used our installed learning management products have transitioned to our Internet-based platform.
Although we no longer sell our installed learning management products, we continue to maintain a
legacy installed product and we provide certain customers ongoing maintenance and support, product
updates, and have developed technology to provide them with additional courseware access
2
Table of Contents
capabilities. Our installed learning management software contracts historically consisted of an
upfront license fee, additional courseware
sales, and ongoing maintenance and support.
We began offering our research and survey products as a result of our acquisition of DMR, which
occurred on March 28, 2005. On March 12, 2007, we acquired TJO, expanding both our customer base
and product strengths. The addition of the research businesses supplemented our existing product
and service offerings to include physician, patient, community, and employee satisfaction surveys,
data analyses of survey results, and other research-based measurement tools. These acquisitions
expanded our product offerings to support our healthcare organization customers in their efforts to
transform insight into action as they measure and benchmark key data points for their
constituencies and then incorporate the results into training and improvement through our learning
products. As a result of these acquisitions we maintain offices in Franklin, Tennessee and Laurel,
Maryland.
Along with the Internet-based HLC, we also offer healthcare organizations full-service capabilities
to convert existing course material, self-author new materials through our Authoring Center
product, and electively share these materials with other HealthStream customers through a
courseware exchange. We also offer Authoring Pro, an upgraded product which includes an industry
leading image library, owned by A.D.A.M., Inc., as an additional subscription to this product.
Pricing for these products is subscription based, with fees based on the number of subscribers and
level of penetration of services, with a separate fee for development licenses.
We are currently developing an updated product that will allow us to offer our customers tools to
assess competency and performance. Competency assessment is a requirement of hospitals and
healthcare organizations for maintaining accreditation, based on JCAHO requirements to evaluate,
document, and report performance competencies. We anticipate that our new product will provide an
effective means of determining which competencies are associated with each position and evaluating
and documenting competency assessments. This new product is also intended to facilitate the
development of a custom training program of courses available through the HLC that uniquely
responds to the needs identified for each employee.
Our strategy is to continue to grow our customer base of approximately 1,452,000 contracted
subscribers using the Internet-based HLC, as well as expanding penetration of additional tools and
content across our customer base. We will continue to expand our offering of research and
information tools that are aligned with healthcare quality initiatives and continuous improvement
efforts. We continue to transition our installed learning management product customers to our
Internet-based HLC platform; however historical transitions have resulted in a smaller installed
product customer base. We believe our sales force and market conditions offer us the opportunity to
continue to grow our hospital-based customer base.
Services to pharmaceutical and medical device companies
Our services to pharmaceutical companies and medical device companies are focused on development,
management, and distribution of education activities for three audiences: provider-based healthcare
professionals, physicians, and the companies’ own sales representatives. We develop, manage and
distribute live, online and print education and training activities for provider-based healthcare
professionals and physicians, as well as online education and training activities for sales
representatives. Certain of the education activities we develop and distribute provide continuing
education credit for learners completing them. Live education and training activities include live
single or multi-day workshops, preceptorships and proctorships, and activities presented in
hospitals by clinical representatives. Online education and training activities include courseware
containing video, animations and simulations and live web meetings. Print education and training
activities include study guides. All of these activities are supported by either pharmaceutical or
medical device companies.
Pricing for all services is based on the scope of the activity, and is attributed to several
categories of services including: activity design and development, accreditation, marketing,
faculty and meeting coordination, maintenance and distribution, project management, and replication
and fulfillment. Not all categories of services apply to all activities. The most significant
exceptions to this pricing approach are distribution and management fees which are based on the
number of facilities or users reached and fees for certain courseware for sales representatives,
which is priced on a per user basis. Fees for non-accredited activities are paid by pharmaceutical
and medical device companies as ordinary service fees. Fees for accredited activities are paid in
the form of unrestricted educational grants.
Our services for pharmaceutical and medical device companies are coordinated by our project
management and clinical education personnel. We employ a team of project managers and clinical
education managers and outsource most other services to third-party individuals and companies. The
most significant exceptions to our outsourcing approach are the distribution and management of
activities, particularly online activities that take advantage of our learning management platform
and customer network. Project managers control all aspects of the development of activities and
manage third-party resources used on their projects. Clinical education managers control all
aspects of the content of accredited activities.
Our strategy includes expanding our revenues by further developing customer relationships and by
leveraging our existing base of Internet-based HLC customers for deployment of pharmaceutical and
medical device training and education through both existing products as well as development of new
products. We seek to grow our pharmaceutical and medical device business, but will focus on
transitioning many of our service offerings to Internet-based products and reducing our focus on
project-based development services.
3
Table of Contents
BUSINESS COMBINATIONS
We acquired TJO on March 12, 2007. For additional information regarding this acquisition, please
refer to the Company’s Current Report on Form 8-K, as filed by the Company with the Securities and
Exchange Commission on March 13, 2007.
We acquired DMR in March 2005. For additional information regarding this acquisition, please see
Note 2 of the Consolidated Financial Statements and Item 7, “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” included elsewhere in this report.
CUSTOMERS
We provide our training, information and education solutions to customers across a broad range of
entities within the healthcare industry, including healthcare organizations (including government
entities) and pharmaceutical and medical device companies. We derived approximately 11% and 14% of
net revenue from HCA, Inc. during 2006 and 2005, respectively. During both 2006 and 2005, no other
customers represented more than 10% of our net revenue. The following is a partial list of
customers that have purchased or contracted for products and services from HealthStream.
| Healthcare Organizations | Pharmaceutical and Medical Device Companies | ||
HCA, Inc.
|
Zimmer Holdings, Inc. | ||
Tenet Healthcare Corporation |
Smith & Nephew, Inc. | ||
Community Health Systems, Inc. |
Baxter Healthcare Corporation | ||
Lifepoint Hospitals, Inc. |
|||
Ardent Health Services, LLC |
|||
Health Management Associates, Inc. |
SALES, MARKETING, AND CUSTOMER SUPPORT
We market our products and services primarily through our direct sales force and our account
relationship managers. As of December 31, 2006, our sales and relationship management personnel
consisted of approximately 39 employees based at our corporate headquarters in Nashville, Tennessee
and in our satellite offices located in Franklin, Tennessee and Denver, Colorado, as well as remote
home office sales locations. Our geographically dispersed field sales organization is divided into
teams focused on our hospital audience and our pharmaceutical and medical device audience. In
addition to sales professionals, we also employ strategic account personnel that manage our largest
customer relationships as well as account relationship managers who work to develop and expand
relationships, including contract renewals, with our hospital customers.
We conduct a variety of marketing programs to promote our products and services, including product
catalogs, user groups and trade shows, online promotion and demonstrations, telemarketing
campaigns, public relations, distribution of product specific literature, direct mail and
advertising. Annually, we host a national users’ group in Nashville known as “The Summit.” We have
an in-house marketing team that is responsible for these initiatives and for working with, and
supporting, our product managers and sales force. We also have an in-house research team focused on
ensuring that our sales professionals have appropriate market and target information.
We believe our ability to establish and maintain long-term customer relationships, adoption of our
products and services and recurring sales are dependent on the strength of our customer service,
operations, training, and support team. As of December 31, 2006, our customer service, operations,
training, and support team consisted of approximately 41 employees located in our corporate
headquarters in Nashville as well as our Franklin, Tennessee office. This team provides customer
support to end users through a toll-free telephone line as well as electronic mail. Our
representatives are trained to understand our philosophy, our products and services, and our
specific sales, marketing and support issues. This team also maintains an ongoing dialog with our
customer base to ensure a complete understanding of customer needs. These personnel also assist
with ongoing issues and training associated with our products as well as to ensure anticipated
renewals and incremental sales are achieved. The remaining personnel on this team are responsible
for training, implementation and support of HLC, HealthStream Express, our survey business, and
installed learning management customers.
TECHNOLOGY MANAGEMENT
Our services are designed to be secure, reliable, and expandable. Our software is a combination of
proprietary and commercially-available software and operating systems. This combination of software
supports acquisition and conversion of content, hosting and management of that content, publication
of our Web sites, downloads of courseware, registration, tracking of users, and reporting of
information for both internal and external use. We designed our services to allow each component to
be independently scaled by adding commercially-available hardware and a combination of
commercially-available and proprietary software components.
Our network infrastructure, Web sites, and servers that deliver most of our services are hosted by
third party providers. Our primary data center and hosting facility is in Chicago, while a second
data center and hosting facility is located in Nashville (with a separate vendor). Our second
hosting facility has been utilized to support product and platform testing by customers, but we
continue to work to configure
4
Table of Contents
this location as a backup facility. Both providers maintain our equipment in a secure environment,
including multiple redundancies in power sources and network connections. Our providers’ hosting
centers are connected to the Internet through multiple, redundant high-speed fiber optic circuits.
Our survey products are hosted on servers located at our Franklin, Tennessee and Laurel, Maryland
offices. Company personnel monitor all servers, networks, and systems on a continuous basis.
Together with our providers, we employ several levels of enterprise firewall systems to protect our
databases, customer information, and courseware library. Backups of customer data are performed on
a daily basis. Data is secured at a remote location on a weekly basis.
COMPETITION
The healthcare education industry is highly fragmented, varies significantly in delivery methods
(i.e., written materials, live events, satellite broadcasts, video, CD-ROM products and online
products), and is composed of a wide variety of entities competing for customers. The sheer volume
of healthcare information available to satisfy continuing education needs, rapid advances in
medical developments, and the time constraints that healthcare professionals face make it difficult
to quickly and efficiently access the continuing education content most relevant to an individual’s
practice or profession. Historically, healthcare professionals have received continuing education
and training through offline publications, such as medical journals and CD-ROMs, and by attending
conferences and seminars. In addition, other healthcare workers and pharmaceutical and medical
device manufacturers’ sales and internal regulatory personnel usually fulfill their education and
training needs through instructor-led programs from external vendors or internal training
departments. While these approaches satisfy the ongoing education and training requirements, they
are typically costly and inconvenient. In addition, live courses are often limited in the breadth
of offerings and do not provide a method for tracking training completion. The related results of
these traditional methods, both from a business and compliance standpoint, are difficult to track
and measure.
In addition to the competing delivery methods described above, we also have direct competitors. A
number of companies offer competitive installed and Web based learning management products to the
healthcare industry. We also compete with learning management system providers such as SABA and
SumTotal Systems that provide their services to multiple industries, including healthcare. We also
compete with large medical publishers that have operating units that offer learning management
systems that focus on healthcare, including Thomson Delmar Net Learning and Reed Elsevier MC
Strategies. In the survey business, we see competition from Press Ganey, National Research
Corporation, and Gallup. Finally, recently we have also seen an increase in a teaming approach
between consulting and technology entities to address larger scale projects.
We believe our solutions, which include both products and services that facilitate training for
healthcare professionals, a wide assortment of courseware, a mechanism for measuring satisfaction
or other results, and the ability to provide all our services on a single platform over the
Internet, provide us with a competitive advantage. We believe that the principal competitive
factors affecting the marketing of information, training and development services to the healthcare
industry include:
| • | features of the HLC product, including reporting, management functionality, ability to manage a variety of events or modalities, courseware assignment, scalability, and the ability to track utilization and results; | ||
| • | scope and variety of Internet-based learning courseware available, including mandated content for OSHA, JCAHO, patient safety, and HIPAA requirements, competency-based content, as well as the ability of our customers to create and host their own Web-enabled courseware; | ||
| • | scope and quality of professional services offered, including survey execution, implementation, benchmarking, training and the expertise and technical knowledge of the customers’ employees; | ||
| • | competitive pricing, which supports a return on investment when compared to other alternative delivery methods; | ||
| • | customer service and support; | ||
| • | effectiveness of sales and marketing efforts; and | ||
| • | company reputation. |
Collectively, we believe these capabilities provide us with the ability to improve the quality of
healthcare by improving the quality and accessibility of healthcare training.
5
Table of Contents
GOVERNMENT REGULATION OF THE INTERNET AND THE HEALTHCARE INDUSTRY
The Internet
The laws and regulations that govern our business change rapidly. The United States government and
the governments of some states and foreign countries have attempted to regulate activities on the
Internet. The following are some of the evolving areas of law that are relevant to our business:
| • | Privacy Law. Current and proposed federal, state and foreign privacy regulations and other laws restricting the collection, use, confidentiality and disclosure of personal information could limit our ability to collect information or use the information in our databases or derived from other sources, to generate revenues. It may be costly to implement security or other measures designed to comply with any new legislation. | ||
| • | Encryption Laws. Many copyright owner associations have lobbied the federal government for laws requiring copyrighted materials transmitted over the Internet to be digitally encrypted in order to track rights and prevent unauthorized use of copyrighted materials. If these laws are adopted, we may incur substantial costs to comply with these requirements or change the way we do business. | ||
| • | Content Regulation. Both foreign and domestic governments have adopted and proposed laws governing the content of material transmitted over the Internet. These include laws relating to obscenity, indecency, libel and defamation. We could be liable if content delivered by us violates these regulations. | ||
| • | Information Security Accountability Regulation. At least six bills are pending in Congress that could require public companies to obtain certification by an independent third party of the company’s computer information security. In addition, California has enacted legislation requiring disclosure of security breaches involving personal information, and legislation has been proposed in at least fifteen other states. If this legislation is enacted, we may incur costs to comply with these security requirements. The preliminary nature of such legislation and the lack of related guidance make estimation of related costs difficult. If the Company is required to make a public announcement regarding a breach of security, it could have a negative impact on our business. | ||
| • | Sales and Use Tax. Through December 31, 2006, we collected sales, use or other taxes on taxable transactions in all states in which we have employees or have a significant level of sales activity. While HealthStream expects that this approach is appropriate, other states or foreign jurisdictions may seek to impose tax collection obligations on companies like us that engage in online commerce. If they do, these obligations could limit the growth of electronic commerce in general and limit our ability to profit from the sale of our services over the Internet. |
Laws and regulations directly applicable to e-commerce and Internet communications are becoming
more prevalent. Congress continues considering laws regarding Internet taxation. The dynamic nature
of this regulatory environment increases the uncertainty regarding the marketplace impact of such
regulation. The enactment of any additional laws or regulations may increase our cost of conducting
business or otherwise harm our business, financial condition and operating results.
Regulation of Education, Training and Other Services for Healthcare Professionals
Allied Disciplines. Various allied health professionals are required to obtain continuing education
to maintain their licenses. For example, emergency medical services personnel may be required to
acquire up to 20 continuing education hours per year. These requirements vary by state and depend
on the classification of the employee.
Occupational Safety and Health Administration (OSHA). OSHA regulations require employers to provide
training to employees to minimize the risk of injury from various potential workplace hazards.
Employers in the healthcare industry are required to provide training with respect to various
topics, including blood borne pathogens exposure control, laboratory safety and tuberculosis
infection control. OSHA regulations require employers to keep records of their employees’
completion of training with respect to these workplace hazards.
Joint Commission on Accreditation of Healthcare Organizations (JCAHO). JCAHO mandates that
employers in the healthcare industry provide certain workplace safety and patient interaction
training to employees. JCAHO required training may include programs on infection control, patient
bill of rights, radiation safety and incident reporting. Healthcare organizations are required to
provide and document training on these topics to receive JCAHO accreditation. In addition, JCAHO
imposes continuing education requirements on physicians that relate to each physician’s specific
staff appointments.
Health Insurance Portability and Accountability Act (HIPAA). HIPAA regulations require certain
organizations, including most healthcare providers and health plans, to adopt safeguards regarding
the use and disclosure of health-related information. HIPAA regulations also require organizations
that maintain or transmit health information electronically in connection with certain transactions
to provide reasonable and appropriate safeguards to protect the privacy, integrity and
confidentiality of individually identifiable healthcare
6
Table of Contents
information. These healthcare organizations are required to establish, maintain and provide
training with regard to their policies and procedures for protecting the integrity and
confidentiality of individually identifiable healthcare information. Healthcare organizations are
required to document training on these topics to support their compliance.
Continuing Nursing Education (CNE). State nurse practice laws are usually the source of authority
for establishing the state board of nursing requirements. The state board of nursing establishes
the state’s CNE requirements for professional nurses. CNE credits are provided through accredited
providers that have been approved by the American Nurses Credentialing Center (ANCC) Commission on
Accreditation and/or the state board of nursing. CNE requirements vary widely from state to state.
Thirty-one states require registered nurses to certify that they have accumulated a minimum number
of CNE credits in order to maintain their licenses. In some states, the CNE requirement only
applies to re-licensure of advance practice nurses, or additional CNEs may be required of this
category of nurses. Required CNE ranges from 12 to 50 credits annually, with reporting generally on
a bi-annual basis. Board certifications (e.g., CNOR — certification of perioperative nursing) also
require CNE credits, with certain percentages required in specific categories based on the
certification type. We are an accredited provider of CNE by the ANCC.
Other Continuing Education. We are also an accredited provider of continuing education and
continuing pharmacy education by the Association of Surgical Technologists, Inc. (AST) and the
Accreditation Council for Pharmacy Education (ACPE), respectively.
Continuing Medical Education (CME). State licensing boards, professional organizations and
employers require physicians to certify that they have accumulated a minimum number of continuing
medical education hours to maintain their licenses. Generally, each state’s medical practice laws
authorize the state’s board of medicine to establish and track CME requirements. Thirty-six state
medical licensing boards currently have CME requirements. The number of CME hours required by each
state ranges from 12 to 50 hours per year. Other sources of CME requirements are state medical
societies and practice specialty boards. The failure to obtain the requisite amount and type of CME
could result in non-renewal of the physician’s license to practice medicine and/or membership in a
medical or practice specialty society. The American Medical Association’s (AMA), Physician
Recognition Award certificate, (PRA), is widely accepted by multiple entities as proof of
participation in CME. The AMA classifies continuing medical education activities as either category
1, which includes formal CME activities, or category 2, which includes most informal activities.
Sponsors want to designate CME activities for AMA PRA category 1 because this has become the
benchmark for quality in formally organized educational activities. Most agencies nationwide that
require CME participation specify AMA PRA category 1 credit. Only institutions and organizations
accredited to provide CME can designate an activity for AMA PRA category 1. The Accreditation
Council for Continuing Medical Education (ACCME), is responsible for awarding accreditation status
to state medical societies, medical schools and other institutions and organizations that provide
CME activities for a national audience of physicians. Only institutions and organizations are
accredited. The ACCME and state medical societies do not accredit or approve individual activities.
State medical societies, operating under the aegis of the ACCME, accredit institutions and
organizations that provide CME activities primarily for physicians within the state or bordering
states. We are an accredited provider of CME by the ACCME.
Consumer Assessment of Healthcare Providers and Systems (CAHPS). The Centers for Medicare and
Medicaid Services (CMS) have partnered with the Agency for Healthcare Research and Quality (AHRQ)
to develop a standardized survey instrument and data collection methodology for measuring patients’
perspectives on hospital care. The intent of the survey is to produce comparable data on the
patients’ perspective to allow consumer-based comparisons between hospitals, align incentives to
drive hospitals to improve their quality of care, and increase the transparency of hospital
reporting. According to the Deficit Reduction Act of 2005, hospitals must now submit data for all
required quality measures — which includes the
CAHPS® Hospital Survey — in order to
receive the full market basket increase to their reimbursement payment rates from CMS. While
hospital participation is voluntary, hospitals that fail to submit this survey data, beginning in
July 2007, will incur a reduction of 2.0 percentage points in payment rates in 2008. Through both
DMR and TJO, we have received certified vendor designation, and will continue to offer
CAHPS® Hospital Survey services.
Office of the Inspector General (OIG) of the Department of Health and Human Services (HHS)
The OIG issued Compliance Program Guidance for Pharmaceutical Manufacturers in April 2003 and
issued Compliance Program Guidance for the Durable Medical Equipment, Prosthetics, Orthotics, and
Supply Industry in July 1999 (collectively, the Guidelines). This document includes guidelines
related to continuing educational activities supported by pharmaceutical and medical device
companies. The Guidelines could affect the type and extent of future support for our continuing
education activities. The trade associations for the pharmaceutical and medical device industries
(PhRMA and AdvaMed, respectively) have also promulgated their own codes of ethics. The AMA has
established its own code of ethics regarding Gifts to Physician from Industry to provide standards
of conduct for the medical profession. The Company follows the rules and guidelines provided by
ACCME, ANCC, and other continuing education accrediting bodies to ensure that its continuing
education programming is free from commercial bias and consistent with the Guidelines.
During 2006, both the ANCC and ACPE adopted ACCME Standards of Commercial Support. Because of the
adoption of the ACCME Standards, rules governing the individuals that may deliver educational
activities (including clinical education activities and live events) and the location of
educational activities at live events are more restricted. Further, ACCME, ANCC, and ACPE are
currently collaborating to develop a Unified Self Study Report. This will allow an organization
that has been awarded an accreditation
7
Table of Contents
status or is seeking accreditation status with all three accrediting bodies the ability to complete
one self study application and process. We believe this will also streamline the reaccreditation
timeline for accredited organizations. Until this Unified Report is completed, we will not be able
to analyze the Report’s impact on our accredited education activities.
The U.S. Food and Drug Administration and the Federal Trade Commission
Current FDA and FTC rules and enforcement actions and regulatory policies or those that the FDA or
the FTC may develop in the future could have a material adverse effect on our ability to provide
existing or future applications or services to our end users or obtain the necessary corporate
sponsorship to do so. The FDA and the FTC regulate the form, content and dissemination of labeling,
advertising and promotional materials, including direct-to-consumer prescription drug and medical
device advertising, prepared by, or for, pharmaceutical, biotechnology or medical device companies.
The FTC regulates over-the-counter drug advertising and, in some cases, medical device advertising.
Generally, regulated companies must limit their advertising and promotional materials to
discussions of the FDA-approved claims and, in limited circumstances, to a limited number of claims
not approved by the FDA. Therefore, any information that promotes the use of pharmaceutical or
medical device products that is presented with our services is subject to the full array of the FDA
and FTC requirements and enforcement actions. We believe that banner advertisements, sponsorship
links and any educational programs that lack independent editorial control that we may present with
our services could be subject to FDA or FTC regulation. While the FDA and the FTC place the
principal burden of compliance with advertising and promotional regulations on the advertiser, if
the FDA or FTC finds that any regulated information presented with our services violates FDA or FTC
regulations, they may take regulatory action against us or the advertiser or sponsor of that
information. In 1996, the FDA announced it would develop a guidance document expressing a broad set
of policies dealing with the promotion of pharmaceutical, biotechnology and medical device products
on the Internet. The FDA has yet to issue that guidance document, and it is not clear when such
document may be released. The FDA guidance document may reflect new regulatory policies that more
tightly regulate the format and content of promotional information on the Internet.
Other Government Regulations
The U.S. Securities and Exchange Commission (the SEC) chartered the Advisory Committee on Smaller
Public Companies (the Committee) on March 23, 2005. The charter directed the Committee to assess
the current regulatory system for smaller public companies, including the impact of the
Sarbanes-Oxley Act of 2002, and make recommendations for change. Currently, our compliance with
Section 404 of the Sarbanes-Oxley Act has been deferred to calendar year 2007. During April 2006,
the Committee issued its final report to the SEC, which included a recommendation to establish a
system of scaled securities regulations for smaller public companies. The Committee also made
specific recommendations with regard to the external audit requirement under Section 404 of the
Sarbanes-Oxley Act. The compliance environment in which we operate continues to evolve. The Company
continues to monitor the resolution of this issue to ensure that we appropriately allocate our
resources to maintain compliance with all applicable regulations.
INTELLECTUAL PROPERTY AND OTHER PROPRIETARY RIGHTS
To protect our proprietary rights, we rely generally on copyright, trademark and trade secret laws,
confidentiality agreements and procedures with employees, consultants and other third parties,
license agreements with consultants, vendors and customers, and by controlling access to our
software, documentation and other proprietary information. We own Federal trademark and service
mark registrations for the marks “HEALTHSTREAM”, “HOSPITAL DIRECT”, “OR PROTOCOL”, “QUALITY CHECK”,
and “RESULTS! On-demand survey analysis.”
We obtain the courseware that we license to our customers through a combination of license
agreements with publishers or authors, assignments and work-for-hire arrangements with third
parties, and development by employees. We require publishers, authors and other third parties to
represent and warrant that their content does not infringe on or misappropriate any third-party
intellectual property rights, that they have the right to provide their content and have obtained
all third-party consents necessary to do so. Our publishers, authors and other third parties also
agree to indemnify us against liability we might sustain due to the content they provide.
If a third party asserts a claim that we have infringed their patents or other intellectual
property, we may be required to redesign our products or enter into royalty or licensing
agreements. In addition, we license technologies from third parties for incorporation into our
services. Royalty and licensing agreements with these third parties may not be available on terms
acceptable to us, if at all. Additionally, the steps we have taken to protect our intellectual
property rights may not be adequate. Third parties may infringe or misappropriate our proprietary
rights. Competitors may also independently develop technologies that are substantially equivalent
or superior to the technologies we employ in our services. If we fail to protect our proprietary
rights adequately, our competitors could offer similar services, potentially significantly harming
our competitive position and decreasing our revenues.
8
Table of Contents
AVAILABLE INFORMATION
The Company files reports with the SEC, including annual reports on Form 10-K, quarterly reports on
Form 10-Q and other reports from time to time. The public may read and copy any materials we file
with the SEC at the SEC’s Public Reference Room at 450 Fifth Street, NW, Washington, DC 20549. The
public may obtain information on the operation of the Public Reference Room by calling the SEC at
1-800-SEC-0330. The Company is an electronic filer and the SEC maintains an Internet site at
http://www.sec.gov that contains the reports, proxy and information statements, and other
information filed electronically. Our website address is www.healthstream.com. Please note that our
website address is provided as an inactive textual reference only. We make available free of charge
through our website, the annual report on Form 10-K, quarterly reports on Form 10-Q, current
reports on Form 8-K, and all amendments to those reports as soon as reasonably practicable after
such material is electronically filed with or furnished to the SEC. The information provided on our
website is not part of this report, and is therefore not incorporated by reference unless such
information is otherwise specifically referenced elsewhere in this report.
OUR EMPLOYEES
As of December 31, 2006, we employed approximately 160 persons. Our success will depend in large
part upon our ability to attract and retain qualified employees. We face competition in this regard
from other companies, but we believe that we maintain good relations with our employees. We are not
subject to any collective bargaining agreements.
EXECUTIVE OFFICERS OF THE REGISTRANT
The following is a brief summary of the business experience of each of the executive officers of
the Company. Officers of the Company are elected by the Board of Directors and serve at the
pleasure of the Board of Directors. The following table sets forth certain information regarding
the executive officers of the Company:
| Name | Age | Position | ||||
Robert A. Frist, Jr.
|
39 | Chief Executive Officer, President and Chairman of the Board of Directors | ||||
Arthur E. Newman
|
58 | Executive Vice President, Compliance Officer | ||||
Susan A. Brownie
|
42 | Senior Vice President and Chief Financial Officer, Corporate Secretary | ||||
J. Edward Pearson
|
44 | Senior Vice President | ||||
Kevin P. O’Hara
|
37 | Senior Vice President and General Counsel | ||||
Robert A. Frist, Jr., one of our co-founders, has served as our chief executive officer and
chairman of the board of directors since 1990 and president since 2001. Mr. Frist graduated with a
Bachelor of Science in business with concentrations in finance, economics and marketing from
Trinity University.
Arthur E. Newman was promoted to executive vice president effective in March 2006. Mr. Newman
previously served as our chief financial officer and senior vice president since joining the
Company in January 2000. Mr. Newman also serves as our compliance officer. From April 1990 to
August 1999, Mr. Newman served as executive vice president overseeing finance, human resources,
information systems and customer service and fulfillment for Lippincott, Williams and Wilkins,
formerly Waverly, Inc., a publicly traded medical sciences publisher. From August 1999 to January
2000, Mr. Newman served as the chief technology officer for Wolters Kluwer’s scientific, technical
and medical companies consisting of five separate units. Mr. Newman holds a Bachelor of Science in
chemistry from the University of Miami and a Masters of Business Administration from Rutgers
University.
Susan A. Brownie was promoted to chief financial officer effective in March 2006 and was promoted
to senior vice president in January 2005. Ms. Brownie previously served as our vice president of
finance and corporate controller since joining us in November 1999. Ms. Brownie also serves as our
corporate secretary. Ms. Brownie serves on the board of directors of Levy’s Inc., a clothing
retailer. She holds a Bachelor of Business Administration from the College of William and Mary and
is a certified public accountant.
J. Edward Pearson joined the company in June 2006 as senior vice president, responsible for our
survey and research business. Effective with the acquisition of TJO on March 12, 2007, Mr. Pearson
was named president of the newly formed HealthStream Research™ group. From
2002 to June 2003, Mr. Pearson served as CEO for Medibuy, an internet-based healthcare
exchange and supply chain efficiency solutions provider. From June 2003 to June 2006, he served as
president and chief executive officer of DigiScript, an Internet-based training and communication
solutions provider for the life sciences industry. He earned a Bachelor of Science in accounting
from Middle Tennessee State University.
Kevin P. O’Hara was promoted to senior vice president and general counsel in February 2007. Mr.
O’Hara was promoted to vice president in 2005, and has served in various roles since joining us in
January 2002. Mr. O’Hara served as vice president of operations and development at
smallbusiness.com from 2000 to 2001. He practiced as an attorney with Bass, Berry, & Sims LLC in
Nashville, Tennessee from 1996 to 2000, with a specialty in technology, electronic commerce, and
healthcare. He earned a Bachelor of Arts degree and a J.D. from Vanderbilt University.
9
Table of Contents
Item 1A. Risk Factors
We believe that the risks and uncertainties described below and elsewhere in this document are the
principal material risks facing the Company as of the date of this report. In the future, we may
become subject to additional risks that are not currently known to us. Our business, financial
condition or results of operations could be materially adversely affected by any of the following
risks and by any unknown risks. The trading price of our common stock could decline due to any of
the following risks or any unknown risks.
Risks related to our business model.
We may be unable to effectively implement our growth strategy which could have an adverse effect on
our business and competitive position in the industry.
Our business strategy includes increasing our market share and presence through sales to new
customers, transitioning existing customers, further penetration and additional sales to existing
customers and introductions of new products and services. Some of the risks that we may encounter
in implementing our growth strategy include:
| • | expenses, delays and difficulties of identifying and integrating new products or services into our existing organization; | ||
| • | inability to leverage our operational and financial systems sufficient to support our growth; | ||
| • | inability to generate sufficient revenue from new products to offset investment costs; and | ||
| • | inability to effectively identify, manage and exploit existing and emerging market opportunities. |
If any of these risks are realized, our business could suffer.
We may be unable to effectively identify, complete or integrate the
operations of TJO and future
acquisitions.
As part of our growth strategy, we are actively reviewing possible acquisitions that complement or
enhance our business. We may not be able to identify, complete or integrate the operations of
future acquisitions, including the integration of our recent acquisition of TJO. In addition, if we
finance acquisitions by issuing equity securities, our existing shareholders may be diluted which
could affect the market price of our stock. As a result, if we fail to properly evaluate and
execute acquisitions and investments, our business prospects may be seriously harmed. Some of the
risks that we may encounter in implementing our acquisition strategy include:
| • | expenses, delays or difficulties of identifying and integrating acquired companies into our organization; | ||
| • | inability to retain personnel associated with acquisitions; | ||
| • | diversion of management’s attention from daily operations; and | ||
| • | inability to generate sufficient revenues from acquisitions to offset acquisition costs. |
Certain revenue components are subject to significant fluctuations.
As revenues from our subscription business continue to increase, a larger portion of our revenues
will be predictable; however, quarterly performance may be more subject to fluctuations associated
with our project based products and services, which generally relates to healthcare organization
customers who use our survey and research services as well as our pharmaceutical and medical device
customers. Our survey and research services are typically contracted by healthcare organizations
for multi-year terms, but the frequency and timing of survey cycles can vary from quarter to
quarter. The pharmaceutical and medical device business is generally associated with recurring
customer relationships; however services are generally specific and relate to product launches or
training events that may vary from year to year. The magnitude of such contracts may vary widely.
Our sales cycle is lengthy and can vary widely.
The period from our initial contact with a potential customer and the first purchase of our
solution by the customer typically ranges from three to nine months, and in some cases has extended
much further. The range in the sales cycle can be impacted by factors including an increasing trend
towards more formal requests for proposals (RFP’s) process, and more competition within our
industry, as well as formal budget timelines which impact timing of purchases by target customers.
As a result of these factors, we have only limited ability to forecast the timing and type of
initial sales. This, in turn, makes it more difficult to predict quarterly financial performance.
10
Table of Contents
We may not be able to maintain our competitive position against current and potential competitors,
especially those with significantly greater financial, technical, marketing, and other resources.
Several of our competitors have longer operating histories and significantly greater financial,
technical, marketing, and other resources than we do. We encounter direct competition from both
large and small e-learning companies focused on training and continuing education in the healthcare
industry. We also face competition from larger survey and research companies. We believe we
maintain a competitive advantage against our competitors with the comprehensive array of products
and services we offer. If our competitors were to offer a complete e-learning solution to the
healthcare industry, our competitive position could be adversely affected. These companies may be
able to respond more quickly than we are to new or changing opportunities, technologies, standards
or customer requirements. Further, most of our customer agreements are for shorter terms ranging
from one to three years, with no obligation to renew. The short terms of these agreements allow
customers to more easily shift to one of our competitors.
Growth in courseware subscription revenues depend, in part, on our obtaining proper distribution
rights from our content partners.
Most of our agreements with content providers are for initial terms of two to three years. The
content partners may choose not to renew their agreements with us or may terminate the agreements
early if we do not fulfill our contractual obligations. If a significant number of our content
providers terminate or fail to renew their agreements with us on acceptable terms, it could result
in a reduction in the number of courses we are able to distribute and decreased revenues. Most of
our agreements with our content partners are also non-exclusive, and our competitors also offer, or
could offer, training and continuing education content that is similar to or the same as ours. If
publishers and authors, including our current content partners, offer information to users or our
competitors on more favorable terms than those offered to us or increase our license fees, our
competitive position and our profit margins and prospects could be harmed. In addition, the failure
by our content partners to deliver high-quality content and to revise their content in response to
user demand and evolving healthcare advances and trends could result in user dissatisfaction and
inhibit our ability to attract and retain subscribers of our courseware offerings.
We may not be able to develop enhancements to our existing products and services or achieve
widespread acceptance of new features or keep pace with technological developments.
Our revenue growth is expected to be generated through sales to new customers as well as increasing
sales of additional courseware subscriptions and other products and services to existing customers.
Our identification of additional features, content, products and services may not result in timely
development of complementary products. In addition, the success of certain new products and
services may be dependent on continued growth in our base of Internet-based customers or adoption
of new methodology by new customers. Because healthcare training continues to change and evolve, we
may be unable to accurately predict and develop features, content and other products to address the
needs of the healthcare industry. If new products, features, or content are not accepted by new or
existing customers, we may not be able to recover the cost of this development and our business
will be harmed. Continued growth of our Internet-based customer population is dependent on our
ability to continue to provide relevant products and services in a timely manner. The success of
our business will depend on our ability to continue providing our products and services as well as
enhancing our courseware, product and service offerings that address the needs of healthcare
organizations.
Within the healthcare industry, our customer channels are focused on two segments: healthcare
organizations and pharmaceutical/ medical device companies. We rely on spending within these two
segments and our business may suffer if financial pressures cause our potential or existing
customers to cut back on our services.
There are several economic factors that have had an impact on the nation’s approximately 5,000
acute care hospitals. Some of these factors include labor costs, which as recently as 2002
constituted 40 percent of 2002 hospital revenues, according to the Centers for Medicare and
Medicaid (CMS), with half of that allocated for staffing nurses. Also, the reduced Medicare payment
increases that resulted from the Balanced Budget Act of 1997 and the lower payments that most
hospitals accepted from managed care companies in the last several years have both had an adverse
financial effect on the hospital segment. These financial pressures, along with several major
hospital defaults and bankruptcies, have resulted in limited access to capital for some hospitals.
As HealthStream’s target market within the healthcare industry, hospitals’ financial pressures are
salient in achieving our business objectives.
Financial analysts generally believe that medical device companies enjoy higher revenues and
earnings growth, relative to their medical supply company counterparts, although they’re considered
more volatile. The medical device industry is highly concentrated; the largest two percent of the
6,000 U.S. medical device firms account for nearly half of the industry’s sales, according to the
CMS. In addition, relatively short product life cycles for medical devices make the management and
marketing strategies particularly crucial in this segment. These economic factors contribute to the
volatility of this customer channel for HealthStream.
11
Table of Contents
The top ten pharmaceutical companies account for 60 percent of U.S. drug sales, with the top
company owning a ten percent market share of the U.S. pharmaceutical market in 2001, according to
CMS. Successful research and development is the key driver for long-term growth, yet this may be
held constant or reduced during profit crunches—like that experienced by some companies as the
patent expires on their blockbuster drugs. Both branded and generic pharmaceutical companies
fiercely litigate intellectually property and, as a result, may experience adverse financial
consequences. Over the past few years, pharmaceutical companies experienced a significant increase
in public scrutiny with respect to product development, testing and introductions in certain
specific treatment areas. Continued restrictions or further extending the testing and product
launch cycle could have a negative impact on our sales to and revenues from pharmaceutical
companies. As one of our two customer channels, these characteristics of the pharmaceutical and
medical device segment could have an impact on HealthStream.
Our product and service offerings include third party technology, the loss of which could
materially harm our business. Errors in third party software or our inability to license this
software in the future could increase our costs and decrease our revenues.
We use some licensed third party technology components in our products. Future licenses to this
technology may not be available to us on commercially reasonable terms, or at all. The loss of or
inability to obtain or maintain any of these technology licenses could result in delays in the
introduction of new products or could force us to discontinue offering portions of our learning
management solutions until equivalent technology, if available, is identified, licensed and
integrated. The operation of our products would be impaired if errors occur in the third party
software that we incorporate, and we may incur additional costs to repair or replace the defective
software. It may be difficult for us to correct any errors in third party software because the
software is not within our control. Accordingly, our revenue could decrease and our costs could
increase in the event of any errors in this technology. Furthermore, we may become subject to legal
claims related to licensed technology based on product liability, infringement of intellectual
property or other legal theories.
Financial Risks
A significant portion of our revenue is generated from a relatively small number of customers.
We provide our Internet-based training and education services and our survey and research services
to HCA, Inc. (HCA) under separate agreements. During 2006, we derived approximately 11%, or $3.5
million, of our net revenues from HCA. Our agreement with HCA for our Internet-based training and
education services was renewed for a four year term effective October 1, 2006, and includes the
option for HCA to renew for an additional year. Our survey and research services agreement with HCA
expires in December 2007. We also derive a significant portion of our revenues from a relatively
small number of other customers. A termination of our agreements with HCA or several of our other
significant customers or a failure by HCA or other significant customers to renew their contracts
on favorable terms, or at all, would have a material adverse effect on our business.
A significant portion of our business is subject to renewal each year, therefore, renewals have a
more significant impact on our revenue and operating results.
For the year ended December 31, 2006, approximately 59 percent of our net revenues were derived
from our Internet-based subscription products. Our Internet-based HLC customers have no obligation
to renew their subscriptions for our products or services after the expiration of the initial
subscription period, and in fact, some customers have elected not to renew their subscription. In
addition, our customers may renew at a lower pricing or activity level. During the year ended
December 31, 2006, we renewed 90% of the annual contract value up for renewal and 96% of the
subscribers which were up for renewal. Because a significant portion of our customer contracts have
only renewed one time, we do not have sufficient historical data to accurately predict future
customer renewal rates. Our customers’ renewal rates may decline or fluctuate as a result of a
number of factors, including their dissatisfaction with our service. If we are unable to renew a
substantial portion of the contracts that are up for renewal or maintain our pricing, our revenues
could be adversely affected, which would have a material adverse affect on our results of
operations and financial position. Contracts for our survey and research services typically range
from one to three years in length, and customers are not obligated to renew their contract with us
after their contract expires. In addition, much of our live event activity is of a recurring and
somewhat predictable nature; however, we do not have any long term contracts that obligate these
customers beyond their current contract terms. If our customers do not renew their arrangements for
our services, or if their activity levels decline, our revenue may decline and our business will
suffer.
Our future success also depends in part on our ability to sell additional features or enhanced
offerings of our services to our current customers. This may require increasingly sophisticated and
costly sales efforts that require targeting, contact with, or approval by our customer’s senior
management. If these efforts are not successful, our business may suffer.
12
Table of Contents
The timing of our revenue recognition from sales activity is dependent upon achievement of certain
events or performance milestones, and our inability to accurately predict them will harm our
operating results.
Our ability to record revenues is dependent upon several factors including the transfer of
customer-specific information such as unique subscriber IDs, which are required for us to implement
customers on our Internet-based learning platform. Accordingly, if customers do not provide us with
the specified information in a timely manner, our ability to recognize revenues will be delayed,
which could adversely impact our operating results. In addition, completion and acceptance by our
customers of developed content and courseware must be achieved, survey responses must be received,
and utilization of courseware is required in connection with subscription Internet-based learning
products and commercial support arrangements for us to recognize revenues. As we noted above, while
we have been successful in achieving growth in our subscription based revenues, our project based
revenues have and may continue to be subject to significant fluctuations.
Because we recognize revenue from subscriptions for our products and services over the term of the
subscription period, downturns or upturns in sales may not be immediately reflected in our
operating results.
We recognize a large portion of our revenue from customers monthly over the terms of their
subscription agreements, which are typically one to three years, although terms can range from less
than one to up to five years. As a result, much of the revenue we report in each quarter is related
to subscription agreements entered into during previous quarters. Consequently, a decline in new or
renewed subscriptions in any one quarter will not necessarily be fully reflected in the revenue in
that quarter and will negatively affect our revenue in future quarters. In addition, we may be
unable to adjust our cost structure to reflect these reduced revenues. Accordingly, the effect of
significant downturns in sales and market acceptance of our products and services may not be fully
reflected in our results of operations until future periods. Additionally, our subscription model
also makes it difficult for us to rapidly increase our revenue through additional sales in any
period, as revenue from new customers must be recognized over the applicable subscription term.
We may not be able to meet our strategic business objectives unless we obtain additional financing,
which may not be available to us on favorable terms or at all.
Our current cash reserves, revolving credit facility, and results of operations are expected to be
sufficient to meet our cash requirements through at least 2007. However, we may need to raise
additional funds in order to:
| • | develop new, or enhance existing, services or products; | ||
| • | respond to competitive pressures; | ||
| • | finance working capital requirements; | ||
| • | sustain content and development relationships; or | ||
| • | acquire complementary businesses, technology, content or products. |
At December 31, 2006, we had approximately $12.8 million in cash, cash equivalents, restricted
cash, investments in marketable securities and related interest receivable. We also have up to
$10.0 million of availability under a revolving credit facility, subject to certain covenants.
During March 2007, we acquired TJO for approximately $11.6 million in cash. We expect to incur up
to $5.0 million of capital expenditures, software feature enhancements and content purchases during
2007 to support our business. We continue to actively review possible business acquisitions that
would complement our products and services. We may not have adequate cash and investments or
availability under our revolving credit facility to consummate one or more acquisitions. We cannot
assure you that if we need additional financing that it will be available on terms favorable to us,
or at all. If adequate funds are not available or are not available on acceptable terms, our
ability to fund expansion, take advantage of available opportunities, develop or enhance services
or products or otherwise respond to competitive pressures would be significantly limited. If we
raise additional funds by issuing equity or convertible debt securities, the percentage ownership
of our shareholders may be reduced.
Our relatively short operating history may prevent us from forecasting our results of operations
accurately.
As a result of our relatively short operating history and lack of sustained success in executing
our growth strategy, we do not have historical financial data for a significant number of periods
upon which to forecast quarterly revenues and results of operations. We believe that
period-to-period comparisons of our operating results are not necessarily meaningful and should not
be relied upon as indicators of future performance. In addition, our operating results may vary
substantially. This variability may be the result of differences in levels of sales activity,
introductions of new products and services, and the related revenue recognition for our various
products and services. In one or more future quarters, our results of operations may fall below
recent operating trends or the expectations of securities analysts and investors, and the trading
price of our common stock may decline.
13
Table of Contents
We have significant goodwill and identifiable intangible assets recorded on our balance sheet that
may be subject to impairment losses that would reduce our reported assets and earnings.
As of December 31, 2006, our balance sheet included goodwill of $10.3 million and identifiable
intangible assets of $2.8 million. The acquisition of TJO in March 2007 will increase these amounts
ranging between approximately $13.0 million to $15.0 million. Economic, legal, regulatory,
competitive, contractual, and other factors may affect the carrying value of goodwill and
identifiable intangible assets in the future. If any of these factors impair the value of these
assets, accounting rules require us to reduce their carrying value and recognize an impairment
charge, which would reduce our reported assets and earnings in the period an impairment is
recognized.
Our stock price is likely to be volatile.
The market price of our common stock is likely to be volatile and could be subject to significant
fluctuations in response to factors such as the following, some of which are beyond our control:
quarterly variations in our operating results; operating results that vary from the expectations of
securities analysts and investors; changes in expectations as to our future financial performance;
changes in market valuations of other online service companies; future sales of our common stock;
stock market price and volume fluctuations; general political and economic conditions, such as a
recession or war or terrorist attacks or interest rate or currency rate fluctuations; and other
risk factors described in this Form 10-K. Moreover, our stock is thinly traded, and we have a
relatively small public float. These factors may adversely affect the market price of our common
stock. In addition, the market prices for stocks of many Internet related and technology companies
have historically experienced significant price fluctuations that in some cases appear to bear no
relationship to the operating performance of these companies.
Risks Related to Sales, Marketing and Competition
We continue to refine our pricing and our products and services and cannot predict whether the
ongoing changes will be accepted.
Over the past few years we have implemented several changes and continue to make changes in our
pricing and our product and service offerings to increase revenue and to meet the needs of our
customers. We cannot predict whether our current pricing and products and services, or any ongoing
refinements we make will be accepted by our existing customer base or by prospective customers. If
our customers and potential customers decide not to accept our current or future pricing or product
and service offerings, it could have a material adverse effect on our business.
Risks Related to Operations
Difficulties
in the release and transition to the new version of our Internet-based HLC platform
could harm our business.
We released a new version of our Internet-based HLC platform during the fourth quarter of 2006 and as of February
28, 2007, we have transitioned approximately one-half of our HLC subscriber base to this platform. Our future
success will depend on our ability to successfully transition all of our customers to the new platform. We have
experienced issues with certain customers that have transitioned to the new platform such as defects in the software,
data migration errors, and customer orientation to certain changed or new features. If we are unable to timely
correct these issues with certain customers that have already transitioned to the new platform or we experience
similar issues with those customers that are yet to transition, customers may become dissatified with our services. If
this happens, we could lose customers or experience increased expenses as a result of accelerated remediation
efforts or provision of product and service credits in excess of our
accrual for service interruptions.
We may be unable to adequately develop our systems, processes and support in a manner that will
enable us to meet the demand for our services.
We have provided our online products and services since 1999 and continue to develop our ability to
provide our courseware and learning management systems on both a subscription and transactional
basis over the Internet. Our future success will depend on our ability to effectively develop the
infrastructure, including additional hardware and software, and implement the services, including
customer support, necessary to meet the demand for our services. Our inability from time to time to
successfully develop the necessary systems and implement the necessary services on a timely basis
has resulted in our customers experiencing some delays or interruptions in their service. Such
delays or interruptions may cause customers to become dissatisfied with our service and move to
competing providers of traditional and online training and education services. If this happens, our
revenues could be adversely affected, which would have a material adverse effect on our financial
condition.
Our business operations could be significantly disrupted if we lose members of, or fail to
integrate, our management team.
Our future performance is substantially dependent on the continued services of our management team
and our ability to retain and motivate them. The loss of the services of any of our officers or
senior managers could harm our business, as we may not be able to find suitable replacements. We do
not have employment agreements with any of our key personnel, other than our chief executive
officer, and we do not maintain any “key person” life insurance policies.
14
Table of Contents
We may not be able to hire and retain a sufficient number of qualified employees and, as a result,
we may not be able to grow as we expect or maintain the quality of our services.
Our future success will depend on our ability to attract, train, retain and motivate other highly
skilled technical, managerial, marketing and customer support personnel. Competition for these
personnel is intense, especially for developers, Web designers and sales personnel, and we may be
unable to successfully attract sufficiently qualified personnel. We have experienced difficulty in
the past hiring qualified personnel in a timely manner for these positions. The pool of qualified
technical personnel, in particular, is limited in Nashville, Tennessee, which is where our
headquarters are located. We will need to maintain the size of our staff to support our anticipated
growth, without compromising the quality of our offerings or customer service. Our inability to
locate, hire, integrate and retain qualified personnel in sufficient numbers may reduce the quality
of our services.
We must continue to upgrade our technology infrastructure, both hardware and software, to
effectively meet demand for our services.
We must continue to add hardware and enhance software to accommodate the increased use of our
platform and increased courseware in our library. In order to make timely decisions about hardware
and software enhancements, we must be able to accurately forecast the growth in demand for our
services. This growth in demand for our services is difficult to forecast and the potential
audience for our services is large. If we are unable to increase the data storage and processing
capacity of our systems at least as fast as the growth in demand, our customers may encounter
delays or disruptions in their service. Unscheduled downtime could harm our business and also could
discourage current and potential customers and reduce future revenues.
Our network infrastructure and computer systems and software may fail.
An unexpected event like a telecommunications failure, fire, earthquake, or other catastrophic loss
at our Internet service providers’ facilities or at our on-site data facility could cause the loss
of critical data and prevent us from offering our products and services. Our business interruption
insurance may not adequately compensate us for losses that may occur. In addition, we rely on third
parties to securely store our archived data, house our Web server and network systems and connect
us to the Internet. While our service providers have planned for certain contingencies, the failure
by any of these third parties to provide these services satisfactorily and our inability to find
suitable replacements would impair our ability to access archives and operate our systems and
software.
We may lose users and lose revenues if our security measures fail.
If the security measures that we use to protect personal information are ineffective, we may lose
users of our services, which could reduce our revenues. We rely on security and authentication
technology licensed from third parties. With this technology, we perform real-time credit card
authorization and verification. We cannot predict whether these security measures could be
circumvented by new technological developments. In addition, our software, databases and servers
may be vulnerable to computer viruses, physical or electronic break-ins and similar disruptions. We
may need to spend significant resources to protect against security breaches or to alleviate
problems caused by any breaches. We cannot assure that we can prevent all security breaches.
Risks Related to Government Regulation, Content and Intellectual Property
Government regulation may require us to change the way we do business.
The laws and regulations that govern our business change rapidly. The United States government and
the governments of states and foreign countries have attempted to regulate activities on the
Internet. Evolving areas of law that are relevant to our business include privacy law, proposed
encryption laws, content regulation, information security accountability regulation, and sales and
use tax laws and regulations. Because of this rapidly evolving and uncertain regulatory
environment, we cannot predict how these laws and regulations might affect our business. In
addition, these uncertainties make it difficult to ensure compliance with the laws and regulations
governing the Internet. These laws and regulations could harm us by subjecting us to liability or
forcing us to change how we do business. See “Business — Government Regulation of the Internet and
the Healthcare Industry” for a more complete discussion of these laws and regulations.
Any reduction or change in the regulation of continuing education and training in the healthcare
industry may adversely affect our business.
Our business model is dependent in part on required training and continuing education for
healthcare professionals and other healthcare workers resulting from regulations of state and
Federal agencies, state licensing boards and professional organizations. Any change in these
regulations that reduce the requirements for continuing education and training for the healthcare
industry could harm our business. In addition, our business with pharmaceutical and medical device
manufacturers is predicated on our ability to maintain accreditation status with organizations such
as the ACCME, ANCC, AST, and ACPE. The failure to maintain status as an accredited provider could
result in a detrimental effect on our business.
15
Table of Contents
New regulations may reduce our business activity with pharmaceutical and medical device customers.
In April 2003, the OIG of the Department of Health and Human Services issued “OIG Compliance
Program Guidance for Pharmaceutical Manufacturers.” In July 1999, the OIG issued Compliance Program
Guidance for the Durable Medical Equipment, Prosthetics, Orthotics and Supply Industry. These
guidelines collectively identify three areas of risks for pharmaceutical and medical device
companies and recommends certain best practices to be included in a compliance plan designed to
avoid the risk of federal healthcare program abuse. The guidance highlighted a number of
arrangements that have the potential to trigger fraud and abuse violations, including educational
grants. The Company follows the rules and guidelines provided by the ACCME, ANCC and other
continuing education accrediting bodies to ensure that its continuing education programming is free
from commercial bias and consistent with the OIG guidance. The majority of the Company’s accredited
continuing education programming is funded by educational grants from our pharmaceutical and
medical device customers. There is no assurance that our pharmaceutical and medical device
customers will continue to provide educational grants consistent with past practices. To the extent
that our customers curtail or restructure their business practices, it could have a material
adverse impact on the Company’s revenues, results of operations, and financial position.
We may be liable to third parties for content that is available from our online library.
We may be liable to third parties for the content in our online library if the text, graphics,
software or other content in our library violates copyright, trademark, or other intellectual
property rights, our content partners violate their contractual obligations to others by providing
content to our library, or the content does not conform to accepted standards of care in the
healthcare profession. We attempt to minimize these types of liabilities by requiring
representations and warranties relating to our content partners’ ownership of the rights to
distribute as well as the accuracy of their content. We also take necessary measures to review this
content ourselves. Although our agreements with our content partners contain provisions providing
for indemnification by the content providers in the event of inaccurate content, we cannot assure
you that our content partners will have the financial resources to meet this obligation. Alleged
liability could harm our business by damaging our reputation, requiring us to incur legal costs in
defense, exposing us to awards of damages and costs and diverting management’s attention away from
our business. See “Business — Intellectual Property and Other Proprietary Rights” for a more
complete discussion of the potential effects of this liability on our business.
Protection
of certain proprietary intellectual property may be difficult and costly.
Despite
protection of certain proprietary rights, a third-party could, without
authorization, copy or otherwise appropriate our content or other
information from our databases, or other intellectual property.
Our agreements with employees, consultants and others who participate in development activities
could be breached, and result in our trade secrets
becoming known or independently developed by competitors. We
may not have adequate remedies for any breach. In addition, the laws of some
foreign countries do not protect our proprietary rights to the same extent as the laws of the
United States, and effective intellectual property protection may not be available
in those jurisdictions. We currently own several trademarks and domain names. The current system for
registering, allocating and managing domain names has been the subject of litigation and proposed
regulatory reform. Additionally, legislative proposals have been made by the federal government
that would afford broad protection to owners of databases of information, such as stock quotes.
This protection of databases already exists in the European Union.
There has been substantial
litigation in the computer and online industries regarding
intellectual property assets, particularly patents.
Third-parties may claim infringement by us with respect to current and future products, trademarks
or other proprietary rights, and we may counterclaim against such parties in such actions. Any
such claims or counterclaims could be time-consuming, result in costly litigation, divert
management’s attention, cause product release delays, require us to redesign our products or
require us to enter into royalty or licensing agreements, any of which could have a material
adverse effect upon our business, financial condition and operating results. Such royalty and
licensing agreements may not be available on terms acceptable to us, if at all.
We may be unable to protect our intellectual property, and we may be liable for infringing the
intellectual property rights of others.
Our
business could be harmed if unauthorized parties infringe upon or
misappropriate our intellectual property
proprietary systems, content, services or other information. Our efforts to protect our
intellectual property through copyright, trademarks and other controls may not be adequate. In the
future, litigation may be necessary to enforce our intellectual property rights or to determine the
validity and scope of the patents, intellectual property, or other proprietary rights of third parties, which could be time consuming and costly.
Intellectual property infringement claims could be made against us,
especially as the number of our competitors
grows. These claims, even if not meritorious, could be expensive and divert our attention from
operating our company. In addition, if we become liable to third parties for infringing their
intellectual property rights, we could be required to pay a substantial damage award and develop
comparable non-infringing intellectual property, to obtain a license or to cease providing the
content or services that contain the infringing intellectual property. We may be unable to develop
non-infringing intellectual property or obtain a license on commercially reasonable terms, if at
all.
16
Table of Contents
Item 1B. Unresolved Staff Comments
Not applicable.
Item 2. Properties
Our principal office is located in Nashville, Tennessee. Our lease for approximately 32,000 square
feet at this location expires in April 2010. The lease provides for a five-year renewal option with
rent at rates which are substantially similar to current rates. Rent at this location is
approximately $23,000 per month.
In connection with the acquisition of TJO in March 2007, we are leasing approximately 19,000 square
feet of office space in Laurel, Maryland. The lease expires in March 2012 and provides for two
renewal options for two years each. Rent at this location is approximately $29,000 per month, with
annual rental increases of approximately three percent.
We are leasing approximately 8,000 square feet of office space in Denver, Colorado for our
satellite office. The lease expires in March 2010 and has monthly rent of approximately $9,000.
We are leasing approximately 8,000 square feet of office space in Franklin, Tennessee for our
satellite office. The lease expires in August 2007, and contains two one year renewal options. Rent
at this location is approximately $8,200 per month through February 2007, and approximately $8,500
per month from March 2007 to August 2007.
Through January 2007, we leased approximately 6,000 square feet of office space in Dallas, Texas.
Item 3. Legal Proceedings
None.
Item 4. Submission of Matters to a Vote of Security Holders
None.
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of
Equity Securities.
The following table sets forth, for the periods indicated, the high and low sales prices per share
of our common stock as reported on the NASDAQ National Market under the ticker symbol HSTM:
| Common Stock Price | ||||||||||||||||
| 2006 | 2005 | |||||||||||||||
| High | Low | High | Low | |||||||||||||
First Quarter |
$ | 3.72 | $ | 2.39 | $ | 3.72 | $ | 2.60 | ||||||||
Second Quarter |
5.03 | 3.25 | 4.00 | 2.65 | ||||||||||||
Third Quarter |
3.90 | 2.50 | 3.96 | 2.95 | ||||||||||||
Fourth Quarter |
4.19 | 3.14 | 2.83 | 1.91 | ||||||||||||
On March 26, 2007, there were 168 registered holders and approximately 3,106 beneficial holders
of our common stock. Because many of such shares are held by brokers and other institutions on
behalf of shareholders, we are unable to estimate the total number of shareholders represented by
these record holders.
DIVIDEND POLICY
We have never declared or paid any cash dividends on our common stock, and we do not anticipate
paying cash dividends in the foreseeable future. We intend to retain earnings to finance the
expansion of our operations.
RECENT SALES OF UNREGISTERED SECURITIES
There have been no sales of unregistered securities since December 31, 2005.
ISSUER PURCHASES OF EQUITY SECURITIES
| There were no stock repurchases by the Company in the fourth quarter of 2006. |
17
Table of Contents
Item 6. Selected Financial Data
The selected statements of operations data for the three-year period ended December 31, 2006 and
the balance sheet data as of December 31, 2006 and 2005 are derived from our consolidated financial
statements that have been audited by Ernst & Young LLP, our independent registered public
accounting firm, and are included elsewhere in this report. You should read the following selected
financial data in conjunction with our consolidated financial statements and the notes to those
statements and “Management’s Discussion and Analysis of Financial Condition and Results of
Operations” located elsewhere in this report.
HealthStream acquired DMR on March 28, 2005. DMR’s results of operations are included within our
consolidated statement of operations effective March 29, 2005. As a result of this acquisition, the
annual results presented below are not comparable. Revenues may be subject to fluctuations as
discussed further in “Management’s Discussion and Analysis of Financial Condition and Results of
Operations” located elsewhere in this annual report. During 2006, we adopted SFAS No. 123(R)
“Share-Based Payment” which resulted in approximately $682,000 of stock based compensation expense
for 2006. During 2002, we adopted SFAS No. 142 “Goodwill and Intangible Assets,” which eliminated
the amortization of goodwill and indefinite lived intangible assets. In accordance with the
provisions of SFAS No. 142, we recorded a transitional goodwill impairment charge of $5.0 million,
in our healthcare organizations (HCO) business unit, as a cumulative effect of a change in
accounting principle as of January 1, 2002. As a result of these accounting changes, the annual
results presented below are not comparable. The operating results for any single year are not
necessarily indicative of the results to be expected in the future.
| Year Ended December 31, | ||||||||||||||||||||
| 2006 | 2005 | 2004 | 2003 | 2002 | ||||||||||||||||
| (in thousands, except per share data) | ||||||||||||||||||||
STATEMENT OF OPERATIONS DATA: |
||||||||||||||||||||
Revenues, net |
$ | 31,783 | $ | 27,359 | $ | 20,057 | $ | 18,195 | $ | 15,790 | ||||||||||
Operating costs and expenses: |
||||||||||||||||||||
Cost of revenues (excluding depreciation and amortization) |
10,869 | 9,746 | 7,277 | 6,268 | 5,970 | |||||||||||||||
Product development |
3,503 | 2,928 | 2,531 | 3,247 | 4,679 | |||||||||||||||
Sales, marketing, general and administrative expenses |
12,613 | 10,411 | 9,433 | 9,431 | 12,835 | |||||||||||||||
Depreciation and amortization |
2,889 | 2,678 | 2,107 | 3,048 | 4,395 | |||||||||||||||
Office consolidation charge |
— | — | — | — | 164 | |||||||||||||||
Impairment of long-lived assets |
— | — | — | — | 105 | |||||||||||||||
Total operating costs and expenses |
29,874 | 25,763 | 21,348 | 21,994 | 28,148 | |||||||||||||||
Income (loss) from operations |
1,909 | 1,596 | (1,291 | ) | (3,799 | ) | (12,358 | ) | ||||||||||||
Other income (expense) |
619 | 338 | 243 | 387 | 717 | |||||||||||||||
Net income (loss), before provision for income taxes and
cumulative effect of a change in accounting principle |
2,528 | 1,934 | (1,048 | ) | (3,412 | ) | (11,641 | ) | ||||||||||||
Provision for income taxes |
28 | 21 | — | — | — | |||||||||||||||
Cumulative effect of a change in accounting principle |
— | — | — | — | (5,000 | ) | ||||||||||||||
Net income (loss) |
$ | 2,500 | $ | 1,913 | $ | (1,048 | ) | $ | (3,412 | ) | $ | (16,641 | ) | |||||||
Net income (loss) per share — basic, before cumulative
effect of a change in accounting principle |
$ | 0.12 | $ | 0.09 | $ | (0.05 | ) | $ | (0.17 | ) | $ | (0.57 | ) | |||||||
Cumulative effect of a change in accounting principle |
— | — | — | — | (0.25 | ) | ||||||||||||||
Net income (loss) per share — basic |
$ | 0.12 | $ | 0.09 | $ | (0.05 | ) | $ | (0.17 | ) | $ | (0.82 | ) | |||||||
Net income (loss) per share — diluted, before cumulative
effect of a change in accounting principle |
$ | 0.11 | $ | 0.09 | $ | (0.05 | ) | $ | (0.17 | ) | $ | (0.57 | ) | |||||||
Cumulative effect of a change in accounting principle |
— | — | — | — | (0.25 | ) | ||||||||||||||
Net income (loss) per share — diluted |
$ | 0.11 | $ | 0.09 | $ | (0.05 | ) | $ | (0.17 | ) | $ | (0.82 | ) | |||||||
Weighted average shares of common stock outstanding — basic |
21,577 | 21,051 | 20,586 | 20,383 | 20,261 | |||||||||||||||
Weighted average shares of common stock outstanding —
diluted |
22,359 | 21,942 | 20,586 | 20,383 | 20,261 | |||||||||||||||
| At December 31, | ||||||||||||||||||||
| 2006 | 2005 | 2004 | 2003 | 2002 | ||||||||||||||||
| (in thousands) | ||||||||||||||||||||
BALANCE SHEET DATA: |
||||||||||||||||||||
Cash and cash equivalents |
$ | 10,726 | $ | 5,726 | $ | 2,257 | $ | 3,220 | $ | 4,070 | ||||||||||
Investments in marketable securities — short and long
term |
1,700 | 6,175 | 14,025 | 13,958 | 15,153 | |||||||||||||||
Working capital |
11,148 | 9,428 | 15,379 | 16,286 | 14,912 | |||||||||||||||
Total assets |
41,008 | 35,216 | 28,436 | 28,399 | 32,913 | |||||||||||||||
Deferred revenue |
5,376 | 4,503 | 3,866 | 3,059 | 3,346 | |||||||||||||||
Long-term debt and capital leases, net of current
portion |
107 | 216 | 29 | 1 | 41 | |||||||||||||||
Shareholders’ equity |
29,634 | 25,800 | 21,730 | 22,558 | 25,896 | |||||||||||||||
18
Table of Contents
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion of the financial condition and results of operations of HealthStream
should be read in conjunction with “Selected Financial Data” and HealthStream’s Consolidated
Financial Statements and related notes thereto included elsewhere in this report. This discussion
contains forward-looking statements that involve risks and uncertainties. HealthStream’s actual
results may differ significantly from the results discussed and those anticipated in these
forward-looking statements as a result of many factors, including but not limited to, those
described under “Risk Factors” and elsewhere in this report.
The following discussion provides an overview of our history together with a summary of our
critical accounting policies and estimates. Our critical accounting policies and estimates include
revenue recognition, product development costs and related capitalization, impairment of goodwill,
intangibles and other long-lived assets, allowance for doubtful accounts, accrual for service
interruptions, stock based compensation, income taxes, and nonmonetary exchanges.
OVERVIEW
HealthStream was incorporated in 1990 and began marketing its Internet-based solutions in March
1999. The Company focuses on being a facilitator of solutions and training tools for entities in
the healthcare industry. Revenues from the healthcare organizations business unit (HCO) are derived
from the following categories: provision of services through our Internet-based HealthStream
Learning Center, courseware subscriptions, survey and research services, a variety of complimentary
online products, and maintenance and support of installed learning management products. Revenues
from the pharmaceutical and medical device company business unit (PMD) are derived from live event
development, online training and content development, and other educational and training services.
Our learning solutions help healthcare organizations improve their required regulatory training,
while also offering an opportunity to train their employees in multiple clinical areas. Our
research products provide customers valuable insight into measuring quality and satisfaction of
physicians, patients, employees, and members of the community.
Revenues for the year ended December 31, 2006 were approximately $31.8 million compared to $27.4
for the year ended December 31, 2005, an increase of 16.2%. Net income improved to $2.5 million for
2006 compared to $1.9 million for 2005, an increase of 30.7%, despite the January 1, 2006 adoption
of SFAS No. 123(R), which resulted in $0.7 million of stock based compensation expense in 2006.
Diluted earnings per share of $0.11 for 2006 improved from $0.09 in 2005. Revenues from our
Internet-based HLC subscriber base grew $2.2 million, and revenues from survey and research
services also grew by $2.2 million. Revenues from our pharmaceutical and medical device products
increased moderately. We had approximately 1,352,000 fully implemented subscribers on our
Internet-based HLC platform at December 31, 2006, representing over 1,400 hospitals in the United
States. During 2006, we renewed approximately 600,000 subscribers, representing a 96% renewal rate
for the subscribers up for renewal, and a 90% renewal rate based on the annual contract value up
for renewal.
During the fourth quarter of 2006, we launched a new and enhanced version of our Internet-based
HLC, which we refer to as our Next Generation HLC. We have invested a significant amount of capital
and internal resources to develop and deploy this new version of our flagship product. We expect
this new version of the HLC will enable us to more efficiently integrate the delivery of new
product offerings to healthcare professionals who subscribe to our learning solutions. Successful
deployment and acceptance of this new HLC version will be the cornerstone to our future growth.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Revenue Recognition
We recognize revenues from our Internet-based learning products and courseware subscriptions to
healthcare workers through healthcare organizations based on a per person subscription basis, with
fees ranging from less than $1 to approximately $5 per month. These fees are based on the size of
the facilities’ or organizations’ employee user population and the service offerings to which they
subscribe. Contracts for our Internet-based learning products generally range from less than $5,000
to approximately $400,000 per year based on the number of users, products and services included in
the contract. Revenue is recognized ratably over the service period of the underlying contract.
Revenues from our survey and research services are determined using the proportional performance
method, and are earned over the estimated survey cycle, which typically ranges from less than one
month to up to four months. The survey cycle is generally initiated based on the receipt of the
first survey response and runs through provision of related survey reports to the customer. All
other revenues are recognized as the related services are performed or products are delivered to
the customer.
Revenues from content maintenance services are associated with maintaining and updating customer
owned content. Fees are based on the time and efforts involved, and revenue is recognized upon
completion of performance milestones using the proportional performance method.
19
Table of Contents
We offer training services for clients to facilitate integration of our Internet-based products.
Fees for training are based on the time and efforts of the personnel involved. Basic online
training is generally included in the initial contract, however, incremental training revenues are
generally recognized upon completion of training services.
Revenues from installed learning management products are associated with ongoing maintenance and
technical support services, typically based on a percentage of the original contract amount and are
recognized as revenue over the term of the service period, generally one year. We have and expect
to continue to transition customers from our existing installed learning management products to our
Internet-based learning products. We expect that revenues resulting from these transition customers
will increase when compared to the annual maintenance and technical support services fees due to
sales of additional services and online courseware.
We recognize revenue from live event development services using a proportional performance method
based on completion of performance milestones. Revenues from content maintenance and development
services are recognized using a percentage of completion method based on labor hours, which
correspond to the completion of performance milestones and deliverables. Sales of products and
services to pharmaceutical and medical device companies can be subject to seasonal factors as a
result of drug and product introductions, meeting and conference dates and budget cycles for such
companies.
Revenues associated with online training are recognized over the term of the subscription period or
over the historical usage period, if usage typically differs from the subscription period. All
other service revenues are recognized as the related services are performed or products are
delivered.
We expect to continue to generate revenues by marketing our Internet-based products and services to
healthcare workers through healthcare organizations and pharmaceutical and medical device
companies. We expect that the portion of our revenues related to services provided via our
Internet-based learning products will increase in absolute dollar amounts. Since revenues from our
survey and research services are not Internet-based, the percentage of total revenues from
Internet-based subscription products has declined compared to historical periods. Specifically, we
will seek to generate revenues from healthcare workers by marketing to their employers or
sponsoring organizations. The fees we charge for courseware resulting from this marketing is
typically paid by either the employer or sponsoring organization.
Product Development Costs
We account for Web site development costs in accordance with EITF Issue No. 00-2 “Accounting for
Web Site Development Costs” and for capitalized software feature enhancements in accordance with
SOP 98-1 “Accounting for the Costs of Computer Software Developed or Obtained for Internal Use,”
which provide guidance on when to capitalize versus expense costs incurred to develop internal use
software or Web sites. We capitalize costs incurred during the development phase for such projects
when such costs are material. Maintenance and operating costs are expensed as incurred.
Product development costs primarily include our internal costs to maintain and internally develop
software feature enhancements and content for our Internet-based learning and installed learning
management products. Once planning is completed and development begins, we capitalize payments to
third parties associated with the cost of software feature enhancement development or content where
the life expectancy is greater than one year and the anticipated cash flows from such software
feature enhancements or content are expected to exceed the cost of the related asset. During both
2006 and 2005, we capitalized approximately $400,000 related to development of content by third
parties. Such amounts are included in the accompanying consolidated balance sheets under the
caption “prepaid development fees” and “other assets.” During 2006 and 2005, we capitalized
approximately $2.3 million and $600,000, respectively, for development of software feature
enhancements by third parties. Such amounts are included in the accompanying balance sheets under
the caption “capitalized software feature enhancements.” A significant portion of these capitalized
costs were associated with the development of our Next Generation HLC platform and a new competency
assessment product. We amortize content and software feature enhancements over their expected life,
which is generally one to four years. Capitalized content and software feature enhancements are
subject to a periodic impairment review.
In connection with product development, our significant estimates involve the assessment of the
development period for new products, as well as the expected useful life of costs associated with
new products, software feature enhancements and content. Once capitalized, software feature
enhancements and content development costs are subject to the policies and estimates described
below regarding goodwill, intangibles and other long-lived assets.
Product development costs also include our systems team, which manages our efforts associated with
product development and maintenance, database management, quality assurance and security. This
team is responsible for new internal product development, integration of external new products, and
continued enhancements and regularly scheduled maintenance (called ServicePacks) to our platform.
This team is also responsible for the migration of customers to our Next Generation HLC platform.
Our product management team, which is responsible for our overall product portfolio as well as
prioritization of new product development, is also included in product development costs. This team
was organized and began administering a more formal product management process during 2006.
20
Table of Contents
Goodwill, intangibles and other long-lived assets
We account for goodwill, intangibles and other long-lived assets in accordance with Statement of
Financial Accounting Standards (SFAS) No. 142, “Goodwill and Intangible Assets,” and SFAS No. 144,
“Accounting for the Impairment or Disposal of Long-Lived Assets.” We measure for impairment at the
reporting unit level using a discounted cash flow model to determine the estimated fair value of
the reporting units. Our discounted cash flow model contains significant assumptions and accounting
estimates about discount rates, future cash flows and terminal values that could materially affect
our operating results or financial position if they were to change significantly in the future and
could result in an impairment. We perform our goodwill impairment test whenever events or changes
in facts or circumstances indicate that impairment may exist and also during the fourth quarter
each year.
Allowance for Doubtful Accounts
We estimate the allowance for doubtful accounts using both a specific and non-specific
identification method. Management’s evaluation includes reviewing past due accounts on a case-by
case basis, and determining whether an account should be reserved, based on the facts and
circumstances surrounding each potentially uncollectible account. An allowance is also maintained
for accounts not specifically identified that may become uncollectible in the future. Uncollectible
accounts are written-off in the period management believes it has exhausted every opportunity to
collect payment from the customer. Bad debt expense is recorded when events or circumstances
indicate an additional allowance is necessary based on our specific identification approach.
Accrual for Service Interruptions
We provide customers with a fully hosted learning management application, and our Internet-based
learning products are subject to periodic downtime. Due to the complexity of our hosted
applications, variability in customer utilization patterns, changes in technology, and potential
software defects, our hosted applications could experience periodic downtime. We maintain an
accrual which is intended to provide for customer concessions in the event customers experience
inconveniences or operation disruption resulting from downtime of our applications. Our accrual for
service interruptions totaled approximately $314,000 as of
December 31, 2006. Certain of our customers who have
transitioned to our new platform have experienced difficulties in
accessing or using certain features of our system, and we expect to
provide these customers with product and service credits.
Stock Based Compensation
We began recognizing compensation expense, using a fair-value based method, for costs related to
share based payments, including stock options on January 1, 2006. Measurement of such compensation
expense requires significant estimation and assumptions, however we believe that the Black Scholes
option pricing model we use for calculating the fair value of our stock based compensation plans
provides measurement using a framework that is widely adopted.
We have a stock option plan and an employee stock purchase plan which qualify as stock based
compensation plans. During the year ended December 31, 2006, we recorded $682,068 of stock based
compensation expense resulting from the adoption of SFAS No. 123(R). We typically grant stock
options to our management group on an annual basis, or when new members of the management group
begin their employment. We grant stock options to members of our board of directors in conjunction
with our annual shareholders meeting, or as new members are added on a pro rata basis based on the
time elapsed since our annual shareholders’ meeting. We expect to continue this practice for the
foreseeable future; however, we may adjust the size of the annual grant. As of December 31, 2006,
total future compensation cost related to non-vested awards not yet recognized was $1,139,874, net
of estimated forfeitures, with a weighted average expense recognition period of 2.7 years. Future
compensation expense recognition for new option grants will vary depending on the timing and size
of new awards granted, changes in the market price or volatility of our common stock, changes in
risk-free interest rates, or if actual forfeitures vary significantly from our estimates.
Accounting
for Income Taxes
The Company accounts for income taxes using the liability method in accordance with SFAS No. 109, “Accounting
for Income Taxes.” The Company has significant net operating loss carryforwards (NOLs) which may be available
to reduce future tax expense. These NOLs are subject to annual limitations under the Internal Revenue Code Section
382, which could result in the expiration of such NOLs before they are fully utilized. Until the Company has a
period of sustained and predictable profitability consistent with realizing some portion of the benefit from the
NOLs, the valuation allowance associated with NOLs will be maintained. Management assesses the valuation
allowance periodically whenever events or changes in circumstances indicate that the benefit associated with such
NOLs may be realized.
Nonmonetary Exchange of Content Rights and Deferred Service Credits
During 2006, we recorded content rights and deferred service credits in connection with a
nonmonetary exchange with one of our customers. In order to account for this transaction, we
estimated the fair value of the related assets and service credits, assessed whether the value
assigned to the content was recoverable, and did and continue to amortize the related assets over
their estimated useful lives. Our future operating results will be impacted by the amortization of
the content rights and by the customer’s utilization of the service credits. We will also review
these assets periodically to determine whether they are recoverable during the remaining useful
life. Revenues for services provided in exchange for service credits will be recognized in
accordance with our revenue recognition policies.
BUSINESS COMBINATIONS
Data Management & Research, Inc. On March 28, 2005, the Company acquired all of the stock of Data
Management & Research, Inc. (DMR) for approximately $10.7 million, consisting of $9.1 million in
cash and 479,234 shares of our common stock. The Company also incurred direct, incremental expenses
associated with the acquisition of approximately $0.4 million. Of the common stock portion, 319,489
shares were released from escrow to the former shareholder of DMR on September 28, 2006. DMR
provides healthcare organizations a wide range of quality and satisfaction surveys, data analyses
of survey results, and other research-based measurement tools focused on physicians, patients, and
employees. This acquisition has been accounted for using the purchase method of accounting. DMR’s
results of operations have been included in the Company’s results in the HCO business unit from the
date of the acquisition.
21
Table of Contents
The Jackson Organization, Research Consultants, Inc. On March 12, 2007, the Company acquired all of
the issued and outstanding common stock of The Jackson Organization, Research Consultants, Inc.
(TJO) for approximately $12.6 million, consisting of approximately $11.6 million payable in cash
and 252,616 shares of HealthStream common stock. Approximately $5.0 million of the cash
consideration is being held in escrow and will be released upon the occurrence of future events.
All of the common stock shares are held in an escrow account until eighteen months after March 12,
2007, and are subject to any claims for indemnification pursuant to the stock purchase agreement.
The Company expects direct, incremental expenses associated with the acquisition of TJO will
approximate $0.7 million. TJO provides healthcare organizations with quality and satisfaction
surveys, data analyses of survey results, and other research-based measurement tools.
RESULTS OF OPERATIONS
Revenues and Expense Components
The following descriptions of the components of revenues and expenses apply to the comparison of
results of operations.
Revenues. Revenues for our HCO business unit currently consist of the provision of services through
our Internet-based HealthStream Learning Center (HLC), authoring tools, survey and research
services, a variety of courseware subscriptions (add-on courseware) maintenance and support
services for our installed learning management products, maintenance of content, and competency
tools. Revenues for our PMD business unit consist of live event development, online training and
content development, online sales training courses, live educational activities for nurses and
other professionals conducted within healthcare organizations, continuing education activities at
association meetings, and HospitalDirect®.
Cost of Revenues (excluding depreciation and amortization). Cost of revenues consists primarily of
salaries and employee benefits, stock based compensation, employee travel and lodging, materials,
contract labor, hosting costs, and other direct expenses associated with revenues as well as
royalties paid by us to content providers based on a percentage of revenues. Personnel costs within
cost of revenues are associated with individuals that facilitate product delivery, provide
services, handle customer support calls or inquiries, manage our web sites, content and survey
services, coordinate content maintenance services, and provide training or implementation services.
Product Development. Product development expenses consist primarily of salaries and employee
benefits, stock based compensation, content acquisition costs before technological feasibility is
achieved, costs associated with the development of content and expenditures associated with
maintaining, developing and operating our training delivery and administration platforms. In
addition, product development expenses are associated with the development of new software feature
enhancements and new products. Personnel costs within product development include our systems team,
product managers, and other personnel associated with content and product development and product
management.
Sales and Marketing Expenses. Sales and marketing expenses consist primarily of salaries,
commissions and employee benefits, stock based compensation, employee travel and lodging,
advertising, trade shows, promotions, and related marketing costs. Annually, we host a national
users’ group in Nashville known as “The Summit,” the costs of which are included in sales and
marketing expenses. Personnel costs within sales and marketing include our sales and marketing
team, strategic account management, as well as our account management group. Our account management
personnel work to ensure our products and services are fully utilized by our customers, provide
consultations with new and prospective customers, as well as support the contract renewal process
for existing hospital customers.
Depreciation and Amortization. Depreciation and amortization consist of fixed asset depreciation,
amortization of intangibles considered to have definite lives, amortization of content or license
fees, and amortization of capitalized software feature enhancements.
Other General and Administrative Expenses. Other general and administrative expenses consist
primarily of salaries and employee benefits, stock based compensation, employee travel and lodging,
facility costs, office expenses, fees for professional services, and other operational expenses.
Personnel costs within general and administrative expenses include individuals associated with
normal corporate functions (accounting, legal, human resources, administrative, internal
information systems, and executive management) as well as accreditation professionals.
Other Income/Expense. The primary component of other income is interest income related to interest
earned on cash, cash equivalents and investments in marketable securities. The primary component of
other expense is interest expense related to capital leases and our revolving credit facility.
22
Table of Contents
2006 Compared to 2005
Revenues. Revenues increased approximately $4.4 million, or 16.2%, to $31.8 million for 2006 from
$27.4 million for 2005. Revenues for 2006 consisted of $25.4 million for HCO and $6.4 million for
PMD. In 2005, revenues consisted of $21.2 million for HCO and $6.2 million for PMD. HCO revenues
include the results of DMR commencing with its acquisition on March 28, 2005.
Revenues for HCO increased approximately $4.3 million, or 20.1%, during 2006. Growth in survey and
research services associated with the acquisition of DMR in March 2005 totaled $2.2 million in
2006, of which $823,000 is the result of organic growth. Revenues from our Internet-based HLC
subscriber base increased $2.2 million over the prior year, resulting primarily from growth in our
subscriber base. Revenues from our courseware subscriptions increased $115,000, or 3.5%, over the
prior year, and included revenue increases of $540,000 from several new product offerings, but was
partially offset by declines in revenue associated with HIPAA courseware subscriptions. We also
experienced expected declines in revenues from maintenance and support fees associated with our
installed learning management products of $243,000. Our Internet-based HLC subscriber base
increased approximately 15% during 2006, from approximately 1,173,000 fully implemented subscribers
at the end of 2005 to approximately 1,352,000 fully implemented subscribers at the end of 2006. We
expect revenues from our Internet-based HLC, survey and research services, and add-on courseware to
increase in 2007. We anticipate that the acquisition of TJO will
result in an increase in survey and research revenues of
approximately $9.0 to $10.0 million during 2007. We expect continued declines in revenues from our installed learning management
products during 2007.
Revenues for PMD increased approximately $141,000, or 2.3%, during 2006, and was primarily related
to growth in our online RepDirect™ training courseware, sales of clinical educational
products, and HospitalDirect®. These revenue increases were partially offset by
declines from our project-based content development services and our live events and association
business. We expect that revenues from HospitalDirect® and online RepDirect™
training courseware will increase during 2007. We expect revenues from our live event
services to decline during 2007 due to a live event held during 2006 that is not recurring in 2007.
We also expect revenues from project-based content development services will remain comparable or
decline slightly during 2007 as we continue to transition our sales efforts to subscription based
products and other online delivery methodologies.
During 2006, 58.9% of our revenues were derived from our Internet-based learning products, 21.1%
from survey and research services, 13.1% from live event development services, 5.5% from content
development and maintenance services, and 1.4% from our installed learning management products.
During 2005, 59.8% of our revenues were derived from our Internet-based learning products, 16.4%
from survey and research services, 14.9% from live event development services, 6.5% from content
development and maintenance services, and 2.4% from our installed learning management products.
Cost of Revenues (excluding depreciation and amortization). Cost of revenues increased
approximately $1.1 million, or 11.5%, to $10.9 million for 2006 from $9.7 million for 2005. The
increase in cost of revenues resulted from incremental expenses associated with the growth in
survey and research services, and higher direct costs associated with the delivery of our live
event services, particularly a significant event held during the second quarter of 2006. In
addition, increased royalties paid by us and stock based compensation expense contributed to the
increase in cost of revenues over the prior year.
Cost of revenues for HCO was comparable between years and approximated $5.5 million for 2006 and
2005. Cost of revenue increases for HCO resulted from the additional expenses associated with the
increase in survey and research services, but was partially offset by lower personnel expenses
associated with direct product and service delivery as well as redesignation of certain product
personnel to product management. Cost of revenues for HCO approximated 21.5% and 25.8% of HCO
revenues for 2006 and 2005, respectively. We expect cost of revenues
for HCO to increase during 2007 due to royalties associated with
increased courseware revenues. In addition to growth in cost of
revenues associated with our organic survey and research products,
HCO cost of revenues will increase due to the addition of TJO call
center and operational personnel.
Cost of revenues for PMD increased approximately $1.0 million, or 28.4%, to $4.7 million for 2006
from $3.7 million for 2005. This increase primarily resulted
from expense overages in production costs associated with a significant live event
held during the second quarter of 2006, which resulted in a financial loss of approximately
$200,000. In addition increased royalties were paid by us that were associated with the revenue
increase from our online
RepDirect™ training courseware.
We expect cost of revenues for PMD during the full year 2007 to be
comparable with the full year of 2006 as a percentage of PMD revenue.
Cost of revenues for unallocated corporate functions increased approximately $67,000, or 10.7%, to
$693,000 for 2006 from $626,000 for 2005. This increase was associated with increased personnel
expenses. Cost of revenues for our corporate unallocated functions is comprised of content support
personnel who handle loading, updating, maintenance, versioning and support of content on our
Internet-based learning platforms, which serve products within both the HCO and PMD business units.
Gross Margin (excluding depreciation and amortization). Gross margin (which we define as revenues
less cost of revenues divided by revenues) improved to 65.8% for 2006 from 64.4% during 2005. This
improvement is primarily the result of revenue increases associated with our Internet-based HLC,
but was partially offset by lower margins from our live events business. Gross margins for HCO were
78.5% and 74.2% for 2006 and 2005, respectively. This improvement resulted from increased revenues
associated with our Internet-based HLC product. Gross margins for PMD were 25.9% and 41.0% for 2006
and 2005, respectively. This decline resulted from the increase in cost of revenues discussed
above, primarily associated with a significant live event during the second quarter of 2006. Gross
margins for PMD are lower than HCO due to the higher costs associated with delivering live event
and content development services, and variability of costs associated
with project-based services. We expect gross margins for the full
year 2007 will approximate our 2006 full year gross margins,
including the impact of the TJO acquisition.
23
Table of Contents
Product development. Product development expenses increased approximately $575,000, or 19.6%, to
$3.5 million for 2006 from $2.9 million for 2005. This increase resulted from our HCO business and
was associated with additional personnel expenses and stock based compensation expense. Product
development efforts for 2006 were primarily associated with the development and deployment of our
Next Generation HLC product, the ongoing maintenance and support for our existing HLC learning
products, and product portfolio management as well as new courseware offerings and competency
tools. Product development expenses as a percentage of revenues approximated 11.0% of revenues for
2006 compared to 10.7% of revenues for 2005. In addition to the expenses incurred, we also
capitalized approximately $2.7 million and $1.1 million of costs associated with development of
software feature enhancements and content during 2006 and 2005,
respectively. We expect product development expenses for the full
year 2007 to increase moderately, but to decline as a percentage of
revenue as we develop and introduce new products in 2007.
Product development expenses for HCO increased approximately $745,000, or 32.6%, to $3.0 million
for 2006 from $2.3 million for 2005. The increase resulted from additional personnel associated
with the maintenance of our Internet-based learning products and the development and deployment of
new products, including our Next Generation HLC. Product development expenses for PMD decreased
approximately $59,000 during 2006, approximating $329,000 for 2006 and $388,000 for 2005. This
decline is primarily due to a reduction in product management personnel. The unallocated corporate
portion of our product development expenses decreased approximately $111,000, or 43.4%, to $144,000
for 2006 from $255,000 for 2005. This decrease resulted from a shift of resources to support the
product development efforts for our HCO products.
Sales and Marketing Expenses. Sales and marketing expenses, including personnel costs, increased
approximately $1.6 million, or 28.8%, to $7.0 million for 2006 from $5.4 million for 2005, and
approximated 22.1% and 19.9% of revenues for 2006 and 2005, respectively. The increase resulted
from additional sales personnel and account management personnel to support our HCO business,
increased direct marketing campaign expenses, stock based compensation expense, and increased
spending associated with our annual customer conference, The Summit, which was attended by
approximately 710 customer representatives in 2006 compared to
approximately 540 in 2005. We expect sales and marketing expenses for
the full year 2007 to increase, but remain comparable with the full
year 2006 as a percentage of revenue.
Sales and marketing expense for HCO increased approximately $1.7 million, or 43.4%, to $5.6 million
for 2006 from $3.9 million for 2005, and approximated 22.1% and 18.6% of HCO revenues for 2006 and
2005, respectively. The expense increases are associated with increases in sales and account
management personnel, and increased spending associated with direct marketing campaigns and The
Summit. Sales and marketing expense for PMD decreased approximately $110,000, or 8.4%, to $1.2
million for 2006 from $1.3 million for 2005, and approximated 18.9% and 21.1% of PMD revenues for
2006 and 2005, respectively. The decrease for PMD is associated with lower sales commissions. Sales
and marketing expense for our unallocated corporate functions decreased modestly during 2006.
Depreciation and Amortization. Depreciation and amortization increased approximately $211,000, or
7.9%, to $2.9 million for 2006 from $2.7 million for 2005. Amortization increased $343,000
associated with additional content fees and capitalized software feature enhancements. Depreciation
declined by $132,000 resulting from certain property and equipment reaching the end of their
estimated useful lives and fewer capital expenditures needed to replace equipment, which somewhat
offset the increase in amortization. We expect depreciation and
amortization to increase during the full year 2007 compared to the
full year 2006 due to increased amortization associated with
capitalized software feature enhancements and content, and
amortization of definite lived intangible assets associated with the
acquisition of TJO.
Other General and Administrative. Other general and administrative expenses increased approximately
$635,000, or 12.8%, to $5.6 million for 2006 from $5.0 million for 2005. This increase is primarily
associated with stock based compensation expense of $358,000, personnel expense increases, higher
employee recruiting costs, and expense increases associated with our status as a public company and
other corporate support functions. Other general and administrative expenses as a percentage of
revenues decreased to 17.6% for 2006 from 18.1% for 2005. The percentage decrease is a result of
the increases in revenues.
Other Income/Expense. Other income/expense increased approximately $281,000, or 83.2%, to $619,000
for 2006 from $338,000 for 2005. This increase resulted from an increase in interest income on
investment in marketable securities, attributable to both increased invested balances and higher
rates of return. We expect interest income for the full year 2007 to
decline due to the use of a significant portion of our cash and
investments to acquire TJO in March 2007.
Provision for Income Taxes. The provision for income taxes for 2006 and 2005 is associated with the
federal alternative minimum tax. Taxable income for both 2006 and 2005 was substantially offset by
the utilization of our net operating loss carryforwards.
Net Income. Net income increased approximately $587,000, or 30.7%, to $2.5 million for 2006 from
$1.9 million for 2005. The improvement over 2005 resulted from the increase in revenues and other
factors mentioned above, noting that $682,000 of stock based compensation was expensed during 2006
with no comparable expense during 2005. Net income is expected to
improve in 2007 compared to the full year 2006, resulting in diluted
earnings per share between $0.13 and $0.15. These estimates reflect
the acquisition of TJO, but are subject to the risks and
uncertainties as further described in “Item 1A. Risk
Factors” located elsewhere in this report.
24
Table of Contents
2005 Compared to 2004
Revenues. Revenues increased approximately $7.3 million, or 36.4%, to $27.4 million for 2005 from
$20.1 million for 2004. Revenues for 2005 consisted of $21.2 million for HCO and $6.2 million for
PMD. In 2004, revenues consisted of $14.0 million for HCO and $6.1 million for PMD.
Revenues for HCO increased approximately $7.2 million, or 51.2%, during 2005 primarily related to
survey and research revenues of $4.5 million resulting from the acquisition of DMR in March 2005,
growth in our Internet-based HLC subscriber base of $2.0 million, $900,000 from growth in add-on
courseware subscription revenues, and $158,000 from content maintenance services. These HCO revenue
increases were partially offset by declines in revenues from maintenance and support fees
associated with our installed learning management products of $368,000. Our Internet-based HLC
subscriber base increased approximately 13% during 2005, from approximately 1,040,000 fully
implemented subscribers at the end of 2004 to approximately 1,173,000 fully implemented subscribers
at the end of 2005.
Revenues for PMD increased approximately $143,000, or 2.3%, during 2005, although the mix of
revenues changed. Revenues from live events and online training courseware increased $272,000 and
$391,000, respectively. These revenue increases were partially offset by declines from our
project-based content development services of $527,000. Revenues from our
HospitalDirect® product increased modestly during 2005.
On a pro forma basis, taking into consideration the effect of the DMR acquisition as if the
acquisition had occurred on January 1, 2004, pro forma revenues for 2005 would have been $28.8
million compared to $25.2 million for 2004.
During 2005, 59.8% of revenues were derived from our Internet-based learning products, 16.4% from
survey and research services, 14.9% from live event development services, 6.5% from content
development and maintenance services, and 2.4% from our installed learning management products.
During 2004, 65.2% of revenues were derived from our Internet-based learning products, 18.9% from
live event development services, 10.7% from content development and maintenance services, and 5.2%
from our installed learning management products.
Cost of Revenues (excluding depreciation and amortization). Cost of revenues increased
approximately $2.5 million, or 33.9%, to $9.8 million for 2005 from $7.3 million for 2004. This
increase was the result of the acquisition of DMR’s survey and research service business, including
personnel and other direct expenses, increased direct expenses associated with live events,
increased royalties paid by us to content partners, and increased hosting expenses. These expense
increases were partially offset by lower direct expenses associated with the decline in revenues
from content development services.
Cost of revenues for HCO increased approximately $2.7 million, or 93.0%, to $5.5 million for 2005
from $2.8 million for 2004. This increase consisted of incremental personnel and direct costs
associated with DMR’s survey and research services, increases in personnel and contract labor
associated with content maintenance services, an increase in the royalties paid by us to content
partners, as well as increased hosting expenses.
Cost of revenues for PMD decreased approximately $200,000, or 5.2%, to $3.7 million for 2005 from
$3.9 million for 2004. This decrease resulted from lower direct expenses associated with the
decline in revenues from content development services and lower personnel expenses, but was
partially offset by royalties paid by us to content partners.
Cost of revenues for the unallocated corporate functions increased approximately $41,000, or 6.9%,
to $626,000 for 2005 from $585,000 for 2004. This increase was associated with increased personnel
expenses.
Gross Margin (excluding depreciation and amortization). Gross margin (which we define as revenues
less cost of revenues divided by revenues) improved to 64.4% for 2005 from 63.7% during 2004. This
improvement is a result of the change in revenue mix and related cost of revenues discussed above.
Gross margins for HCO were 74.2% and 79.8% for 2005 and 2004, respectively. This decline resulted
from the acquisition of DMR’s survey and research services, which yielded lower gross margins than
our Internet-based products. Gross margins for PMD were 41.0% and 36.3% for 2005 and 2004,
respectively. This improvement resulted from the change in revenue mix for PMD noted above. Gross
margins for PMD are lower than HCO due to the higher costs associated with delivering live event
and content development services, and variability of costs associated with project-based services.
Product development. Product development expenses increased approximately $397,000, or 15.7%, to
$2.9 million for 2005 from $2.5 million for 2004. This increase resulted from increased personnel
expenses associated with the DMR acquisition and additional personnel to support and maintain our
Internet-based platform products. Product development efforts for 2005 consisted primarily of new
courseware offerings, development of new software features, and the ongoing maintenance and support
for our Internet-based platform. Product development expenses as a percentage of revenues decreased
as a result of the increased revenues to 10.7% of revenues for 2005 from 12.6% of revenues for
2004. In addition to the expenses incurred, we also capitalized approximately $1.0 million and
$900,000 of costs associated with development of software feature enhancements and content during
2005 and 2004, respectively.
25
Table of Contents
Product development expenses for HCO increased approximately $277,000, or 13.8%, to $2.3 million
for 2005 from $2.0 million for 2004. The increase resulted from additional personnel associated
with the acquisition of DMR. Product development expenses for PMD were comparable for both 2005 and
2004, approximating $388,000 for 2005 and $379,000 for 2004. The unallocated corporate portion of
our product development expenses increased approximately $110,000, or 76.3%, to $255,000 for 2005
from $145,000 for 2004. This increase resulted from time and efforts associated with corporate
oversight and projects that were not specific to either the HCO or PMD business units.
Sales and Marketing Expenses. Sales and marketing expenses, including personnel costs, increased
approximately $653,000, or 13.6%, to $5.5 million for 2005 from $4.8 million for 2004, and
approximated 19.9% and 23.9% of revenues for 2005 and 2004, respectively. The increase resulted
from additional personnel expenses associated with the acquisition of DMR, increased commission
expense, and increased spending associated with our annual customer conference, The Summit, which
was attended by 540 customer representatives in 2005 compared to approximately 400 in 2004.
Sales and marketing expense for HCO increased approximately $360,000, or 10.1%, to $3.9 million for
2005 from $3.6 million for 2004, and approximated 18.6% and 25.5% of revenues for 2005 and 2004,
respectively. The expense increase is associated with both DMR personnel and increased spending
associated with The Summit. Sales and marketing expense for PMD increased approximately $289,000,
or 28.2%, to $1.3 million for 2005 from $1.0 million for 2004, and approximated 21.1% and 16.9% of
revenues for 2005 and 2004, respectively. This increase for PMD was associated with increases in
sales personnel and related commission expense. Sales and marketing expense for our unallocated
corporate functions was comparable between periods.
Depreciation and Amortization. Depreciation and amortization increased approximately $572,000, or
27.1%, to $2.7 million for 2005 from $2.1 million for 2004. The increase was associated with
amortization of DMR intangible assets, amortization of capitalized content and software feature
enhancements, and depreciation of property and equipment.
Other General and Administrative. Other general and administrative expenses increased approximately
$324,000, or 7.0%, to $5.0 million for 2005 from $4.6 million for 2004, and approximated 18.1% and
23.1% of revenues for 2005 and 2004, respectively. This expense increase resulted primarily from
the additional personnel and office expenses associated with the DMR acquisition, and was partially
offset by other corporate expense savings. The decrease as a percentage of revenues was the result
of the increase in revenues.
Other Income/Expense. Other income/expense increased approximately $96,000, or 39.3%, to $338,000
for 2005 from $242,000 for 2004. This increase resulted from an increase in interest income on
investment in marketable securities, and was partially offset by increased interest expense
associated with capital lease obligations.
Provision for Income Taxes. The provision for income taxes for 2005 consisted of $21,500 associated
with the federal alternative minimum tax. Taxable income for 2005 was substantially offset by the
utilization of our net operating loss carryforwards.
Net Income (Loss). Net income was $1.9 million for 2005 compared to a net loss of $1.0 million for
2004. The improvement from a net loss in 2004 to net income in 2005 resulted from the increase in
revenues and other factors mentioned above.
26
Table of Contents
SELECTED QUARTERLY OPERATING RESULTS
The following tables set forth selected statement of operations data for the eight quarters ended
December 31, 2006 both in absolute dollars and as a percentage of total revenues. The information
for each quarter has been prepared on substantially the same basis as the audited statements
included in other parts of this report and, in our opinion, includes all adjustments, consisting of
only normal recurring adjustments, necessary for a fair presentation of the results of operations
for these periods. You should read this information in conjunction with HealthStream’s Consolidated
Financial Statements and related notes thereto included elsewhere in this report. The operating
results for any quarter are not necessarily indicative of the results to be expected in the future.
Factors Affecting Quarterly Operating Results
Revenues from our subscription products are recognized ratably over the subscription term. Revenues
from sales of products and services to pharmaceutical and medical device companies can be subject
to seasonal factors resulting from the timing of conferences and live events as well as drug and
product introductions and budget cycles for such companies. DMR’s survey and research revenues are
impacted by seasonal factors resulting from the timing of survey cycles, with the fourth quarter
comprising the highest percentage of annual revenues. The results of operations for DMR have been
included in the Company’s statements of operations, effective March 29, 2005. Effective January 1,
2006, our results of operations include stock based compensation expense associated with the
adoption SFAS No. 123(R) “Share-Based Payment.”
| Quarter Ended | ||||||||||||||||
| March 31, | June 30, | September 30, | December 31, | |||||||||||||
| 2006 | 2006 | 2006 | 2006 | |||||||||||||
| (In thousands, except per share data) | ||||||||||||||||
STATEMENT OF OPERATIONS DATA: |
||||||||||||||||
Revenues, net |
$ | 7,523 | $ | 8,224 | $ | 7,481 | $ | 8,556 | ||||||||
Operating costs and expenses: |
||||||||||||||||
Cost of revenues (excluding depreciation and amortization) |
2,575 | 3,162 | 2,378 | 2,754 | ||||||||||||
Product development |
889 | 837 | 891 | 886 | ||||||||||||
Sales and marketing |
1,629 | 2,033 | 1,648 | 1,710 | ||||||||||||
Depreciation |
336 | 328 | 375 | 367 | ||||||||||||
Amortization |
308 | 339 | 385 | 452 | ||||||||||||
Other general and administrative expenses |
1,237 | 1,397 | 1,509 | 1,450 | ||||||||||||
Total operating costs and expenses |
6,974 | 8,096 | 7,186 | 7,619 | ||||||||||||
Income from operations |
549 | 128 | 295 | 937 | ||||||||||||
Other income, net |
134 | 153 | 165 | 167 | ||||||||||||
Income before income taxes |
683 | 281 | 460 | 1,104 | ||||||||||||
Provision (benefit) for income taxes |
25 | (8 | ) | (14 | ) | 25 | ||||||||||
Net income |
$ | 658 | $ | 289 | $ | 474 | $ | 1,079 | ||||||||
Net income per share: |
||||||||||||||||
Basic |
$ | 0.03 | $ | 0.01 | $ | 0.02 | $ | 0.05 | ||||||||
Diluted |
$ | 0.03 | $ | 0.01 | $ | 0.02 | $ | 0.05 | ||||||||
Weighted average shares of common stock outstanding: |
||||||||||||||||
Basic |
21,284 | 21,475 | 21,619 | 21,928 | ||||||||||||
Diluted |
22,139 | 22,469 | 22,364 | 22,463 | ||||||||||||
| Quarter Ended | ||||||||||||||||
| March 31, | June 30, | September 30, | December 31, | |||||||||||||
| 2005 | 2005 | 2005 | 2005 | |||||||||||||
| (In thousands, except per share data) | ||||||||||||||||
STATEMENT OF OPERATIONS DATA: |
||||||||||||||||
Revenues, net |
$ | 5,682 | $ | 6,806 | $ | 6,831 | $ | 8,040 | ||||||||
Operating costs and expenses: |
||||||||||||||||
Cost of revenues (excluding depreciation and amortization) |
2,036 | 2,460 | 2,392 | 2,858 | ||||||||||||
Product development |
636 | 743 | 720 | 829 | ||||||||||||
Sales and marketing |
1,190 | 1,601 | 1,340 | 1,321 | ||||||||||||
Depreciation |
408 | 402 | 374 | 354 | ||||||||||||
Amortization |
210 | 358 | 278 | 294 | ||||||||||||
Other general and administrative expenses |
1,156 | 1,272 | 1,245 | 1,285 | ||||||||||||
Total operating costs and expenses |
5,636 | 6,836 | 6,349 | 6,941 | ||||||||||||
Income (loss) from operations |
46 | (30 | ) | 482 | 1,099 | |||||||||||
Other income, net |
98 | 68 | 72 | 100 | ||||||||||||
Income before income taxes |
144 | 38 | 554 | 1,199 | ||||||||||||
Provision for income taxes |
— | 15 | — | 7 | ||||||||||||
Net income |
$ | 144 | $ | 23 | $ | 554 | $ | 1,192 | ||||||||
Net income per share: |
||||||||||||||||
Basic |
$ | 0.01 | $ | 0.00 | $ | 0.03 | $ | 0.06 | ||||||||
Diluted |
$ | 0.01 | $ | 0.00 | $ | 0.02 | $ | 0.05 | ||||||||
Weighted average shares of common stock outstanding: |
||||||||||||||||
Basic |
20,686 | 21,054 | 21,212 | 21,253 | ||||||||||||
Diluted |
21,467 | 22,064 | 22,357 | 21,881 | ||||||||||||
27
Table of Contents
| Quarter Ended | ||||||||||||||||
| March 31, | June 30, | September 30, | December 31, | |||||||||||||
| 2006 | 2006 | 2006 | 2006 | |||||||||||||
| (% of Revenues) | ||||||||||||||||
STATEMENT OF OPERATIONS DATA: |
||||||||||||||||
Revenues |
100.0 | 100.0 | 100.0 | 100.0 | ||||||||||||
Operating costs and expenses: |
||||||||||||||||
Cost of revenues (excluding depreciation and amortization) |
34.2 | 38.4 | 31.8 | 32.2 | ||||||||||||
Product development |
11.8 | 10.2 | 11.9 | 10.3 | ||||||||||||
Sales and marketing |
21.7 | 24.7 | 22.0 | 20.0 | ||||||||||||
Depreciation |
4.5 | 4.0 | 5.1 | 4.3 | ||||||||||||
Amortization |
4.1 | 4.1 | 5.1 | 5.3 | ||||||||||||
Other general and administrative expenses |
16.4 | 17.0 | 20.2 | 16.9 | ||||||||||||
Total operating costs and expenses |
92.7 | 98.4 | 96.1 | 89.0 | ||||||||||||
Income from operations |
7.3 | 1.6 | 3.9 | 11.0 | ||||||||||||
Other income, net |
1.8 | 1.8 | 2.2 | 1.9 | ||||||||||||
Income before income taxes |
9.1 | 3.4 | 6.1 | 12.9 | ||||||||||||
Provision (benefit) for income taxes |
0.3 | (0.1 | ) | (0.2 | ) | 0.3 | ||||||||||
Net income |
8.8 | 3.5 | 6.3 | 12.6 | ||||||||||||
| Quarter Ended | ||||||||||||||||
| March 31, | June 30, | September 30, | December 31, | |||||||||||||
| 2005 | 2005 | 2005 | 2005 | |||||||||||||
| (% of Revenues) | ||||||||||||||||
STATEMENT OF OPERATIONS DATA: |
||||||||||||||||
Revenues |
100.0 | 100.0 | 100.0 | 100.0 | ||||||||||||
Operating costs and expenses: |
||||||||||||||||
Cost of revenues (excluding depreciation and amortization) |
35.8 | 36.1 | 35.0 | 35.6 | ||||||||||||
Product development |
11.2 | 10.9 | 10.5 | 10.3 | ||||||||||||
Sales and marketing |
20.9 | 23.5 | 19.6 | 16.4 | ||||||||||||
Depreciation |
7.2 | 5.9 | 5.5 | 4.4 | ||||||||||||
Amortization |
3.7 | 5.3 | 4.1 | 3.7 | ||||||||||||
Other general and administrative expenses |
20.3 | 18.7 | 18.2 | 16.0 | ||||||||||||
Total operating costs and expenses |
99.2 | 100.4 | 92.9 | 86.3 | ||||||||||||
Income (loss) from operations |
0.8 | (0.4 | ) | 7.1 | 13.7 | |||||||||||
Other income, net |
1.7 | 1.0 | 1.1 | 1.2 | ||||||||||||
Income before income taxes |
2.5 | 0.6 | 8.1 | 14.9 | ||||||||||||
Provision for income taxes |
— | 0.2 | — | 0.1 | ||||||||||||
Net income |
2.5 | 0.4 | 8.1 | 14.8 | ||||||||||||
Liquidity and Capital Resources
Since our inception, we have financed our operations largely through proceeds from our IPO, private
placements of equity securities, loans from related parties and, to an increasing extent, from
revenues generated from the sale of our products and services.
Net cash provided by operating activities was approximately $4.0 million during 2006 compared to
$5.8 million during 2005. Although our revenues increased and net income improved over the prior
year, working capital increases associated with accounts and unbilled receivables negatively
impacted our cash flows from operations. Our primary sources of cash are generated from receipts
from the sales of our products and services, as well as receipts associated with commercial support
grants. Cash receipts associated with commercial support grants are often received after we have
made payments for which such grants are to be used. At December 31, 2006, increases in our accounts
and unbilled receivable balances were partially attributable to such timing. The $1.8 million
increase in accounts receivable at December 31, 2006 compared to December 31, 2005 resulted in a
corresponding increase in the number of days sales outstanding (DSO). DSO was 64 days for 2006
compared to 59 days for 2005. This increase resulted primarily from delays in cash receipts from
commercial support grants, of which a portion relate to pass through expenses we paid during 2006.
The Company calculates DSO by dividing the average accounts receivable balance (excluding unbilled
and other receivables) by average daily revenues for the year. The primary uses of cash to fund our
operations include personnel expenses, payments of employee bonuses, sales commissions, royalty
payments, payments for contract labor and other direct expenses associated with delivery of our
products and services, and general corporate expenses, as well as payments associated with content
development. Cash generated from operating activities during 2005 resulted from cash receipts from
customers and receipts of commercial support grants, which exceeded cash used to fund our operating
expenses.
28
Table of Contents
Net cash provided by investing activities was approximately $536,000 for 2006 while $3.1 million of
cash was used in 2005. During 2006, the primary uses of cash related to payments associated with
software feature enhancements and property and equipment purchases. These purchases were associated
with development costs of our Next Generation HLC and other new products as well as hardware and
software to support our Internet-based product infrastructure and leasehold improvements for our
corporate headquarters. In addition, during 2006 we incurred approximately $270,000 of expenses
associated with the March 2007 acquisition of TJO. These uses of cash were offset by the net
proceeds from sales of investments in marketable securities. During 2005, we utilized approximately
$9.5 million of cash and investments to purchase DMR, $752,000 for purchases of property and
equipment and $626,000 for software feature enhancements, which was partially offset by net
proceeds from sales of investments in marketable securities.
Cash provided by financing activities was approximately $466,000 and $722,000 during 2006 and 2005,
respectively. The primary sources of cash for both 2006 and 2005 resulted from proceeds associated
with the issuance of common stock from both the exercise of employee stock options and the Employee
Stock Purchase Plan, offset by payments under capital lease obligations. Cash received from stock
options is dependent on many factors, including our stock price, option exercise prices, and the
option holder’s intent to exercise. Due to these factors we are unable to estimate future proceeds
from stock options.
As of December 31, 2006, our primary source of liquidity was $12.8 million of cash and cash
equivalents, restricted cash, investments in marketable securities, and related interest
receivable. The Company also has a revolving credit facility loan agreement, of which the available
balance was increased from $7.0 million to $10.0 million in February 2007, subject to certain
covenants. We believe this loan agreement provides us additional ability to fund investments within
our business, including any potential future business acquisitions. There were no amounts
outstanding under this loan agreement as of December 31, 2006, and we had no indebtedness other
than capital lease obligations.
We believe that our existing cash and cash equivalents, restricted cash, investments in marketable
securities and related interest receivable, and available borrowings under our revolving credit
facility will be sufficient to meet anticipated cash needs for working capital, new product
development and capital expenditures for at least the next 12 months. As part of our growth
strategy, we are actively reviewing possible acquisitions that complement our products and
services. On March 12, 2007, we acquired TJO for
$11.6 million in cash, utilizing a significant portion of our
cash and investment balances, and 252,616 shares of our
common stock. We anticipate that any future acquisitions would be effected through a combination of
stock and cash consideration. We may need to raise additional capital through the issuance of
equity or debt securities and/or borrowings under our revolving credit facility, or other facility,
to finance any future acquisitions. The issuance of our stock as consideration for an acquisition
would have a dilutive effect and could adversely affect our stock price. There can be no assurance
that additional sources of financing will be available to us on acceptable terms, or at all, to
consummate any acquisitions. Failure to generate sufficient cash flow from operations or raise
additional capital when required in sufficient amounts and on terms acceptable to us could harm our
business, financial condition and results of operations.
Commitments and Contingencies
We expect that our capital expenditures, software feature enhancements, and content purchases will
approximate $5.0 million in 2007. We expect to fund these capital expenditures with existing cash
and investments and from cash generated from operations, and if necessary from our revolving credit
facility. From January 1 through February 28, 2007, we had capital expenditures of approximately
$527,000, primarily related to hardware, software, content, and software feature enhancements.
Our strategic alliances have typically provided for payments to content partners based on revenues
and development partners and other parties based on services rendered. We expect to continue
similar arrangements in the future. We also have commitments for our live event services associated
with securing hotel arrangements, which are typically fully funded from commercial support grants.
In addition to these commitments, we have capital lease obligations for computer hardware and
operating lease commitments for our operating facilities in Nashville, TN, Franklin, TN, and
Denver, CO, and a closed facility in Dallas, TX, which we sublease.
A summary of future anticipated payments for commitments and other contractual obligations as of
December 31, 2006 are outlined below:
| Payments due by period | ||||||||||||||||||||
| More than 5 | ||||||||||||||||||||
| Less than 1 year | 1-3 years | 3-5 years | years | Total | ||||||||||||||||
Capital lease obligations |
$ | 193,611 | $ | 111,334 | $ | — | $ | — | $ | 304,945 | ||||||||||
Operating leases |
706,626 | 779,743 | 116,407 | — | 1,602,776 | |||||||||||||||
Purchase commitments |
217,892 | 97,200 | — | — | 315,092 | |||||||||||||||
Other contractual obligations |
1,436,687 | — | — | — | 1,436,687 | |||||||||||||||
Total |
$ | 2,554,816 | $ | 988,277 | $ | 116,407 | $ | — | $ | 3,659,500 | ||||||||||
29
Table of Contents
Off-Balance Sheet Arrangements
The Company’s off-balance sheet arrangements are included in the table of commitments listed above.
In addition, the Company’s other significant off-balance sheet arrangement relates to the Revolving
Credit Facility, and is described further in Note 13 to the Company’s consolidated financial
statements contained elsewhere in this report.
Recent Accounting Pronouncements
In June 2006, the Financial Accounting Standards Board issued FASB Interpretation No. 48,
“Accounting for Uncertainty in Income Taxes — an interpretation of FASB Statement No. 109” (“FIN
48”). This Interpretation clarifies the accounting for uncertainty in income taxes recognized in
the financial statements, and requires companies to use a more-likely-than-not recognition
threshold based on the technical merits of the tax position taken. Tax positions that meet the
more-likely-than-not recognition threshold should be measured in order to determine the tax benefit
to be recognized in the financial statements. FIN 48 is effective in fiscal years beginning after
December 15, 2006. The Company is currently evaluating the impact that the adoption of FIN 48 will
have on its financial position and results of operations. The Company
is required to adopt the provisions of FIN
48 effective January 1, 2007.
On September 15, 2006, the FASB issued, SFAS No. 157, “Fair Value Measurements.” The standard
provides guidance for using fair value to measure assets and liabilities and applies whenever other
standards require (or permit) assets or liabilities to be measured at fair value. The standard
does not expand the use of fair value in any new circumstances. SFAS No. 157 is effective for
financial statements issued for fiscal years beginning after November 15, 2007. Management is in
the process of evaluating the impact of this new standard on the Company’s financial position and
results of operations.
In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and
Financial Liabilities.” This new standard provides companies with an option to report selected
financial assets and liabilities at fair value. Generally accepted accounting principles have
required different measurement attributes for different assets and liabilities that can create
artificial volatility in earnings. The FASB believes that Statement 159 helps to mitigate this type
of accounting-induced volatility by enabling companies to report related assets and liabilities at
fair value, which would likely reduce the need for companies to comply with detailed rules for
hedge accounting. Statement 159 also establishes presentation and disclosure requirements designed
to facilitate comparisons between companies that choose different measurement attributes for
similar types of assets and liabilities. The new Statement does not eliminate disclosure
requirements included in other accounting standards, including requirements for disclosures about
fair value measurements included in SFAS No. 157 and No. 107. This Statement is effective beginning
January 1, 2008 for the Company, with early adoption permitted under certain circumstances.
Management is currently evaluating the impact that adoption of SFAS No. 159 will have on the
Company’s financial position and results of operations
Item 7A. Quantitative and Qualitative Disclosures about Market Risk
We are exposed to market risk from changes in interest rates. We do not have any foreign currency
exchange rate risk or commodity price risk. As of December 31, 2006, we had no outstanding
indebtedness other than approximately $283,000 of capital lease obligations. In February 2007, we
increased the amount available under our revolving credit facility from $7.0 million to $10.0
million. We may become subject to interest rate market risk associated with borrowings under this
credit facility, which bears interest at a variable rate based on the 30 Day LIBOR Rate plus 150
basis points. We are also exposed to market risk with respect to our cash and investment balances.
At December 31, 2006, the Company had cash and cash equivalents, restricted cash, investments in
marketable securities, and related interest receivable totaling approximately $12.8 million.
Current investment rates of return approximate 5.0-5.5%. Assuming a 5.25% rate of return on $12.8
million, a hypothetical 10% decrease in interest rates would decrease interest income and decrease
net income on an annualized basis by approximately $67,000.
The Company manages its investment risk by investing in corporate debt securities, foreign
corporate debt, secured corporate debt, and municipal debt securities with minimum acceptable
credit ratings. For certificates of deposit and corporate obligations, ratings must be A2/A or
better; A1/P1 or better for commercial paper; A2/A or better for taxable or tax advantaged auction
rate securities and AAA or better for tax free auction rate securities. The Company also requires
that all securities must mature within 24 months from the original settlement date, the average
portfolio shall not exceed 18 months, and the greater of 10% or $5.0 million shall mature within 90
days. Further, the Company’s investment policy also limits concentration exposure and other
potential risk areas. As of December 31, 2006, all of our investments in marketable securities
were in auction rate securities. During March 2007, all investments in marketable securities,
totaling approximately $1.7 million, were sold in order to fund the acquisition of TJO.
The above market risk discussion and the estimated amounts presented are forward-looking statements
of market risk assuming the occurrence of certain adverse market conditions. Actual results in the
future may differ materially from those projected as a result of actual developments in the market.
30
Table of Contents
Item 8. Financial Statements and Supplementary Data
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | ||||
| 32 | ||||
| 33 | ||||
| 34 | ||||
| 35 | ||||
| 36 | ||||
| 37 | ||||
31
Table of Contents
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Shareholders of
HealthStream, Inc.
HealthStream, Inc.
We have audited the accompanying consolidated balance sheets of HealthStream, Inc. as of December
31, 2006 and 2005, and the related consolidated statements of operations, shareholders’ equity, and
cash flows for each of the three years in the period ended December 31, 2006. These financial
statements are the responsibility of the Company’s management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement. We
were not engaged to perform an audit of the Company’s internal control over financial reporting.
Our audit included consideration of internal control over financial reporting as a basis for
designing audit procedures that are appropriate in the circumstances, but not for the purpose of
expressing an opinion on the effectiveness of the Company’s internal control over financial
reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test
basis, evidence supporting the amounts and disclosures in the financial statements, assessing the
accounting principles used and significant estimates made by management, and evaluating the overall
financial statement presentation. We believe that our audits provide a reasonable basis for our
opinion.
In our opinion, the financial statements referred to above present fairly, in all material
respects, the consolidated financial position of HealthStream, Inc. at December 31, 2006 and 2005,
and the consolidated results of its operations and its cash flows for each of the three years in
the period ended December 31, 2006, in conformity with U.S. generally accepted accounting
principles.
As discussed in Notes 1 and 11 to the consolidated financial statements, the Company
changed its method of accounting for share-based payments in accordance with Statement of Financial
Accounting Standards No. 123(R), Share-Based Payment, on January 1, 2006.
| /s/ Ernst & Young LLP | ||||
Nashville, Tennessee
March 27, 2007
March 27, 2007
32
Table of Contents
HEALTHSTREAM, INC.
CONSOLIDATED BALANCE SHEETS
| December 31, | December 31, | |||||||
| 2006 | 2005 | |||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 10,725,780 | $ | 5,726,151 | ||||
Investments in marketable securities |
1,700,000 | 6,175,000 | ||||||
Restricted cash |
264,714 | 238,538 | ||||||
Interest receivable |
68,435 | 54,524 | ||||||
Accounts receivable, net of allowance for doubtful accounts of $112,234
and $115,090 at December 31, 2006 and 2005, respectively |
6,518,624 | 4,691,402 | ||||||
Accounts receivable — unbilled |
1,274,511 | 706,011 | ||||||
Prepaid development fees, net of amortization |
1,055,135 | 548,084 | ||||||
Other prepaid expenses and other current assets |
603,461 | 488,324 | ||||||
Total current assets |
22,210,660 | 18,628,034 | ||||||
Property and equipment: |
||||||||
Equipment |
8,218,525 | 7,446,451 | ||||||
Leasehold improvements |
1,773,701 | 1,281,460 | ||||||
Furniture and fixtures |
1,091,494 | 1,011,877 | ||||||
| 11,083,720 | 9,739,788 | |||||||
Less accumulated depreciation and amortization |
(8,899,863 | ) | (7,636,306 | ) | ||||
| 2,183,857 | 2,103,482 | |||||||
Capitalized software feature enhancements, net of accumulated amortization of $622,298
and $249,276 at December 31, 2006 and 2005, respectively |
2,572,111 | 720,447 | ||||||
Goodwill |
10,317,393 | 10,317,393 | ||||||
Intangible assets, net of accumulated amortization of $7,756,161
and $7,247,828 at December 31, 2006 and 2005, respectively |
2,755,981 | 3,264,314 | ||||||
Other assets |
968,484 | 182,470 | ||||||
Total assets |
$ | 41,008,486 | $ | 35,216,140 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 1,616,105 | $ | 933,895 | ||||
Accrued liabilities |
2,465,123 | 1,487,568 | ||||||
Accrued compensation and related expenses |
874,064 | 639,468 | ||||||
Registration liabilities |
240,399 | 231,142 | ||||||
Commercial support liabilities |
315,210 | 1,239,124 | ||||||
Deferred revenue |
5,375,625 | 4,502,924 | ||||||
Current portion of capital lease obligations |
176,574 | 166,022 | ||||||
Total current liabilities |
11,063,100 | 9,200,143 | ||||||
Capital lease obligations, less current portion |
106,780 | 215,856 | ||||||
Other long term liabilities |
204,167 | — | ||||||
Commitments and contingencies |
— | — | ||||||
Shareholders’ equity: |
||||||||
Common stock, no par value, 75,000,000 shares authorized;
21,928,687 and 21,574,904 shares issued and outstanding
at December 31, 2006 and 2005, respectively |
95,134,550 | 93,799,932 | ||||||
Accumulated deficit |
(65,500,111 | ) | (67,999,791 | ) | ||||
Total shareholders’ equity |
29,634,439 | 25,800,141 | ||||||
Total liabilities and shareholders’ equity |
$ | 41,008,486 | $ | 35,216,140 | ||||
See accompanying notes to the consolidated financial statements.
33
Table of Contents
HEALTHSTREAM, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
| For the Year Ended December 31, | ||||||||||||
| 2006 | 2005 | 2004 | ||||||||||
Revenues, net |
$ | 31,783,469 | $ | 27,359,406 | $ | 20,057,308 | ||||||
Operating costs and expenses: |
||||||||||||
Cost of revenues (excluding depreciation and amortization) |
10,869,303 | 9,745,470 | 7,277,173 | |||||||||
Product development |
3,502,790 | 2,928,112 | 2,531,177 | |||||||||
Sales and marketing |
7,020,051 | 5,452,168 | 4,798,687 | |||||||||
Depreciation |
1,405,616 | 1,537,959 | 1,366,216 | |||||||||
Amortization of intangibles, content fees and software feature enhancements |
1,483,552 | 1,140,481 | 740,542 | |||||||||
Other general and administrative expenses |
5,593,026 | 4,958,508 | 4,634,377 | |||||||||
Total operating costs and expenses |
29,874,338 | 25,762,698 | 21,348,172 | |||||||||
Income (loss) from operations |
1,909,131 | 1,596,708 | (1,290,864 | ) | ||||||||
Other income (expense): |
||||||||||||
Interest and other income |
657,431 | 367,707 | 258,144 | |||||||||
Interest expense |
(36,715 | ) | (23,524 | ) | (13,095 | ) | ||||||
Other expense |
(2,123 | ) | (6,463 | ) | (2,565 | ) | ||||||
Total other income (expense) |
618,593 | 337,720 | 242,484 | |||||||||
Income (loss) before income taxes |
2,527,724 | 1,934,428 | (1,048,380 | ) | ||||||||
Provision for income taxes |
28,044 | 21,500 | — | |||||||||
Net income (loss) |
$ | 2,499,680 | $ | 1,912,928 | $ | (1,048,380 | ) | |||||
Net income (loss) per share: |
||||||||||||
Basic |
$ | 0.12 | $ | 0.09 | $ | (0.05 | ) | |||||
Diluted |
$ | 0.11 | $ | 0.09 | $ | (0.05 | ) | |||||
Weighted average shares of common stock outstanding: |
||||||||||||
Basic |
21,576,553 | 21,051,373 | 20,585,825 | |||||||||
Diluted |
22,358,648 | 21,942,182 | 20,585,825 | |||||||||
See accompanying notes to the consolidated financial statements.
34
Table of Contents
HEALTHSTREAM, INC.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
| Accumulated | ||||||||||||||||||||
| Other | Total | |||||||||||||||||||
| Common Stock | Accumulated | Comprehensive | Shareholders’ | |||||||||||||||||
| Shares | Amount | Deficit | Income | Equity | ||||||||||||||||
Balance at December 31, 2003 |
20,455,746 | $ | 91,416,853 | $ | (68,864,339 | ) | $ | 5,475 | $ | 22,557,989 | ||||||||||
Net loss |
— | — | (1,048,380 | ) | — | (1,048,380 | ) | |||||||||||||
Unrealized loss on
investments in marketable
securities, net of tax |
— | — | — | (5,475 | ) | (5,475 | ) | |||||||||||||
Comprehensive loss |
(1,053,855 | ) | ||||||||||||||||||
Exercise of stock options |
121,503 | 148,804 | — | — | 148,804 | |||||||||||||||
Issuance of common stock to
Employee Stock Purchase
Plan |
90,266 | 76,726 | — | — | 76,726 | |||||||||||||||
Balance at December 31, 2004 |
20,667,515 | 91,642,383 | (69,912,719 | ) | — | 21,729,664 | ||||||||||||||
Net income |
— | — | 1,912,928 | — | 1,912,928 | |||||||||||||||
Exercise of stock options |
344,413 | 654,955 | — | — | 654,955 | |||||||||||||||
Issuance of common stock to
Employee Stock Purchase
Plan |
83,742 | 159,445 | — | — | 159,445 | |||||||||||||||
Issuance of common stock in
connection with acquisition |
479,234 | 1,343,149 | — | — | 1,343,149 | |||||||||||||||
Balance at December 31, 2005 |
21,574,904 | 93,799,932 | (67,999,791 | ) | — | 25,800,141 | ||||||||||||||
Net income |
— | — | 2,499,680 | — | 2,499,680 | |||||||||||||||
Stock based compensation |
— | 682,068 | — | — | 682,068 | |||||||||||||||
Exercise of stock options |
285,681 | 490,467 | — | — | 490,467 | |||||||||||||||
Issuance of common stock to
Employee Stock Purchase
Plan |
68,102 | 162,083 | — | — | 162,083 | |||||||||||||||
Balance at December 31, 2006 |
21,928,687 | $ | 95,134,550 | $ | (65,500,111 | ) | $ | — | $ | 29,634,439 | ||||||||||
See accompanying notes to the consolidated financial statements.
35
Table of Contents
HEALTHSTREAM, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
| For the Year Ended December 31, | ||||||||||||
| 2006 | 2005 | 2004 | ||||||||||
OPERATING ACTIVITIES: |
||||||||||||
Net income (loss) |
$ | 2,499,680 | $ | 1,912,928 | $ | (1,048,380 | ) | |||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
||||||||||||
Depreciation |
1,405,616 | 1,537,959 | 1,366,216 | |||||||||
Amortization of intangibles, content fees and software feature enhancements |
1,483,552 | 1,140,481 | 740,542 | |||||||||
Stock based compensation expense |
682,068 | — | — | |||||||||
Impairment of capitalized software feature enhancements |
— | 55,000 | — | |||||||||
Provision for doubtful accounts |
15,000 | 40,000 | 40,000 | |||||||||
Realized loss on disposal of property and equipment |
2,713 | 5,698 | 1,153 | |||||||||
Changes in operating assets and liabilities, excluding effects of acquisitions: |
||||||||||||
Accounts and unbilled receivables |
(2,410,722 | ) | (524,468 | ) | (1,415,518 | ) | ||||||
Restricted cash |
(26,176 | ) | (54,497 | ) | 539,837 | |||||||
Interest receivable |
(13,911 | ) | (28,625 | ) | 93,364 | |||||||
Prepaid development fees |
(730,083 | ) | (428,509 | ) | (612,948 | ) | ||||||
Other prepaid expenses and other current assets |
(115,137 | ) | 164,614 | 197,443 | ||||||||
Other assets |
2,806 | 91,044 | (65,485 | ) | ||||||||
Accounts payable |
682,210 | 68,155 | (34,036 | ) | ||||||||
Accrued liabilities and compensation |
657,151 | 475,073 | 260,723 | |||||||||
Registration liabilities |
9,257 | 56,445 | (560,568 | ) | ||||||||
Commercial support liabilities |
(923,914 | ) | 860,231 | 378,893 | ||||||||
Deferred revenue |
777,701 | 427,710 | 807,035 | |||||||||
Net cash provided by operating activities |
3,997,811 | 5,799,239 | 688,271 | |||||||||
INVESTING ACTIVITIES: |
||||||||||||
Acquisition, net of cash acquired |
— | (9,524,076 | ) | — | ||||||||
Proceeds from maturities and sale of investments in marketable securities |
18,785,000 | 20,500,000 | 18,951,000 | |||||||||
Purchases of investments in marketable securities |
(14,303,816 | ) | (12,650,000 | ) | (19,077,045 | ) | ||||||
Other assets |
(270,004 | ) | — | — | ||||||||
Collection of note receivable — related party |
— | — | 233,003 | |||||||||
Payments associated with capitalized software feature enhancements |
(2,274,684 | ) | (626,122 | ) | (312,806 | ) | ||||||
Purchases of property and equipment |
(1,400,637 | ) | (752,222 | ) | (1,620,906 | ) | ||||||
Net cash provided by (used in) investing activities |
535,859 | (3,052,420 | ) | (1,826,754 | ) | |||||||
FINANCING ACTIVITIES: |
||||||||||||
Issuance of common stock to Employee Stock Purchase Plan |
162,083 | 159,445 | 76,726 | |||||||||
Proceeds from exercise of stock options |
490,467 | 654,955 | 148,804 | |||||||||
Payments on capital lease obligations |
(186,591 | ) | (92,440 | ) | (49,482 | ) | ||||||
Net cash provided by financing activities |
465,959 | 721,960 | 176,048 | |||||||||
Net increase (decrease) in cash and cash equivalents |
4,999,629 | 3,468,779 | (962,435 | ) | ||||||||
Cash and cash equivalents at beginning of period |
5,726,151 | 2,257,372 | 3,219,807 | |||||||||
Cash and cash equivalents at end of period |
$ | 10,725,780 | $ | 5,726,151 | $ | 2,257,372 | ||||||
SUPPLEMENTAL CASH FLOW INFORMATION: |
||||||||||||
Interest paid |
$ | 36,404 | $ | 23,524 | $ | 13,095 | ||||||
Income taxes paid |
$ | 21,000 | $ | 15,000 | $ | — | ||||||
NON-CASH INVESTING AND FINANCING ACTIVITIES: |
||||||||||||
Capital lease obligations incurred |
$ | 88,067 | $ | 420,777 | $ | 62,804 | ||||||
Acquisition of content rights in exchange for future services |
$ | 904,167 | $ | — | $ | — | ||||||
Issuance of common stock in connection with acquisition of company |
$ | — | $ | 1,343,149 | $ | — | ||||||
Effects of acquisition: |
||||||||||||
Estimated fair value of tangible assets acquired |
$ | — | $ | 718,357 | $ | — | ||||||
Estimated fair value of liabilities assumed |
— | (494,026 | ) | — | ||||||||
Purchase price in excess of net tangible assets acquired |
— | 10,660,705 | — | |||||||||
Less fair value of stock issued |
— | (1,343,149 | ) | — | ||||||||
Cash paid |
— | 9,541,887 | — | |||||||||
Less cash acquired |
— | (17,811 | ) | — | ||||||||
Net cash paid for acquisition |
$ | — | $ | 9,524,076 | $ | — | ||||||
See accompanying notes to the consolidated financial statements.
36
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Reporting Entity
HealthStream, Inc. (the “Company”) was incorporated in 1990 as a Tennessee corporation and is
headquartered in Nashville, Tennessee. We provide Internet-based services and solutions to meet
the ongoing training, information, and education needs of the healthcare community. These
solutions provide, deliver and track computer based education for our customers in the United
States through our application service provider (ASP) products and installed learning management
products. We also provide healthcare organizations a wide range of quality and satisfaction
surveys, analyses of survey results, and other research-based services. We also develop, manage,
and distribute live, online and print education and training activities for provider-based
healthcare professionals and physicians as well as online education and training activities for
sales representatives, which are all supported by pharmaceutical and medical device companies.
Business Segments
We operate our business in two segments: 1) services provided to healthcare organizations and
professionals, and 2) services provided to pharmaceutical and medical device companies. Services
to healthcare organizations and professionals include offerings of our Internet-based learning
products, including authoring, survey and research services, maintenance and support of our
installed learning management products, courseware subscriptions, content maintenance, and
competency tools. Our services to pharmaceutical and medical device companies include live and
online educational training activities for healthcare professionals, content development services,
as well as online training for medical industry representatives.
Recognition of Revenue
Revenues are derived from providing services through our Internet-based learning products,
provision of survey and research services, maintenance and support of our installed learning
management products, courseware subscriptions, live event development, content maintenance and
development and other education and training services.
We recognize revenue in accordance with American Institute of Certified Public Accountants (AICPA)
Statement of Position (SOP) 97-2, “Software Revenue Recognition,” SEC Staff Accounting Bulletin
No. 104, “Revenue Recognition,” Emerging Issues Task Force (EITF) Issue No. 99-19 “Reporting
Revenue Gross Versus Net,” EITF Issue No. 00-3 “Application of AICPA Statement of Position 97-2,
Software Revenue Recognition, to Arrangements that Include the Right to Use Software Stored on
Another Entity’s Hardware,” EITF Issue No. 00-21 “Revenue Arrangements with Multiple Deliverables”
and other authoritative guidance. This guidance provides that revenue recognized from software and
other arrangements is to be allocated to each element of the arrangement based on the relative
fair values of the elements. While elements include software products and post contract customer
support, fair value of each element is based on objective evidence specific to the vendor. If fair
value cannot be determined for each element of the arrangement, all revenue from the arrangement
is deferred until fair value can be determined or until all elements of the arrangement are
delivered and customer acceptance has occurred. Sales of our Internet-based learning products
include customer support, implementation services, and training; therefore all revenues are
deferred until the Internet-based learning product is implemented, at which time revenues are
recognized ratably over the subscription service period. In the event that circumstances occur,
which give rise to uncertainty regarding the collectibility of contracted amounts, revenue
recognition is suspended until such uncertainty is resolved. Fees for these services are billed on
either a monthly, quarterly, or annual basis.
Revenues derived from the delivery of services through our Internet-based learning products and
courseware subscriptions are recognized ratably over the term of the subscription service
agreement. Software support and maintenance revenues associated with our installed learning
management products are recognized ratably over the term of the related agreement, generally one
year. Other training revenues are generally recognized upon the completion of training.
Revenues recognized from our survey and research services are determined using the proportional
performance method. Revenues are earned over the estimated survey cycle, which typically ranges
from less than one month to up to four months. The survey cycle is generally initiated based on
the receipt of the first survey response and runs through provision of related survey reports to
the customer. All other revenues are recognized as the related services are performed or products
are delivered. Fees for these services are billed upon initiation of the survey cycle, with
progress billings made throughout the survey cycle.
37
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Revenues derived from live event development services are recognized using the proportional
performance method based on the completion of performance milestones. Revenues from content
maintenance and development services are recognized using a percentage of completion method based
on labor hours, which correspond to the completion of performance milestones and deliverables. All
other revenues are recognized as the related services are performed or products are delivered.
Fees for these services are billed at initiation of the project and upon completion of the
project.
Principles of Consolidation
The consolidated financial statements include the accounts of the Company and its subsidiaries,
all of which are wholly-owned. All inter-company accounts and transactions have been eliminated in
consolidation.
Reclassifications
Certain reclassifications have been made to the prior year’s financial statements to conform with
the current year presentation.
We have classified capitalized software feature enhancements as a separate long term asset in our
financial statements based on our increased investments in software feature enhancements during
2006. We have made a corresponding reclassification to the December 31, 2005 balance sheet to
present separately capitalized software feature enhancements which were previously included within
“Prepaid expenses and other current assets” and “Other assets.” We have also reclassified our
payments associated with capitalized software feature enhancements to present those payments in
the investing activities section within the statement of cash flows for the years ended December
31, 2006, 2005, and 2004.
Use of Estimates
The preparation of the consolidated financial statements in conformity with accounting principles
generally accepted in the United States requires management to make estimates and assumptions that
affect the amounts reported in the financial statements and accompanying notes. Actual results
could differ from those estimates and such differences could be material to the consolidated
financial statements.
Cash and Cash Equivalents
We consider cash and cash equivalents to be unrestricted, highly liquid investments with initial
maturities of less than three months.
Restricted Cash
Cash received for registration fees is classified as restricted cash on the accompanying
consolidated balance sheets. The use of this cash is restricted because it is held on behalf of
the commercial supporter until services have been rendered, at which time the registration fees
are used to pay certain expenses and fees for conducting those services. Excess registration funds
are typically remitted to the commercial supporter or applied to other projects. Any deficiency in
registration funds is billed to the commercial supporter.
Accounts Receivable-Unbilled and Deferred Revenue
Accounts receivable-unbilled represents revenue earned for contracts accounted for on the
proportional performance basis for which invoices have not been generated or contractual billing
dates have not been reached. Deferred revenue represents amounts, which have been billed or
collected, but not yet recognized in revenue.
Allowance for Doubtful Accounts
The Company estimates its allowance for doubtful accounts using a specific identification method.
Management determines the allowance for doubtful accounts on a case-by-case basis, based on the
facts and circumstances surrounding each potentially uncollectible receivable. An allowance is
also maintained for accounts that are not specifically identified that may become uncollectible in
the future. Uncollectible receivables are written-off in the period management believes it has
exhausted every opportunity to collect payment from the customer. Bad debt expense is recorded
when events or circumstances indicate an additional allowance is required based on our specific
identification approach.
38
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Changes in the allowance for doubtful accounts and the amounts charged to bad debt expense
were as follows:
| Allowance Balance at | Charged to Costs and | Allowance Balance at | ||||||||||||||
| Beginning of Period | Expenses | Write-offs | End of Period | |||||||||||||
Year ended December 31, |
||||||||||||||||
2006 |
$ | 115,090 | $ | 15,000 | $ | 17,856 | $ | 112,234 | ||||||||
2005 |
$ | 234,167 | $ | 40,000 | $ | 159,077 | $ | 115,090 | ||||||||
2004 |
$ | 278,502 | $ | 40,000 | $ | 84,335 | $ | 234,167 | ||||||||
Investments in marketable securities
Investments in marketable securities are classified as available-for-sale and are stated at fair
market value, with any unrealized gains and losses, net of tax, reported in other comprehensive
income on the accompanying consolidated balance sheets. Realized gains and losses and declines in
market value judged to be other-than-temporary on investments in marketable securities are
included in interest and other income on the accompanying consolidated statements of operations.
The cost of securities sold is based on the specific identification method. Interest and dividends
on securities classified as available-for-sale are included in interest and other income on the
accompanying consolidated statements of operations.
The Company invests in auction rate securities, corporate debt securities, foreign corporate debt
and secured corporate debt securities with minimum acceptable credit ratings. The Company
classifies investments in auction rate securities as short-term investments although their
scheduled maturities may be greater than 12 months. This determination is based on management’s
intent of holding such securities for less than 12 months from the current balance sheet date.
Capitalized Software Feature Enhancements
We account for capitalized software feature enhancements in accordance with SOP 98-1 “Accounting
for the Costs of Computer Software Developed or Obtained for Internal Use.” Capitalized software
feature enhancements are stated on the basis of cost, and are presented net of accumulated
amortization. We capitalize costs incurred during the development phase for such projects when
such costs are material. These assets are amortized using the straight-line method, generally over
one to four years. The Company capitalized approximately $2.3 million and $626,000 during 2006 and
2005, respectively. Maintenance and operating costs are expensed as incurred. As of December 31,
2006 and 2005, we had no capitalized internal development costs for computer software developed
for resale.
Property and Equipment
Property and equipment are stated on the basis of cost. Depreciation and amortization are provided
on the straight-line method over the following estimated useful lives, except for assets under
capital leases and leasehold improvements, which are amortized over the shorter of the estimated
useful life or their respective lease term.
| Years | ||||
Furniture and fixtures |
5-10 | |||
Equipment |
3-5 | |||
Goodwill and Intangible Assets
Goodwill represents the excess of purchase price over fair value of net tangible assets acquired.
We account for goodwill and intangible assets in accordance with Statement of Financial Accounting
Standards (SFAS) No. 142, “Goodwill and Other Intangible Assets.” We measure goodwill for
impairment at the reporting unit level using a discounted cash flow model to determine the fair
value of the reporting units. We will perform our goodwill impairment test whenever events or
changes in facts or circumstances indicate that impairment may exist, or at least annually during
the fourth quarter each year.
39
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Intangible assets acquired through acquisitions are comprised of content, contract rights,
customer relationships, non-competition agreements and favorable lease rights. As of December 31,
2006 intangible assets with remaining unamortized balances include contract rights, customer
relationships and non-competition agreements recorded in connection with the acquisition of Data
Management and Research, Inc. (DMR). Intangible assets are considered to have definite useful
lives and are being amortized on a straight line basis over the expected periods to be benefited,
generally three to five years for content, two to eight years for contract rights, customer lists
and customer relationships, six months to three years for non-competition agreements, and over the
lease term for favorable lease rights. Our weighted average amortization period for definite lived
intangible assets as of December 31, 2006 is 7.7 years. Intangible assets are reviewed for
impairment whenever events or changes in facts or circumstances indicate that the carrying amount
of the assets may not be recoverable.
Long-Lived Assets
We account for assets of a long term nature (“long-lived assets”) in accordance with SFAS No. 144,
“Accounting for the Impairment or Disposal of Long-Lived Assets,” which requires that companies
consider whether events or changes in facts and circumstances, both internally and externally, may
indicate that an impairment of long-lived assets held for use are present. We measure any
impairment at the reporting unit level based on discounted future cash flows from the reporting
unit including the long-lived assets. The cash flow estimates and discount rates incorporate
management’s best estimates, using appropriate and customary assumptions and projections at the
date of evaluation. Management periodically evaluates the carrying value of long-lived assets,
including property and equipment, other assets and intangible assets. We recorded a $55,000
impairment charge within our HCO segment associated with capitalized software feature enhancements
for the year ended December 31, 2005. There were no impairments identified or recorded for the
years ended December 31, 2006 or 2004.
Other Assets
Other assets are comprised of the long term portion of content development fees and other assets
of a long term nature.
Income Taxes
Income taxes have been provided using the liability method in accordance with SFAS No. 109, “Accounting for
Income Taxes.” Under the liability method, deferred tax assets and liabilities are determined based on the
temporary differences between the financial statement and tax bases of assets and liabilities measured at tax rates
that will be in effect for the year in which the differences are expected to affect taxable income. Management
reviews the realizability of deferred tax assets each period and has established a full valuation allowance for net
deferred tax assets at year-end in order to reduce deferred tax assets to amounts that are more likely than not
expected to be realized. Under SFAS No. 109, all available evidence, both positive and negative, should be
considered to determine whether, based on the weight of that evidence, a valuation allowance is needed. Future
realization of the tax benefit of an existing deductible temporary difference or carryforward ultimately depends on
the existence of sufficient taxable income of the appropriate character within the carryback or carryforward period
available under the tax law. SFAS No. 109 identifies four possible sources of taxable income that may be
available under the tax law to realize a tax benefit for deductible temporary differences and carryforwards: 1)
future reversals of existing taxable temporary differences, 2) future taxable income exclusive of reversing
temporary differences and carryforwards, 3) taxable income in prior carryback year(s) if carryback is permitted
under the tax law, and 4) tax-planning strategies that would, if necessary, be implemented to realize deductible
temporary differences or carryforwards prior to their expiration. Until the Company has a period of sustained and
predictable profitability consistent with realizing some portion of the benefit from deferred tax assets, a valuation
allowance will be maintained.
Commercial Support Liabilities
Commercial support liabilities represent grant funds received from entities supporting educational
activities, such as live events, in which we are the accredited provider. The funds are
unrestricted, and are primarily used to pay for expenses associated with conducting the event.
Accrual for Service Interruptions
We maintain an accrual for service interruptions that may occur from our Internet-based learning
products. The accrual is estimated using management’s judgment and analysis of potential risk of
loss associated with downtime of our hosted applications. At December 31, 2006, and 2005, the
accrual for service interruptions balance was approximately $314,000 and $264,000, respectively,
and is included on the accompanying consolidated balance sheets under the caption “accrued
liabilities.”
Advertising
We expense the costs of advertising as incurred in accordance with SOP 93-7, “Reporting on
Advertising Costs.” Advertising expense for the years ended December 31, 2006, 2005, and 2004 was
approximately $329,000, $123,000, and $226,000, respectively.
Shipping and Handling Costs
Shipping and handling costs that are associated with our products and services are included in
cost of revenues.
40
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Product Development Costs
Product development costs include internal and external costs to develop and convert content for
our Internet-based learning and installed learning management products. We account for these
assets in accordance with EITF Issue No. 00-2 “Accounting for Web Site Development Costs.” We
capitalize the cost of content developed by third parties where the life expectancy is greater
than one year and the anticipated cash flows from such content is expected to exceed its cost. The
Company capitalized approximately $399,000 and $429,000 of content development costs during 2006
and 2005, respectively. Capitalized content development costs are included in the accompanying
consolidated balance sheets under the captions “prepaid development fees” and “other assets.” We
amortize content development over its expected life, which is generally one to three years.
Content development costs that have been capitalized are subject to a periodic impairment review
in accordance with our policy. We did not capitalize any internal Web site development costs
during 2006 or 2005, since the costs were related to planning or operation of such products and
sites.
Net Income (Loss) Per Share
We compute net income (loss) per share in accordance with SFAS No. 128, “Earnings Per Share.”
Under the provisions of Statement 128, basic net income (loss) per share is computed by dividing
the net income (loss) available to common shareholders for the period by the weighted average
number of common shares outstanding during the period. Diluted net income (loss) per share is
computed by dividing the net income (loss) for the period by the weighted average number of common
and common equivalent shares outstanding during the period. Common equivalent shares, composed of
incremental common shares issuable upon the exercise of stock options and warrants, escrowed or
restricted shares, and shares subject to vesting are included in diluted net income per share to
the extent these shares are dilutive. Common equivalent shares are dilutive when the average
market price during the period exceeds the exercise price of the underlying shares. Common
equivalent shares that have an anti-dilutive effect on diluted net income (loss) per share have
been excluded from the calculation of diluted weighted average shares outstanding for the years
ended December 31, 2006, 2005, and 2004.
Concentrations of Credit Risk and Significant Customers
We place our temporary excess cash investments in high quality, short-term money market
instruments. At times, such investments may be in excess of the FDIC insurance limits.
We sell our learning management systems and other education services to various companies in the
healthcare industry that are located in the United States. We perform ongoing credit evaluations
of our customers’ financial condition and generally require no collateral from customers. We have
one significant customer, HCA, who comprised approximately 11%, or $3.5 million, of net revenues
during 2006 for our HCO segment, approximately 14% or $3.9 million, of net revenues during 2005,
and approximately 15%, or $2.9 million, of net revenues during 2004. The total amounts receivable
from HCA at December 31, 2006 and 2005 were approximately $470,000 and $250,000, respectively.
Stock Based Compensation
As of December 31, 2006, the Company has two stock based compensation plans, which are described
in Note 11. Prior to January 1, 2006, we accounted for stock option grants in accordance with
Accounting Principles Board Opinion (APB) No. 25 “Accounting for Stock Issued to Employees” and
related interpretations. During the years ended December 31, 2005 and 2004, we did not recognize
stock based compensation expense within our consolidated statements of operations because the
exercise price of our employee stock options was not less than the market price of the underlying
stock on the date of grant.
In December 2004, the Financial Accounting Standards Board (FASB) issued SFAS No. 123(R),
“Share-Based Payment.” SFAS No. 123(R) supersedes APB Opinion No. 25, “Accounting for Stock Issued
to Employees,” (APB 25) and requires companies to recognize compensation expense, using a
fair-value based method, for costs related to share-based payments, including stock options. The
Company adopted SFAS No. 123(R) on January 1, 2006 and implemented it using the
modified-prospective method for transition purposes. Therefore, prior period financial results
have not been restated. The modified-prospective method requires compensation expense to be
recorded for all unvested share-based payments outstanding prior to adoption and for all
share-based payments issued subsequent to adoption using a fair value approach. We use the Black
Scholes option pricing model for calculating the fair value of awards issued under our stock based
compensation plans.
The impact on our results from operations during 2006 from adopting SFAS No. 123(R) resulted in
additional compensation expense of approximately $682,000, or $0.03 per diluted share.
41
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Prior to adopting SFAS No. 123(R), we accounted for our stock based compensation plans under the
intrinsic value-based method of accounting prescribed by APB 25 and related interpretations. The
following pro forma table reflects our net income (loss) and net income (loss) per share had the
fair value provisions of SFAS No. 123 “Accounting for Stock Based Compensation” been followed
during the years ended December 31, 2005 and 2004:
| Year Ended December 31, | ||||||||
| 2005 | 2004 | |||||||
Net income (loss) as reported |
$ | 1,912,928 | $ | (1,048,380 | ) | |||
Add: Stock based employee compensation expense included in reported
net income (loss), net of related taxes |
— | — | ||||||
Deduct: Total stock based employee compensation expense determined
under fair value based method for all awards, net of related tax
effects |
(586,804 | ) | (542,560 | ) | ||||
Pro forma net income (loss) |
$ | 1,326,124 | $ | (1,590,940 | ) | |||
Basic net income (loss) per share — as reported |
$ | 0.09 | $ | (0.05 | ) | |||
Basic net income (loss) per share — pro forma |
$ | 0.06 | $ | (0.08 | ) | |||
Diluted net income (loss) per share — as reported |
$ | 0.09 | $ | (0.05 | ) | |||
Diluted net income (loss) per share — pro forma |
$ | 0.06 | $ | (0.08 | ) | |||
Fair Value of Financial Instruments
The following methods and assumptions were used in estimating fair value for financial
instruments:
Cash, cash equivalents and restricted cash: The carrying amounts approximate the fair value
because of the short-term maturity or short-term nature of such instruments.
Accounts receivable, accounts receivable-unbilled, interest receivable, accounts payable, accrued
liabilities and deferred revenue: The carrying amounts, net of any allowance for doubtful
accounts, approximate the fair value because of the short-term nature of such instruments.
Investments in marketable securities: The carrying amounts approximate the fair value based on
quoted market prices.
Newly Issued Accounting Standards
In June 2006, the Financial Accounting Standards Board issued FASB Interpretation No. 48,
“Accounting for Uncertainty in Income Taxes — an interpretation of FASB Statement No. 109” (“FIN
48”). This Interpretation clarifies the accounting for uncertainty in income taxes recognized in
the financial statements, and requires companies to use a more-likely-than-not recognition
threshold based on the technical merits of the tax position taken. Tax positions that meet the
more-likely-than-not recognition threshold should be measured in order to determine the tax
benefit to be recognized in the financial statements. FIN 48 is effective in fiscal years
beginning after December 15, 2006. The Company is currently evaluating the impact that the
adoption of FIN 48 will have on its financial position and results of operations. The Company
is required to adopt the provisions of FIN 48 effective January 1, 2007.
On September 15, 2006, the FASB issued, SFAS No. 157, “Fair Value Measurements.” The standard
provides guidance for using fair value to measure assets and liabilities and applies whenever
other standards require (or permit) assets or liabilities to be measured at fair value. The
standard does not expand the use of fair value in any new circumstances. SFAS No. 157 is
effective for financial statements issued for fiscal years beginning after November 15, 2007.
Management is in the process of evaluating the impact of this new standard on the Company’s
financial position and results of operations.
42
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and
Financial Liabilities.” This new standard provides companies with an option to report selected
financial assets and liabilities at fair value. Generally accepted accounting principles have
required different measurement attributes for different assets and liabilities that can create
artificial volatility in earnings. The FASB believes that Statement 159 helps to mitigate this
type of accounting-induced volatility by enabling companies to report related assets and
liabilities at fair value, which would likely reduce the need for companies to comply with
detailed rules for hedge accounting. Statement 159 also establishes presentation and disclosure
requirements designed to facilitate comparisons between companies that choose different
measurement attributes for similar types of assets and liabilities. The new Statement does not
eliminate disclosure requirements included in other accounting standards, including requirements
for disclosures about fair value measurements included in SFAS No. 157 and No. 107. This Statement
is effective beginning January 1, 2008 for the Company, with early adoption permitted under
certain circumstances. Management is currently evaluating the impact that adoption of SFAS No. 159
will have on the Company’s financial position and results of operations.
2. BUSINESS COMBINATION
On March 28, 2005, the Company acquired all of the stock of DMR for approximately $10.7 million,
consisting of $9.1 million in cash and 479,234 shares of our common stock, of which 319,489 shares
were released from escrow on September 28, 2006. The Company also incurred direct, incremental
expenses associated with the acquisition of approximately $0.4 million. Goodwill recorded in
connection with the acquisition will generate deductible amortization for federal income tax
purposes. DMR provides healthcare organizations a wide range of quality and satisfaction surveys,
data analyses of survey results, and other research-based measurement tools. The results of
operations for DMR have been included in the Company’s statement of operations, effective March
29, 2005. The allocation of purchase price was as follows:
Estimated fair value of tangible assets acquired |
$ | 718,357 | ||
Estimated fair value of liabilities assumed |
(494,026 | ) | ||
Purchase price in excess of net tangible assets acquired |
10,660,705 | |||
Less fair value of stock issued |
(1,343,149 | ) | ||
Cash paid |
9,541,887 | |||
Less cash acquired |
(17,811 | ) | ||
Net cash paid for acquisition |
$ | 9,524,076 | ||
The purchase price in excess of the net tangible assets acquired was allocated as follows:
Goodwill |
$ | 7,010,705 | |
Customer related intangibles |
$ | 3,400,000 | |
Non-compete agreement |
$ | 250,000 |
The following unaudited pro forma results of operations for the year ended December 31, 2005 gives
effect to the operations of DMR as if the acquisition had occurred as of January 1, 2005. These
unaudited pro forma results of operations include certain adjustments arising from the acquisition
such as owner compensation and amortization expense. The pro forma results of operations do not
purport to represent what the Company’s results of operations would have been had such
transactions in fact occurred at the beginning of the period presented or to project the Company’s
results of operations in any future period.
Revenue (pro-forma) |
$ | 28,769,609 | ||
Net income (pro-forma) |
$ | 2,400,039 | ||
Net income per share (pro-forma): |
||||
Basic |
$ | 0.11 | ||
Diluted |
$ | 0.11 | ||
43
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
3. SHAREHOLDERS’ EQUITY
Common Stock
We are authorized to issue up to 75 million shares of common stock. The number of common shares
issued and outstanding as of December 31, 2006 and 2005 was 21,928,687 and 21,574,904,
respectively.
Preferred Stock
We are authorized to issue up to 10 million shares of preferred stock in one or more series,
having the relative voting powers, designations, preferences, rights and qualifications,
limitations or restrictions, and other terms as the Board of Directors may fix in providing for
the issuance of such series, without any vote or action of the shareholders. During 2000, all
outstanding shares of preferred stock were converted into common stock in connection with our IPO.
There have been no shares of preferred stock outstanding since our IPO.
Warrants
In connection with a distribution agreement we entered into during 1999, we provided a business
partner with a warrant to purchase 245,032 shares of our common stock at $4.06 per share. The
warrants expire in June 2009 and no part of the warrant has been exercised as of December 31,
2006.
4. NET INCOME (LOSS) PER SHARE
The following table sets forth the computation of basic and diluted net income (loss) per share:
| Year Ended December 31, | ||||||||||||
| 2006 | 2005 | 2004 | ||||||||||
Numerator: |
||||||||||||
Net income (loss) |
$ | 2,499,680 | $ | 1,912,928 | $ | (1,048,380 | ) | |||||
Denominator: |
||||||||||||
Weighted-average shares outstanding: |
||||||||||||
Basic |
21,576,553 | 21,051,373 | 20,585,825 | |||||||||
Employee stock options and escrowed shares |
782,095 | 890,809 | — | |||||||||
Diluted |
22,358,648 | 21,942,182 | 20,585,825 | |||||||||
Net income (loss) per share: |
||||||||||||
Basic |
$ | 0.12 | $ | 0.09 | $ | (0.05 | ) | |||||
Diluted |
$ | 0.11 | $ | 0.09 | $ | (0.05 | ) | |||||
For the years ended December 31, 2006, 2005, and 2004, the calculation of weighted average
and equivalent shares excluded options and warrants that were
anti-dilutive. The equivalent common shares related to such options and warrants were 1,964,460 in 2006, 1,447,561 in 2005 and
3,048,842 in 2004.
In March 2007, the Company granted stock options to its management group to purchase up to 436,000
shares. The grants were made on March 7, 2007 and March 12, 2007 with exercise prices of $3.75 and
$3.91 per share, respectively. These options vest over four years and expire eight years after
issuance.
44
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
5. INVESTMENTS IN MARKETABLE SECURITIES
At December 31, 2006, investments in marketable securities, which were all classified as
available-for-sale and considered to be short-term based on management’s intent of holding such
securities for less than 12 months, included the following:
| Amortized | Unrealized | Unrealized | Fair | |||||||||||||
| Cost | Losses | Gains | Value | |||||||||||||
Auction Rate Securities |
$ | 1,700,000 | $ | — | $ | — | $ | 1,700,000 | ||||||||
At December 31, 2005, investments in marketable securities, which were all classified as
available-for-sale and considered to be short-term based on management’s intent of holding such
securities for less than 12 months, included the following:
| Amortized | Unrealized | Unrealized | Fair | |||||||||||||
| Cost | Losses | Gains | Value | |||||||||||||
Auction Rate Securities |
$ | 6,175,000 | $ | — | $ | — | $ | 6,175,000 | ||||||||
The scheduled maturities of the above auction rate securities at December 31, 2006 is shown
below:
Maturing after ten years |
$ | 1,700,000 | ||
6. GOODWILL
We account for goodwill under the provisions of Statement 142, which specifies the approach and
timing for evaluating impairment of intangible assets, and also requires that goodwill be tested
for impairment at least annually using a fair value method. We test goodwill for impairment using
a discounted cash flow model. The technique used to determine the fair value of our reporting
units is sensitive to estimates and assumptions associated with cash flow from operations and its
growth, discount rates, and reporting unit terminal values. If these estimates or their related
assumptions change in the future, we may be required to record additional impairment charges,
which could adversely impact our operating results for the period in which such a determination is
made. We perform our annual impairment evaluation of goodwill during the fourth quarter of each
year and as changes in facts and circumstances indicate impairment exists. During our annual
impairment evaluation in the fourth quarter of 2006 and 2005, the results of our goodwill
impairment analysis indicated the fair value of our reporting units exceeded their carrying
values. Therefore no impairment existed at December 31, 2006 and 2005.
On March 28, 2005 we acquired DMR. We recorded goodwill of $7,010,705 in connection with this
acquisition, which will generate deductible amortization for federal income tax purposes. The
changes in the carrying amount of goodwill for the years ended December 31, 2006 and 2005 are as
follows:
| HCO | PMD | Total | ||||||||||
Balance at January 1, 2006 |
$ | 8,993,666 | $ | 1,323,727 | $ | 10,317,393 | ||||||
Changes in carrying value of goodwill |
— | — | — | |||||||||
Balance at December 31, 2006 |
$ | 8,993,666 | $ | 1,323,727 | $ | 10,317,393 | ||||||
| HCO | PMD | Total | ||||||||||
Balance at January 1, 2005 |
$ | 1,982,961 | $ | 1,323,727 | $ | 3,306,688 | ||||||
Changes in carrying value of goodwill |
7,010,705 | — | 7,010,705 | |||||||||
Balance at December 31, 2005 |
$ | 8,993,666 | $ | 1,323,727 | $ | 10,317,393 | ||||||
45
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
7. INTANGIBLE ASSETS
All intangible assets have been evaluated in accordance with Statement 142 and are considered to
have finite useful lives. The intangibles are being amortized over their estimated useful lives,
ranging from one to eight years. Amortization of intangible assets was approximately $508,000,
$552,000, and $344,000, for the years ended December 31, 2006, 2005 and 2004, respectively.
Identifiable intangible assets are comprised of the following:
| As of December 31, 2006 | As of December 31, 2005 | |||||||||||||||||||||||
| Accumulated | Accumulated | |||||||||||||||||||||||
| Gross Amount | Amortization | Net | Gross Amount | Amortization | Net | |||||||||||||||||||
Customer related |
$ | 6,340,000 | $ | (3,687,243 | ) | $ | 2,652,757 | $ | 6,340,000 | $ | (3,262,243 | ) | $ | 3,077,757 | ||||||||||
Content |
3,500,000 | (3,500,000 | ) | — | 3,500,000 | (3,500,000 | ) | — | ||||||||||||||||
Other |
672,142 | (568,918 | ) | 103,224 | 672,142 | (485,585 | ) | 186,557 | ||||||||||||||||
Total |
$ | 10,512,142 | $ | (7,756,161 | ) | $ | 2,755,981 | $ | 10,512,142 | $ | (7,247,828 | ) | $ | 3,264,314 | ||||||||||
Estimated amortization expense for the years ending December 31, is as follows:
2007 |
$ | 508,333 | ||
2008 |
444,891 | |||
2009 |
425,000 | |||
2010 |
425,000 | |||
2011 |
425,000 | |||
Thereafter |
527,757 | |||
Total |
$ | 2,755,981 | ||
8. CONTENT RIGHTS AND DEFERRED SERVICE CREDITS
During the second quarter of 2006, we completed updates and maintenance required to publish
certain courseware owned by one of our customers and were provided the right to distribute and
resell such courseware to our Internet-based customers. In exchange for receipt of an exclusive
license to distribute and resell this courseware, we provided the customer with service credits
that can be used to make future purchases of our products and services. We accounted for this
transaction in accordance with Accounting Principles Board Opinion No. 29 “Accounting for
Nonmonetary Transactions” as amended by SFAS No. 153, “Exchanges of Nonmonetary Assets.” The
initial value assigned to the content rights and the deferred service credits was $904,167, which
represents the estimated fair value of the assets relinquished. The content rights are classified
within prepaid development fees and other assets, and the service credits are classified within
accrued liabilities and other long term liabilities on our condensed consolidated balance sheet as
of December 31, 2006.
The service credits will be issued annually through December 31, 2008, and expire twenty-four
months after issuance. Any unused credits will be forfeited. As of December 31, 2006, we were
obligated to issue remaining credits of $759,167 through December 31, 2008. Additional service
credits may be provided in the future if the customer provides additional courseware rights to us.
The content rights are being amortized on a straight-line basis through December 31, 2008.
Revenues for services provided in exchange for service credits will be recognized in accordance
with our revenue recognition policies.
9. BUSINESS SEGMENTS
We have two reportable segments, services provided to healthcare organizations and professionals
(HCO) and services provided to pharmaceutical and medical device companies (PMD). On March 28,
2005, we acquired DMR, a company focused on offering healthcare organizations a wide range of
quality and satisfaction surveys, data analyses of survey results, and other research-based
measurement tools. Accordingly, DMR is included in our HCO business segment. The accounting
policies of the segments are the same as those described in Note 1, “Summary of Significant
Accounting Policies.” We manage and operate our business segments based on the markets they serve
and the products and services provided to those markets. Substantially all sales from both
business units during 2006 were made to customers in the United States.
46
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
9. BUSINESS SEGMENTS (continued)
The following is our business segment information as of and for the years ended December 31, 2006,
2005 and 2004. We measure segment performance based on operating loss before income taxes and
prior to the allocation of corporate overhead expenses, interest income, interest expense, and
depreciation. The unallocated component below includes corporate functions, such as accounting,
human resources, legal, marketing, administrative, and executive personnel, as well as
depreciation, a portion of amortization, and certain other expenses, which are not currently
allocated in measuring segment performance.
| Year ended December 31, 2006 | ||||||||||||||||
| HCO | PMD | Unallocated | Consolidated | |||||||||||||
Revenues, net |
$ | 25,431,875 | $ | 6,351,594 | $ | — | $ | 31,783,469 | ||||||||
Cost of revenues (excluding depreciation
and amortization) |
5,467,808 | 4,708,633 | 692,862 | 10,869,303 | ||||||||||||
Product development |
3,029,751 | 328,793 | 144,246 | 3,502,790 | ||||||||||||
Sales and marketing |
5,629,316 | 1,202,973 | 187,762 | 7,020,051 | ||||||||||||
Depreciation and amortization |
1,417,335 | 64,856 | 1,406,977 | 2,889,168 | ||||||||||||
Other general and administrative |
158,293 | 63,730 | 5,371,003 | 5,593,026 | ||||||||||||
Segment income (loss) from operations |
$ | 9,729,372 | $ | (17,391 | ) | $ | (7,802,850 | ) | $ | 1,909,131 | ||||||
*Segment assets |
$ | 21,608,441 | $ | 5,507,828 | $ | 13,892,217 | $ | 41,008,486 | ||||||||
Purchases of property and equipment |
$ | 683,188 | $ | 206,569 | $ | 510,880 | $ | 1,400,637 | ||||||||
Payments associated with capitalized software
feature enhancements |
$ | 2,255,403 | $ | 19,281 | $ | — | $ | 2,274,684 | ||||||||
| Year ended December 31, 2005 | ||||||||||||||||
| HCO | PMD | Unallocated | Consolidated | |||||||||||||
Revenues, net |
$ | 21,148,413 | $ | 6,210,993 | $ | — | $ | 27,359,406 | ||||||||
Cost of revenues (excluding depreciation
and amortization) |
5,453,671 | 3,665,963 | 625,836 | 9,745,470 | ||||||||||||
Product development |
2,285,119 | 388,117 | 254,876 | 2,928,112 | ||||||||||||
Sales and marketing |
3,924,604 | 1,312,906 | 214,658 | 5,452,168 | ||||||||||||
Depreciation and amortization |
930,055 | 200,552 | 1,547,833 | 2,678,440 | ||||||||||||
Other general and administrative |
209,898 | 138,478 | 4,610,132 | 4,958,508 | ||||||||||||
Segment income (loss) from operations |
$ | 8,345,066 | $ | 504,977 | $ | (7,253,335 | ) | $ | 1,596,708 | |||||||
*Segment assets |
$ | 17,440,077 | $ | 4,666,897 | $ | 13,109,166 | $ | 35,216,140 | ||||||||
Purchases of property and equipment |
$ | 316,019 | $ | 145,938 | $ | 290,265 | $ | 752,222 | ||||||||
Payments associated with capitalized software
feature enhancements |
$ | 567,936 | $ | 58,186 | $ | — | $ | 626,122 | ||||||||
| Year ended December 31, 2004 | ||||||||||||||||
| HCO | PMD | Unallocated | Consolidated | |||||||||||||
Revenues, net |
$ | 13,988,818 | $ | 6,068,490 | $ | — | $ | 20,057,308 | ||||||||
Cost of revenues (excluding depreciation and amortization) |
2,826,444 | 3,865,545 | 585,184 | 7,277,173 | ||||||||||||
Product development |
2,008,007 | 378,569 | 144,601 | 2,531,177 | ||||||||||||
Sales and marketing |
3,564,673 | 1,024,406 | 209,608 | 4,798,687 | ||||||||||||
Depreciation and amortization |
338,012 | 402,530 | 1,366,216 | 2,106,758 | ||||||||||||
Other general and administrative |
173,246 | 115,824 | 4,345,307 | 4,634,377 | ||||||||||||
Segment income (loss) from operations |
$ | 5,078,436 | $ | 281,616 | $ | (6,650,916 | ) | $ | (1,290,864 | ) | ||||||
*Segment assets |
$ | 6,496,190 | $ | 4,254,682 | $ | 17,684,815 | $ | 28,435,687 | ||||||||
Purchases of property and equipment |
$ | 608,200 | $ | 340,131 | $ | 672,575 | $ | 1,620,906 | ||||||||
Payments associated with capitalized software
feature enhancements |
$ | 312,806 | $ | — | $ | — | $ | 312,806 | ||||||||
| * | Segment assets include restricted cash, accounts and unbilled receivables, prepaid and other current assets, other assets, capitalized software feature enhancements, property and equipment, and intangible assets. Investments in marketable securities and cash and cash equivalents are not allocated to individual segments, and are included within Unallocated. |
47
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
10. INCOME TAXES
The provision for income taxes is comprised of:
| Year Ended December 31, | ||||||||||||
| 2006 | 2005 | 2004 | ||||||||||
Current federal |
$ | 28,044 | $ | 21,500 | $ | — | ||||||
Current state |
— | — | — | |||||||||
Deferred federal |
— | — | — | |||||||||
Deferred state |
— | — | — | |||||||||
Provision for income taxes |
$ | 28,044 | $ | 21,500 | $ | — | ||||||
Income tax provision (benefit) differs from the amounts computed by applying the federal
statutory rate of 34% to the income (loss) before income taxes as follows:
| Year Ended December 31, | ||||||||||||
| 2006 | 2005 | 2004 | ||||||||||
Federal tax provision (benefit) at the statutory rate |
$ | 859,427 | $ | 657,705 | $ | (356,449 | ) | |||||
State income tax provision (benefit), net of federal benefit |
102,681 | 80,275 | (39,631 | ) | ||||||||
Other |
254,624 | (32,265 | ) | (94,670 | ) | |||||||
(Decrease) increase in valuation allowance |
(1,188,688 | ) | (684,215 | ) | 490,750 | |||||||
Provision for income taxes |
$ | 28,044 | $ | 21,500 | $ | — | ||||||
Deferred federal and state income taxes reflect the net tax effects of temporary differences
between the carrying amounts of assets and liabilities for financial reporting purposes and the
amounts used for income tax purposes. Significant components of deferred tax assets are as
follows:
| December 31, | ||||||||
| 2006 | 2005 | |||||||
Deferred tax assets: |
||||||||
Allowance for doubtful accounts |
$ | 42,649 | $ | 43,734 | ||||
Differences related to business combinations |
772,817 | 1,105,153 | ||||||
Depreciation |
467,503 | 396,098 | ||||||
Accrued liabilities |
318,201 | 296,609 | ||||||
Difference related to warrants |
1,227,388 | 1,227,388 | ||||||
Research and development credits |
285,787 | 322,469 | ||||||
Stock based compensation |
57,006 | — | ||||||
Alternative minimum tax credits |
49,544 | 21,500 | ||||||
Other |
13,541 | 13,416 | ||||||
Net operating loss carryforwards |
15,041,694 | 15,842,174 | ||||||
Total deferred tax assets |
18,276,130 | 19,268,541 | ||||||
Less: Valuation allowance |
(18,276,130 | ) | (19,268,541 | ) | ||||
Net deferred tax asset |
$ | — | $ | — | ||||
As of December 31, 2006, we had federal and state net operating loss carryforwards of
$40,541,767 and $31,437,329, respectively. These losses will expire in years 2012 through 2024. As
of December 31, 2006, $2,522,368 of our net operating loss carryforwards is attributable to the
exercise of stock options, and if realized, the tax benefit will be recorded as an increase to
additional paid-in capital. Our net operating loss carryforwards are subject to annual limitations
under Internal Revenue Code Section 382. The annual limitations could result in the expiration of
the net operating loss and tax credit carryforwards before they are fully utilized. During the
year, the valuation allowance decreased by $992,411, which was comprised of a $1,188,688 decrease
related to current taxes and an increase of $196,277 related to the exercise of stock options.
We have research and development tax credit carryforwards of $285,787 that expire in varying
amounts through 2024. We have alternative minimum tax credit carryforwards of $49,544 that are
available to offset future regular tax liabilities and they do not expire.
We have established a valuation allowance for deferred tax assets at December 31, 2006 and 2005,
due to the uncertainty of realizing these assets in the future. Federal income tax payments of
$21,000, $15,000, and $-0- were made during the years ended December 31, 2006, 2005, and 2004,
respectively. There were no state income tax payments made during the years ended December 31,
2006, 2005, and 2004.
48
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
11. STOCK BASED COMPENSATION
Total stock based compensation expense recorded, as a result of adopting Statement 123(R), for the
year ended December 31, 2006, which is recorded in our statements of operations, is as follows:
Cost of revenues (excluding depreciation and amortization) |
$ | 53,790 | ||
Product development |
142,058 | |||
Sales and marketing |
127,953 | |||
Other general and administrative |
358,267 | |||
Total stock based compensation expense |
$ | 682,068 | ||
Stock Option Plans
Our 2000 Stock Incentive Plan (2000 Plan) and 1994 Employee Stock Option Plan (1994 Plan) (the
2000 Plan and the 1994 Plan are collectively referred to as “the Plan”) authorize the grant of
options or other forms of stock based compensation to employees, officers, directors and others,
and such grants must be approved by the Compensation Committee of the Board of Directors. The
terms of both plans are substantially similar. Options granted under the Plan have terms of no
more than ten years, with certain restrictions. The Plan allows the Compensation Committee of the
Board of Directors to determine the vesting period of each grant. The vesting period of the
options granted ranges from immediate vesting (generally associated with professional consulting
boards and directors’ options) to annual vesting over four years, beginning one year after the
grant date (generally for employee and officer options). As of December 31, 2006, 2,126,123 shares
of unissued common stock remained reserved for future grants under the Plan. The Company issues
new shares of common stock when options are exercised.
The weighted average fair value of options granted was estimated using the Black-Scholes method.
The ranges of assumptions used for these estimates include:
| 2006 | 2005 | 2004 | ||||||||||
Risk-free interest rate |
4.55 - 5.07 | % | 3.77 - 4.45 | % | 2.50-3.50 | % | ||||||
Expected dividend yield |
0.0 | % | 0.0 | % | 0.0 | % | ||||||
Expected life (in years) |
5 to 8 | 5 to 8 | 5 to 8 | |||||||||
Expected forfeiture rate |
0 -15 | % | 0 | % | 0 | % | ||||||
Volatility |
75 | % | 75 | % | 75 | % | ||||||
Risk-free interest rate is based on the U.S. Treasury rate in effect at the time of
the option grant having a term equivalent to the expected life of the option.
Expected dividend yield is zero because the Company has not made any dividend payments in
its history and does not plan to pay dividends in the foreseeable future.
Expected life is the period of time the option is expected to remain outstanding, and is
based on historical experience. The contractual option life ranges from eight to ten years. We
estimate the expected life of options granted to members of management to be five years and eight
years for directors.
Expected forfeiture rate is the estimated percentage of options granted that are not
expected to become fully vested. This estimate is based on historical experience, and will be
adjusted as necessary to match the actual forfeiture experience.
Volatility is the measure of the amount by which the price is expected to fluctuate. We
estimate volatility based on the actual historical volatility of our common stock, and we believe
future volatility will be similar to our past experience.
We amortize the fair value of all stock based awards on a straight-line basis over the requisite
service period, which generally is the vesting period.
49
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
11. STOCK BASED COMPENSATION (continued)
A progression of activity and various other information relative to stock options is presented in
the table below.
| 2006 | 2005 | 2004 | ||||||||||||||||||||||
| Weighted- | Weighted- | Weighted- | ||||||||||||||||||||||
| Average | Average | Average | ||||||||||||||||||||||
| Common | Exercise | Common | Exercise | Common | Exercise | |||||||||||||||||||
| Shares | Price | Shares | Price | Shares | Price | |||||||||||||||||||
Outstanding — beginning of
period |
2,794,415 | $ | 3.41 | 2,813,810 | $ | 3.27 | 2,840,880 | $ | 3.28 | |||||||||||||||
Granted |
516,420 | 2.99 | 438,000 | 3.10 | 460,000 | 2.59 | ||||||||||||||||||
Exercised |
(285,681 | ) | 1.72 | (344,413 | ) | 1.90 | (121,503 | ) | 1.22 | |||||||||||||||
Expired |
(69,725 | ) | 4.81 | (17,616 | ) | 1.77 | (19,008 | ) | 5.86 | |||||||||||||||
Forfeited |
(148,750 | ) | 2.37 | (95,366 | ) | 3.76 | (346,559 | ) | 3.03 | |||||||||||||||
Outstanding — end of period |
2,806,679 | $ | 3.52 | 2,794,415 | $ | 3.41 | 2,813,810 | $ | 3.27 | |||||||||||||||
Exercisable at end of period |
1,887,429 | $ | 3.86 | 1,886,164 | $ | 3.83 | 1,993,435 | $ | 3.81 | |||||||||||||||
Other information relative to option activity during the years ended December 31, 2006,
2005, and 2004 is as follows:
| Year Ended December 31, | ||||||||||||
| 2006 | 2005 | 2004 | ||||||||||
Weighted average grant date fair value of stock options granted |
$ | 2.01 | $ | 1.97 | $ | 1.60 | ||||||
Total fair value of stock options vested |
$ | 582,189 | $ | 348,032 | $ | 577,998 | ||||||
Total intrinsic value of stock options exercised |
$ | 663,202 | $ | 414,948 | $ | 118,661 | ||||||
Cash proceeds from exercise of stock options |
$ | 490,467 | $ | 654,955 | $ | 148,804 | ||||||
Weighted average exercise prices per share and various other information for options outstanding
at December 31, 2006 are segregated into ranges as follows:
| Options Outstanding | Options Exercisable | |||||||||||||||||||
| Weighted | Weighted | Weighted | ||||||||||||||||||
| Average | Average | Average | ||||||||||||||||||
| Number of | Exercise Price | Remaining | Number of | Exercise Price | ||||||||||||||||
| Range of Exercise Price | Shares | Per Share | Contractual Life | Shares | Per Share | |||||||||||||||
$0.54 - $1.19 |
90,000 | $ | 1.10 | 2.7 | 90,000 | $ | 1.10 | |||||||||||||
$1.20 - $2.38 |
781,494 | 1.64 | 3.0 | 702,244 | 1.66 | |||||||||||||||
$2.39 - $3.57 |
1,154,045 | 2.96 | 6.6 | 314,045 | 2.94 | |||||||||||||||
$3.58 - $4.76 |
316,350 | 4.06 | 0.7 | 316,350 | 4.06 | |||||||||||||||
$4.77 - $5.95 |
25,000 | 5.42 | 1.5 | 25,000 | 5.42 | |||||||||||||||
$5.96 - $7.13 |
220,150 | 6.49 | 1.0 | 220,150 | 6.49 | |||||||||||||||
$8.33 - $9.50 |
77,595 | 8.95 | 2.8 | 77,595 | 8.95 | |||||||||||||||
$9.51 - $10.70 |
75,850 | 10.00 | 1.2 | 75,850 | 10.00 | |||||||||||||||
$10.71 - $11.89 |
66,195 | 11.89 | 1.2 | 66,195 | 11.89 | |||||||||||||||
| 2,806,679 | $ | 3.52 | 2.3 | 1,887,429 | $ | 3.86 | ||||||||||||||
Aggregate Intrinsic Value |
$ | 3,200,052 | $ | 2,162,757 | ||||||||||||||||
The aggregate intrinsic value in the table above represents the total difference between the
Company’s closing stock price on December 29, 2006 (the last trading day of the year) of $3.95 and
the option exercise price, multiplied by the number of in-the-money options as of December 31,
2006. As of December 31, 2006, total unrecognized compensation expense related to non-vested stock
options was $1,139,874, net of estimated forfeitures, with a weighted average expense recognition
period of 2.7 years.
50
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
11. STOCK BASED COMPENSATION (continued)
Employee Stock Purchase Plan
Our Employee Stock Purchase Plan (Purchase Plan) incorporates the provisions of Section 423 of the
Internal Revenue Code. Under the Purchase Plan, 1,000,000 shares of common stock have been
reserved for purchase by employees. The Purchase Plan provides for annual offer periods of twelve
months to eligible employees. Under the Purchase Plan, eligible employees can purchase through
payroll deductions, the lesser of up to 15% of their eligible base compensation or 2,500 shares of
common stock, at a price equivalent to 85% of the lesser of the beginning or end of Purchase Plan
year price. During 2006, 68,102 shares were purchased under the plan at $2.38 per share, and
during 2005, 83,742 shares were purchased under the plan at $1.90 per share. As of December 31,
2006, there were 623,774 shares available for issuance under the Purchase Plan. In accordance with
the provisions of SFAS No. 123(R), the Company recognized $58,639 of stock based compensation
expense for the Purchase Plan during the year ended December 31, 2006. No compensation expense was
recognized under this plan prior to the adoption of SFAS No. 123(R).
12. EMPLOYEE BENEFIT PLAN
401(k) Plan
We have a defined-contribution employee benefit plan (401(k) Plan) incorporating provisions of
Section 401(k) of the Internal Revenue Code. Our employees must have attained the age of 21 and
have completed thirty days of service to be eligible to participate in the 401(k) Plan. Under the
provisions of the 401(k) Plan, a plan member may make contributions, on a tax-deferred basis, not
to exceed 20% of compensation, subject to IRS limitations. The Company provided eligible employees
with a discretionary contribution totaling approximately $73,000 for the year ended December 31,
2004. The Company did not provide a discretionary contribution for the year ended December 31,
2006 or 2005. The Company has not provided matching contributions through December 31, 2006.
13. REVOLVING CREDIT FACILITY
On July 21, 2006, the Company entered into a Loan Agreement (the “Revolving Credit Facility”) with
SunTrust Bank (“SunTrust”) in the aggregate principal amount of $7.0 million, which matures on
July 21, 2009. The obligations under the revolving credit facility are guaranteed by each of the
Company’s subsidiaries. The Company’s borrowings under the revolving credit facility bear interest
at a LIBOR rate generally defined as the sum of (i) a variable rate of interest equal to the
30-Day LIBOR Rate and (ii) 150 basis points per annum. Principal is payable in full on the
maturity date. The Company is required to pay a commitment fee of 10 basis points per annum of the
average daily unused portion of the revolving credit facility.
The purpose of the revolving credit facility is for general working capital needs, permitted
acquisitions (as defined in the Loan Agreement), and for stock repurchase and/or redemption
transactions that the Company may authorize.
The revolving credit facility contains certain covenants that, among other things, restrict
additional indebtedness, liens and encumbrances, changes to the character of the Company’s
business, acquisitions, asset dispositions, mergers and consolidations, sale or discount of
receivables, creation or acquisitions of additional subsidiaries, and other matters customarily
restricted in such agreements.
In addition, the revolving credit facility requires the Company to meet certain financial tests,
including, without limitation:
| • | a maximum total leverage ratio (consolidated debt/consolidated EBITDA) of 2.0 to 1.0; and | ||
| • | a minimum consolidated tangible net worth of $5.0 million. |
As of December 31, 2006, the Company believes it was in compliance with all covenants. There were
no balances outstanding on the revolving credit facility as of December 31, 2006. See Note 15
regarding an amendment to this agreement made during February 2007.
51
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
14. COMMITMENTS AND CONTINGENCIES
Lease Commitments
As of December 31, 2006, we lease office facilities in Nashville, TN, Franklin, TN, Denver, CO,
and Dallas, TX, under agreements that expire before or during April 2010. The Dallas, TX facility
was subleased to a third party through the expiration of the original lease, which ended in
January 2007. Some lease agreements contain provisions for escalating rent payments over the
initial terms of the lease. We account for these leases by recognizing rent expense on the
straight-line basis and adjusting the deferred rent expense liability for the difference between
the straight-line rent expense and the amount of rent paid. The Company also leases certain office
equipment under both operating and capital leases. Total rent expense under all operating leases
was approximately $897,000, $895,000, and $723,000, for the years ended December 31, 2006, 2005,
and 2004, respectively. We also lease certain computer equipment from third parties which are
accounted for as capital leases.
Future rental payment commitments at December 31, 2006 under capital and non-cancelable operating
leases, with initial terms of one year or more, are as follows:
| Capital Leases | Operating Leases | |||||||
2007 |
$ | 193,611 | $ | 700,648 | ||||
2008 |
103,676 | 403,597 | ||||||
2009 |
7,658 | 376,146 | ||||||
2010 |
— | 116,407 | ||||||
2011 |
— | — | ||||||
Total minimum lease payments |
304,945 | $ | 1,596,798 | |||||
Less amounts representing interest |
(21,591 | ) | ||||||
Present value of minimum lease payments (including $176,574 classified as current) |
$ | 283,354 | ||||||
Sublease rental income related to the Dallas, TX facility was approximately $80,000 in 2006
and $78,000 in 2005. Future operating lease commitments listed in the above table have been
reduced by anticipated sublease income of approximately $6,000 in 2007.
The carrying value of assets under capital leases, which are included with owned assets in the
accompanying consolidated balance sheets was $279,494 and $375,516 at December 31, 2006 and 2005,
respectively. Amortization of the assets under the capital leases is included in depreciation
expense on the accompanying consolidated statements of operations.
Litigation
We are subject to various legal proceedings and claims that arise in the ordinary course of our
business. In the opinion of management, the ultimate liability with respect to those proceedings
and claims will not materially affect our financial position, operations or liquidity.
15. SUBSEQUENT EVENTS
Revolving Credit Facility
On February 16, 2007, the Company entered into the First Amendment to Loan Agreement, by and
between the Company and SunTrust Bank. The aggregate amount of the Revolving Credit Facility was
increased from $7.0 million to $10.0 million. Under the amendment, the minimum consolidated
tangible net worth covenant was removed and replaced with a Funded Debt to Total Capitalization
limit of forty percent (40%).
Business Combination
On March 12, 2007, the Company entered into a Stock Purchase Agreement with The Jackson
Organization, Research Consultants, Inc. (“TJO”), a Maryland corporation, and David Jackson and
the Jackson Charitable Remainder Trust (collectively the “Seller”), the owners of 100% of the
stock of TJO. On the same day and in accordance with the terms of the Stock Purchase Agreement,
the Company acquired 100% of the stock of TJO from the Seller for approximately $11.6 million in
cash and 252,616 shares of Company common stock resulting in TJO becoming a wholly-owned
subsidiary of the Company (the “TJO Transaction”). Approximately $5.0 million of cash
consideration and 252,616 shares of common stock are to be held in escrow until satisfaction of
certain items as outlined in the stock purchase agreement. TJO provides survey and research
services to the healthcare industry.
52
Table of Contents
HEALTHSTREAM, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
15. SUBSEQUENT EVENTS (continued)
The Company will account for the acquisition of TJO in accordance with SFAS No. 141 and SFAS No.
142. We expect to record a significant amount of goodwill and intangible assets in connection
with the allocation of purchase price. As of the date of this report, we do not have the
information available to provide a preliminary purchase price allocation.
Also in connection with the TJO Transaction, the Company entered into a new lease for an office
facility located in Laurel, Maryland, with an entity owned by David Jackson, the former majority
shareholder or TJO. The new lease includes a five year term, with two options to renew the lease
for two years each. Monthly rent is approximately $29,600, and is subject to annual increases of
three percent.
53
Table of Contents
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures
Evaluation of Controls and Procedures
HealthStream’s chief executive officer and principal financial officer have reviewed and evaluated
the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules
13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange
Act”)) as of December 31, 2006. Based on that evaluation, the chief executive officer and
principal financial officer have concluded that HealthStream’s disclosure controls and procedures
were effective to ensure that the information required to be disclosed by the Company in the
reports the Company files or submits under the Exchange Act is recorded, processed, summarized and
reported within the time periods specified in the Securities and Exchange Commission’s rules and
forms, and the information required to be disclosed in the reports the Company files or submits
under the Exchange Act was accumulated and communicated to the Company’s management, including its
principal executive and principal financial officer, or persons performing similar functions, as
appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in HealthStream’s internal control over financial reporting that occurred
during the fourth quarter of 2006 that have materially affected, or that are reasonably likely to
materially affect, HealthStream’s internal control over financial reporting.
Item 9B. Other Information
None.
PART III
Item 10.
Directors, Executive Officers and Corporate Governance
Information as to directors of the Company and corporate governance is incorporated by reference
from the information contained in our proxy statement for the 2007 Annual Meeting of Shareholders
that we will file with the Securities and Exchange Commission within 120 days of the end of the
fiscal year to which this report relates. Pursuant to General Instruction G(3), certain
information concerning executive officers of the Company is included in Part I of this Form 10-K,
under the caption “Executive Officers of the Registrant.”
Item 11. Executive Compensation
Incorporated by reference from the information contained in our proxy statement for the 2007
Annual Meeting of Shareholders that we will file with the Securities and Exchange Commission
within 120 days of the end of the fiscal year to which this report relates.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters
Incorporated by reference from the information contained in our proxy statement for the 2007
Annual Meeting of Shareholders that we will file with the Securities and Exchange Commission
within 120 days of the end of the fiscal year to which this report relates.
Item 13. Certain Relationships and Related Transactions, and Director Independence
Incorporated by reference from the information contained in our proxy statement for the 2007
Annual Meeting of Shareholders that we will file with the Securities and Exchange Commission
within 120 days of the end of the fiscal year to which this report relates.
Item 14. Principal Accountant Fees and Services
Incorporated by reference from the information contained in our proxy statement for the 2007
Annual Meeting of Shareholders that we will file with the Securities and Exchange Commission
within 120 days of the end of the fiscal year to which this report relates.
54
Table of Contents
PART IV
Item 15. Exhibits and Financial Statement Schedules
(a)(1) Financial Statements
Reference is made to the financial statements included in Item 8 to this Report on Form 10-K.
(a)(2) Financial Statement Schedules
All schedules are omitted because they are not applicable or the required information is shown in the Consolidated Financial Statements or the
notes thereto.
(a)(3) Exhibits
| Number | Description | |
*2.1
|
Asset Purchase Agreement, dated July 23, 1999, among SilverPlatter Education, Inc., SilverPlatter Information, Inc. and HealthStream, Inc. | |
*2.2
|
Agreement and Plan of Merger, dated January 5, 2000, among HealthStream, Inc., HealthStream Acquisition I, Inc., Quick Study, Inc. and each shareholder of Quick Study, Inc. | |
*2.3
|
Asset Purchase Agreement, dated December 16, 1999, among KnowledgeReview, LLC, Louis Bucelli and Maksim Repik, and HealthStream, Inc. | |
*2.4
|
Agreement and Plan of Merger, dated January 25, 2000 among HealthStream, Inc., HealthStream Acquisition II, Inc., Multimedia Marketing, Inc., and the stockholders of Multimedia Marketing, Inc. | |
*2.5
|
Asset Purchase Agreement, dated January 27, 2000, between Emergency Medicine Internetwork, Inc. and HealthStream, Inc. | |
2.6(1)
|
Stock Purchase Agreement, dated as of March 28, 2005, by and among HealthStream, Inc., Mel B. Thompson and Data Management & Research, Inc. | |
2.7(2)
|
Stock Purchase Agreement, dated as of March 12, 2007, by and among HealthStream, Inc., The Jackson Organization, Research Consultants, Inc., David Jackson and the Jackson Charitable Remainder Trust | |
*3.1
|
Form of Fourth Amended and Restated Charter of HealthStream, Inc. | |
*3.2
|
Form of Amended and Restated Bylaws of HealthStream, Inc. | |
*4.1
|
Form of certificate representing the common stock, no par value per share, of HealthStream, Inc. | |
4.2
|
Article 7 of the Fourth Amended and Restated Charter — included in Exhibit 3.1 | |
4.3
|
Article II of the Amended and Restated Bylaws — included in Exhibit 3.2 | |
*4.4
|
Warrant to purchase common stock of HealthStream, Inc., dated June 14, 1999, held by GE Medical Systems. | |
*4.6
|
Common Stock Purchase Agreement between HealthStream, Inc. and Healtheon/WebMD Corporation | |
*10.1^
|
1994 Employee Stock Option Plan, effective as of April 15, 1994 | |
*10.2^
|
2000 Stock Incentive Plan, effective as of April 10, 2000 | |
*10.3^
|
Form of Indemnification Agreement | |
*10.4^
|
Executive Employment Agreement, dated April 21, 1999, between HealthStream, Inc. and Robert A. Frist, Jr. | |
*10.5
|
Lease dated March 27, 1995, as amended June 6, 1995 and September 22, 1998, between Cummins Station LLC, as landlord, and NewOrder Media, Inc., as tenant | |
*+10.6
|
Development and Distribution Agreement between HealthStream, Inc. and GE Medical Systems | |
*+10.7
|
Education Services Provider Agreement dated October 1, 2001 between HealthStream, Inc. and HCA Information Technology & Services, Inc. | |
*^10.8
|
Form of Employee Stock Purchase Plan | |
^10.9
|
Form of Director Stock Option Agreement | |
^10.10
|
Form of Employee and Executive Officer Stock Option Agreement | |
10.12 (3)
|
Loan Agreement dated July 21, 2006 between HealthStream, Inc. and SunTrust Bank | |
10.13 (4)
|
Amendment to Loan Agreement dated February 16, 2007 between HealthStream, Inc. and SunTrust Bank | |
21.1
|
Subsidiaries of HealthStream, Inc. | |
23.1
|
Consent of Independent Registered Public Accounting Firm | |
31.1
|
Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
31.2
|
Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32.1
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
32.2
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| + | Confidential treatment was received, with respect to certain portions of this document. Such portions were omitted and filed separately with the Securities and Exchange Commission. | |
| * | Incorporated by reference to Registrant’s Registration Statement on Form S-1 (Reg. No. 333-88939). | |
| ^ | Management contract or compensatory plan or arrangement | |
| (1) | Incorporated by reference from exhibit filed on our Current Report on Form 8-K, dated March 29, 2005. | |
| (2) | Incorporated by reference from exhibit filed on our Current Report on Form 8-K, dated March 12, 2007. | |
| (3) | Incorporated by reference from exhibit filed on our Current Report on Form 8-K, dated July 25, 2006. | |
| (4) | Incorporated by reference from exhibit filed on our Current Report on Form 8-K, dated February 20, 2007. |
55
Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized on this 30th day of March 2007.
| HEALTHSTREAM, INC. |
||||
| By: | /s/ Robert A. Frist, Jr. | |||
| Robert A. Frist, Jr. | ||||
| Chief Executive Officer | ||||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by
the following persons on behalf of the registrant and in the capacities and on the dates indicated:
| Signature | Title(s) | Date | ||
/s/ Robert A. Frist, Jr.
|
President, Chief Executive Officer and | March 30, 2007 | ||
| Chairman (Principal Executive Officer) | ||||
/s/ Susan A. Brownie
|
Chief Financial Officer, Senior Vice-President and | March 30, 2007 | ||
| Corporate Secretary (Principal Financial and Accounting Officer) | ||||
/s/ James Daniell
|
Director | March 30, 2007 | ||
/s/ Thompson Dent
|
Director | March 30, 2007 | ||
/s/ Frank Gordon
|
Director | March 30, 2007 | ||
/s/ Gerard Hayden
|
Director | March 30, 2007 | ||
/s/ Ron Hinds
|
Director | March 30, 2007 | ||
/s/ Jeffrey L. McLaren
|
Director | March 30, 2007 | ||
/s/ Dale Polley
|
Director | March 30, 2007 | ||
/s/ Linda Rebrovick
|
Director | March 30, 2007 | ||
/s/ Michael Shmerling
|
Director | March 30, 2007 | ||
/s/ William Stead
|
Director | March 30, 2007 | ||
56
Table of Contents
INDEX TO EXHIBITS
| Exhibit | ||
| Number | Description | |
*2.1
|
Asset Purchase Agreement, dated July 23, 1999, among SilverPlatter Education, Inc., SilverPlatter Information, Inc. and HealthStream, Inc. | |
*2.2
|
Agreement and Plan of Merger, dated January 5, 2000, among HealthStream, Inc., HealthStream Acquisition I, Inc., Quick Study, Inc. and each shareholder of Quick Study, Inc. | |
*2.3
|
Asset Purchase Agreement, dated December 16, 1999, among KnowledgeReview, LLC, Louis Bucelli and Maksim Repik, and HealthStream, Inc. | |
*2.4
|
Agreement and Plan of Merger, dated January 25, 2000 among HealthStream, Inc., HealthStream Acquisition II, Inc., Multimedia Marketing, Inc., and the stockholders of Multimedia Marketing, Inc. | |
*2.5
|
Asset Purchase Agreement, dated January 27, 2000, between Emergency Medicine Internetwork, Inc. and HealthStream, Inc. | |
2.6(1)
|
Stock Purchase Agreement, dated as of March 28, 2005, by and among HealthStream, Inc., Mel B. Thompson and Data Management & Research, Inc. | |
2.7(2)
|
Stock Purchase Agreement, dated as of March 12, 2007, by and among HealthStream, Inc., The Jackson Organization, Research Consultants, Inc., David Jackson and the Jackson Charitable Remainder Trust | |
*3.1
|
Form of Fourth Amended and Restated Charter of HealthStream, Inc. | |
*3.2
|
Form of Amended and Restated Bylaws of HealthStream, Inc. | |
*4.1
|
Form of certificate representing the common stock, no par value per share, of HealthStream, Inc. | |
4.2
|
Article 7 of the Fourth Amended and Restated Charter — included in Exhibit 3.1 | |
4.3
|
Article II of the Amended and Restated Bylaws — included in Exhibit 3.2 | |
*4.4
|
Warrant to purchase common stock of HealthStream, Inc., dated June 14, 1999, held by GE Medical Systems. | |
*4.6
|
Common Stock Purchase Agreement between HealthStream, Inc. and Healtheon/WebMD Corporation | |
*10.1^
|
1994 Employee Stock Option Plan, effective as of April 15, 1994 | |
*10.2^
|
2000 Stock Incentive Plan, effective as of April 10, 2000 | |
*10.3^
|
Form of Indemnification Agreement | |
*10.4^
|
Executive Employment Agreement, dated April 21, 1999, between HealthStream, Inc. and Robert A. Frist, Jr. | |
*10.5
|
Lease dated March 27, 1995, as amended June 6, 1995 and September 22, 1998, between Cummins Station LLC, as landlord, and NewOrder Media, Inc., as tenant | |
*+10.6
|
Development and Distribution Agreement between HealthStream, Inc. and GE Medical Systems | |
*+10.7
|
Education Services Provider Agreement dated October 1, 2001 between HealthStream, Inc. and HCA Information Technology & Systems, Inc. | |
*^10.8
|
Form of Employee Stock Purchase Plan | |
^10.9
|
Form of Director Stock Option Agreement | |
^10.10
|
Form of Employee and Executive Officer Stock Option Agreement | |
10.12(3)
|
Loan Agreement dated July 21, 2006 between HealthStream, Inc. and SunTrust Bank | |
10.13(4)
|
Amendment to Loan Agreement dated February 16, 2007 between HealthStream, Inc. and SunTrust Bank | |
21.1
|
Subsidiaries of HealthStream, Inc. | |
23.1
|
Consent of Independent Registered Public Accounting Firm | |
31.1
|
Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
31.2
|
Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32.1
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
32.2
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| + | Confidential treatment was received with respect to certain portions of this document. Such portions were omitted and filed separately with the Securities and Exchange Commission. | |
| * | Incorporated by reference to Registrant’s Registration Statement on Form S-1 (Reg. No. 333-88939). | |
| ^ | Management contract or compensatory plan or arrangement | |
| (1) | Incorporated by reference from exhibit filed on our Current Report on Form 8-K, dated March 29, 2005. | |
| (2) | Incorporated by reference from exhibit filed on our Current Report on Form 8-K, dated March 12, 2007. | |
| (3) | Incorporated by reference from exhibit filed on our Current Report on Form 8-K, dated July 25, 2006. | |
| (4) | Incorporated by reference from exhibit filed on our Current Report on Form 8-K, dated February 20, 2007. |
EXHIBIT 10.9
FORM OF DIRECTOR STOCK OPTION AGREEMENT
HEALTHSTREAM, INC.
2000 STOCK INCENTIVE PLAN
HEALTHSTREAM, INC.
2000 STOCK INCENTIVE PLAN
OPTION granted this day of , 200__ (“Grant Date”) by HealthStream, Inc. (the
“Company”) to Optionee (the “Director”).
1. Stock Option. The Company hereby grants to the Director an option (the
“Option”) to purchase up to
shares of the common stock of the Company, no par value, to be
issued upon the exercise of the Option, in the manner hereafter set forth, fully paid and
nonassessable. This Option is being granted under the provisions of the Company’s 2000 Stock
Incentive Plan (the “Plan”), which are incorporated herein by reference. The Plan is administered
by the Compensation Committee of the Board of Directors of the Company.
2. Time of Exercise. This Option shall be exercisable and have a term as follows:
(a) This Option shall expire on the tenth anniversary of the Grant
Date.
(b) One hundred percent (100%) of the shares granted under this Option shall vest and
become exercisable on the Grant Date.
(c)
This Option shall be exercisable only in the lesser of round lots of One Hundred (100) shares or the total number of shares remaining under this Grant.
3. Purchase Price. The purchase price per share shall be , being not less than
the fair market value of the common stock as of the Grant Date.
4. Rights as a Shareholder. The Director shall have no rights as a shareholder with
respect to any shares covered by this Option until the Director has given written notice of
exercise, has paid in full for such shares and taken such other actions as may be required by the
Committee in accordance with the provisions of the Plan. No adjustment shall be made for dividends
for which the record date is prior to the date of issuance of such stock certificate.
5. Holding Period. The Director shall hold any shares issued upon exercise of this
Option for a period of not less than one (1) year following the date of such exercise.
HEALTHSTREAM, INC.
The undersigned:
(a) Acknowledges receipt of the foregoing Option and the attachments referenced therein and
understands all rights and liabilities with respect to this Option and the Plan, including, but not
limited to, the undersigned’s obligation to hold any shares issued upon exercise of the foregoing
Option for a period of not less than one (1) year from the date of such exercise; and
(b) Acknowledges that as of the date of grant of this Option, it sets forth the entire
understanding between the undersigned Director and the Company and its Affiliates regarding the
acquisition of stock in the Company pursuant to this grant and supersedes all prior oral and
written agreements on that subject.
Optionee
EXHIBIT 10.10
FORM OF EMPLOYEE AND EXECUTIVE OFFICER STOCK OPTION AGREEMENT
HEALTHSTREAM, INC.
2000 STOCK INCENTIVE PLAN
HEALTHSTREAM, INC.
2000 STOCK INCENTIVE PLAN
OPTION
granted this day of , 200__ (“Grant Date”) by HealthStream, Inc. (the “Company”) to Optionee (the “Employee”).
1. Stock Option. The Company hereby grants to the Employee an option (the
“Option”) to purchase up to
shares of the common stock of the Company, no par value, to be
issued upon the exercise of the Option, in the manner hereafter set forth, fully paid and
nonassessable. This Option is being granted under the provisions of the Company’s 2000 Stock
Incentive Plan (the “Plan”), which are incorporated herein by reference. The Plan is administered
by the Compensation Committee of the Board of Directors of the Company.
2. Time of Exercise. This Option shall be exercisable and have a term as follows:
(a) This Option shall expire on the eighth anniversary of the Grant
Date.
(b) One fourth (1/4) of the shares granted under this Option shall vest and become
exercisable on the first anniversary of the Grant Date.
(c) One half (1/2) of the shares granted under this Option shall vest and become
exercisable on the second anniversary of the Grant Date.
(d) Three fourths (3/4) of the shares granted under this Option shall vest and become
exercisable on the third anniversary of the Grant Date.
(e) The remaining one fourth (1/4) of the shares granted under this Option shall vest and
become exercisable on the fourth anniversary of the Grant Date.
(f)
This Option shall be exercisable only in the lesser of round lots of One Hundred (100) shares or the total number of shares remaining under this Grant.
3. Purchase Price. The purchase price per share shall be , being not less than
the fair market value of the common stock as of the Grant Date.
4. Rights as a Shareholder. The Employee shall have no rights as a shareholder with
respect to any shares covered by this Option until the Employee has given written notice of
exercise, has paid in full for such shares and taken such other actions as may be required by the
Committee in accordance with the provisions of the Plan. No adjustment shall be made for dividends
for which the record date is prior to the date of issuance of such stock certificate.
HEALTHSTREAM, INC.
The undersigned:
(a) Acknowledges receipt of the foregoing Option and the attachments referenced therein and
understands that all rights and liabilities with respect to this Option and the Plan; and
(b) Acknowledges that as of the date of grant of this Option, it sets forth the entire
understanding between the undersigned Employee and the Company and its Affiliates regarding the
acquisition of stock in the Company pursuant to this grant and supersedes all prior oral and
written agreements on that subject.
Optionee
EXHIBIT 21.1
SUBSIDIARIES OF HEALTHSTREAM, INC.
| State or Other | ||
| Jurisdiction of | ||
| Incorporation or | ||
| Names Under Which We Do Business | Organization | |
Education Design, Inc.
|
Tennessee | |
Data Management & Research, Inc.
|
Tennessee | |
The Jackson Organization, Research Consultants, Inc.
|
Tennessee | |
HealthStream Acquisition I, Inc.
|
Tennessee | |
HealthStream Acquisition II, Inc.
|
Tennessee |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-37440)
pertaining to the (1) HealthStream, Inc. 1994 Employee Stock Option Plan; (2) HealthStream, Inc.
2000 Stock Incentive Plan; and (3) HealthStream, Inc. Employee Stock Purchase Plan, of our report
dated March 27, 2007, with respect to the consolidated financial statements of HealthStream, Inc.
included in this Annual Report (Form 10-K) for the year ended December 31, 2006.
/s/ Ernst & Young LLP
Nashville, Tennessee
March 27, 2007
March 27, 2007
EXHIBIT 31.1
CERTIFICATION
I, Robert A. Frist, Jr., certify that:
| 1. | I have reviewed this annual report on Form 10-K of HealthStream, Inc.; | |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
a) designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being
prepared;
b) evaluated the effectiveness of the registrant’s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation;
and
c) disclosed in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant’s internal control
over financial reporting; and
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions): |
a) all significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrant’s ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have
a significant role in the registrant’s internal control over financial reporting.
| Date: March 30, 2007 | /s/ robert a. frist, Jr. | |||
| Robert A. Frist, Jr. | ||||
| Chief Executive Officer | ||||
EXHIBIT 31.2
CERTIFICATION
I, Susan A. Brownie, certify that:
| 1. | I have reviewed this annual report on Form 10-K of HealthStream, Inc.; | |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
a) designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being
prepared;
b) evaluated the effectiveness of the registrant’s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation;
and
c) disclosed in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant’s internal control
over financial reporting; and
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions): |
a) all significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrant’s ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have
a significant role in the registrant’s internal control over financial reporting.
| Date: March 30, 2007 | /s/ Susan A. Brownie | |||
| Susan A. Brownie | ||||
| Chief Financial Officer | ||||
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of HealthStream, Inc. (the “Company”) on Form 10-K for the
year ending December 31, 2006, as filed with the Securities and Exchange Commission on the date
hereof (the “Report”), Robert A. Frist, Jr., Chief Executive Officer of the Company certifies,
pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | ||
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ robert a. frist, Jr.
|
||
Chief Executive Officer |
||
March
30, 2007 |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of HealthStream, Inc. (the “Company”) on Form 10-K for the
year ending December 31, 2006, as filed with the Securities and Exchange Commission on the date
hereof (the “Report”), Susan A. Brownie, Chief Financial Officer of the Company certifies, pursuant
to 18 U.S.C. § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | ||
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Susan A. Brownie
|
||
Susan A. Brownie |
||
Chief Financial Officer |
||
March
30, 2007 |